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Aim and outline of this thesis
Enzymes are macromolecules that are used by all organisms to catalyze reactions 
necessary to sustain life. e vast number of dierent chemical transformations that 
take place within cells has resulted in a plethora of unique, highly specialized enzymes. 
e application of enzymes (puried, as cell free extract or in whole cells) as catalysts for 
chemical synthesis is referred to as biocatalysis. Due to their biodegradability and high 
eciency under mild reaction conditions, enzymes have become a strong alternative 
to traditional metal catalysts for the development of ecient and sustainable chemical 
processes. Especially for transformations that involve the formation of one or more 
asymmetric carbon atoms, enzymes are oen the number one choice catalyst, as the 
enantio- and regioselectivity of enzymes are unparalleled. Despite the highly diverse 
reactions that can be catalyzed by enzymes, most enzymes are optimized towards the 
relatively uniform reaction condition of the cell. As a consequence, it is oen possible 
to nd reaction conditions that ensure eective catalysis of several vastly dierent 
chemical transformations in one pot using enzymes as catalysts. e highly specialized 
nature of enzymes also limits the cross-reactivity towards intermediate products, which 
maximizes the yield of the nal product. is has enabled scientists to combine enzymes 
from various sources and construct articial metabolic networks that can be used for 
the ecient synthesis of important pharmaceuticals. Recent advances in recombinant 
DNA technologies and large scale fermentations have facilitated the sustainable and 
cost-eective production of enzymes. erefore, the application of enzymes in chemical 
synthesis is expected to further increase.
However, the application of enzymes for chemical synthesis has brought new challenges. 
Due to the highly specialized nature of enzymes, it can be dicult to nd a suitable 
biocatalyst for a given desired chemical transformation. In fact, for a number of highly 
important classes of chemical transformations in organic synthesis, no natural enzymes 
have been discovered. is has prompted researchers to investigate the use of enzymes as 
biocatalysts for other reactions than their natural reactions. Indeed, many enzymes show 
a certain degree of promiscuity towards alternative substrates (substrate promiscuity) and 
some enzymes can even catalyze completely dierent reactions (catalytic promiscuity).
The catalytic efficiency of enzymes towards non-natural reactions is typically 
considerably lower compared to their natural reactions, as enzymes have not evolved 
for these reactions. To improve the catalytic eciency of enzymes towards non-natural 
reactions, scientists have applied a protein engineering methodology that is referred 
to as directed evolution. Similar to natural evolution, directed evolution starts with 
BNW_Lieuwe.indd   8 31-08-20   15:17
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the introduction of variation by means of mutations. Mutants that show the desired 
characteristic (improved catalytic eciency towards a non-natural reaction) are selected 
and subjected to a new round of mutagenesis and selection. is iterative process can 
be repeated many times until a mutant enzyme is found that shows a high catalytic 
eciency towards the desired non-natural reaction. Directed evolution is not only 
applied to engineer the catalytic eciency of enzymes, but can be used to engineer any 
characteristic of an enzyme (e.g. solvent tolerance, thermostability, enantioselectivity, 
etc.).
A prime example of a catalytically promiscuous enzyme is 4-oxalocrotonate tautomerase 
(4-OT). is exceptionally small enzyme (only 62 amino acids) naturally catalyzes the 
enol-keto tautomerization of 2-hydroxy-2,4-hexadienedioate to 2-oxo-3-hexenedioate, 
using the amino-terminal proline (Pro-1) as key catalytic base. However, because of the 
unusually low pKa of Pro-1 (pKa ~6.4), it can also act as a nucleophile and react with 
aldehydes to form highly reactive enamine or iminium species (Figure 1). In the eld of 
organocatalysis, iminium or enamine activation by small proline-derived catalysts has 
formed the basis for many dierent asymmetric C-C bond-forming transformations. 
is has inspired Poelarends and coworkers to investigate 4-OT as a potential biocatalyst 
for these reactions. Contrary to organocatalysts that typically only function in organic 
solvents due to their low solubility and relatively high pKa in water, Pro-1 of 4-OT folds 
into a hydrophobic active site which lowers its pKa and allows for catalysis in water. It was 
discovered that 4-OT can catalyze several promiscuous C-C bond-forming reactions, 
including the Michael-type addition of acetaldehyde to nitroalkene acceptors and the 
aldol condensation of acetaldehyde with benzaldehyde. Interestingly, there are no 
enzymes known that can naturally catalyze these reactions. e products of the 4-OT 
catalyzed Michael-type additions and aldol condensations form important chemical 
building blocks with various applications. For instance, the 4-OT catalyzed Michael-type 
addition of acetaldehyde to nitroalkenes yields γ-nitroaldehydes, which are important 
precursors to γ-aminobutyric acid (GABA) analogues, a class of abundantly prescribed 
pharmaceuticals.
Poelarends and coworkers have started directed evolution eorts on 4-OT to identify 
mutants with improved activity towards dierent promiscuous activities. For instance, 
4-OT M45T/F50A was identified as a promising aldolase, showing a 3300-fold 
improvement in catalytic eciency compared to 4-OT wild-type (wt). Similarly, 4-OT 
A33D showed a 3.5-fold increase in ‘Michaelase’ activity. An important goal has been to 
invert the enantioselectivity of the 4-OT catalyzed Michael-type addition of acetaldehyde 
to nitroalkenes, as 4-OT wt is enantioselective towards the pharmaceutically irrelevant 
BNW_Lieuwe.indd   9 31-08-20   15:17
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enantiomer. Important steps have been made, resulting in the identication of a double 
mutant, 4-OT M45Y/F50A, with inverted enantioselectivity compared to 4-OT wt albeit 
its enantioselectivity is not excellent. e aim of the work described in this thesis was to 
use enzyme engineering to further improve 4-OT for enantioselective C-C bond-forming 
reactions and apply the best enzyme variants in new (chemo)enzymatic reaction cascades 
towards the synthesis of important pharmaceuticals.
Figure 1. Aldehyde activation by 4-OT and promiscuous reactions catalyzed by 4-OT. A) 
Aldehydes reacting with 4-OT forming electrophilic iminium or nucleophilic enamine species. 
B) Michael-type addition and aldol condensation reactions catalyzed by 4-OT.
e success of directed evolution largely depends on the strategy applied to introduce 
mutations in a target enzyme and the method used for selection of improved enzyme 
variants. In chapter 1, we review an emerging enzyme engineering technique referred to 
as mutability-landscape-guided enzyme engineering. e principal behind this technique 
is to map the eect (detrimental, neutral and benecial) of all, or nearly all, single 
mutations of an enzyme on a desired characteristic. is information can consequently 
be used to design smart libraries to eciently engineer an improved enzyme.
In chapter 2, we describe our engineering eorts to further improve the enantioselectivity 
of 4-OT for the Michael-type addition of acetaldehyde to nitroalkene acceptors. 
e previously engineered 4-OT M45Y/F50A was used as a starting point. We show 
BNW_Lieuwe.indd   10 31-08-20   15:17
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that the enantioselectivity of 4-OT M45Y/F50A can be improved by performing the 
reaction in the presence of small diols, such as ethylene glycol and 1,3-propanediol, 
as co-solvents. Further structure-guided enzyme engineering aorded two triple 
mutants, 4-OT L8F/M45Y/F50A and 4-OT L8Y/M45Y/F50A, with improved activity 
and near perfect enantioselectivity. Comparison of a crystal structure of 4-OT L8Y/
M45Y/F50A with a crystal structure of 4-OT M45Y/F50A in complex with nitrostyrene 
revealed that the volume of the binding pocket of 4-OT L8Y/M45Y/F50A is reduced. 
is is likely to restrict the rotational freedom of the substrate, which could explain the 
high enantioselectivity of this mutant. We show that this articial ‘Michaelase’ can be 
combined with a natural aldehyde dehydrogenase and a chemocatalyst (nickel boride) 
to synthesize a range of GABA-analogues in one pot in high overall yields (up to 70%) 
and with excellent enantiopurity (e.r. up to 99:1).
In chapter 3, we report mutability-landscape-guided enzyme engineering to improve 
4-OT for catalysis in elevated ethanol concentrations. We identied two “hot-spot” 
positions in the enzyme that contribute to ethanol tolerance, Ser-30 and Ala-33. Mutating 
“hot-spot” position Ala-33 in the context of the highly enantioselective, but ethanol-
sensitive, mutant 4-OT L8F/M45Y/F50A aorded several highly solvent-stable mutants, 
that allow enantioselective catalysis in the presence of up to 40% v/v ethanol.
In chapter 4, we describe the engineering of 4-OT for a complementary enzymatic 
route towards γ-nitroaldehydes, via the Michael-type addition of nitromethane to 
cinnamaldehyde. e key catalytic step in this reaction is the iminium-activation of 
cinnamaldehyde by Pro-1 of 4-OT. We show that iminium activation of a mimic of 
cinnamaldehyde, 2-hydroxycinnamaldehyde, by Pro-1 of 4-OT results in the formation 
of a brightly colored species resembling a merocyanine dye. is iminium-activated 
colorimetric “turn-on” probe can be used as a pre-screening tool, as many inactive 
mutants do not form this brightly colored species. We developed a facile solid-phase pre-
screening assay, termed as Activated Iminium Colony Staining (AICS), which reduced 
the screening burden up to 20-fold. Aer 2 rounds of directed evolution we identied 
two new mutants, 4-OT A33E/M45I/F50A and 4-OT S37E/M45I/F50A, with up to 39-
fold increase in activity compared to the parental enzyme 4-OT F50A.
e highly reactive and toxic nature of acetaldehyde requires intricate handling, which 
can impede its usage in practical synthesis. In chapter 5, we describe our eorts to 
develop three enzymatic routes for in situ synthesis of acetaldehyde from a less toxic 
and less reactive precursor such as trans-3-chloroacrylic acid, ethanol or pyruvate. Two 
routes, using either trans-3-chloroacrylic acid or ethanol as starting substrate, aorded 
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eective concentrations of acetaldehyde and could be applied with 4-OT in one-pot 
cascade reactions to prepare pharmaceutical building blocks.
In chapter 6, we describe a study on the promiscuous aldolase activity of 4-OT. Earlier, 
a 4-OT mutant (4-OT M45T/F50A) with strongly enhanced aldolase activity for the 
condensation of acetaldehyde with benzaldehyde was identied. We show that this 
mutant can accept a wide range of aldehyde acceptors. Moreover, we identied four 
dierent aldehyde acceptors that undergo aldol coupling with acetaldehyde without 
noticeable dehydration of the resultant aldol products, resulting in the accumulation 
of chiral β-hydroxyaldehydes in the reaction mixtures. Aer reduction by NaBH4, the 
corresponding 1,3-diols could be isolated in good yield and with excellent enantiopurity. 
Finally, we have screened a collection of 4-OT homologues and identied a synthetically 
useful carboligase, TAUT015, that was successfully applied as biocatalyst to expand the 
scope of accessible chiral 1,3-diols.
In chapter 7, we summarize the work described in this thesis and provide some future 
perspectives. An overview of the (chemo)enzymatic reactions reported in this thesis is 
presented in Figure 2.
Figure 2. Overview of the (chemo)enzymatic reactions described in this thesis. Abbreviations: CaaD: chlo-
roacrylic acid dehalogenase, MSAD: malonate semialdehyde decarboxylase, ScADH: alcohol dehydrogenase, 
ZmPDC: pyruvate decarboxylase, TAUT015: 4-OT homologue, PRO-ALDH(003): aldehyde dehydrogenase.
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New Trends in Enzyme Engineering: 
e Generation and Exploitation of Protein 
Mutability Landscapes for Enzyme engineering
Jan-Ytzen van der Meer,[a] Lieuwe Biewenga[a] and Gerrit J. Poelarends*,[a]
[a]Mr. J.-Y. Van der Meer, Mr. L. Biewenga, Prof. Dr. G.J. Poelarends
aDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, 
University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, e Netherlands.
*Corresponding author. Tel.: +31503633354; E-mail: g.j.poelarends@rug.nl; 
Web: http://www.rug.nl/sta/g.j.poelarends/
Published in ChemBioChem 10.1002/cbic.201600382




 e increasing number of enzyme applications in chemical synthesis calls for new 
engineering methods to develop the biocatalysts of the future. An interesting concept 
in enzyme engineering is the generation of large-scale mutational data to chart protein 
mutability landscapes.  ese landscapes allow the important discrimination between 
bene cial mutations and those that are neutral or detrimental, providing detailed insight 
into sequence-function relationships. As such, mutability landscapes are a powerful 
tool to identify functional hotspots at any place in the amino acid sequence of an 
enzyme.  ese hotspots can be used as targets for combinatorial mutagenesis to yield 
superior enzymes with improved catalytic properties, stability or even new enzymatic 
activities.  e generation of mutability landscapes for multiple properties of one enzyme 
provides the exciting opportunity to select mutations that are bene cial for either one 
or several of these properties.  is review presents an overview of the recent advances 
in the construction of mutability landscapes and discusses their importance for enzyme 
engineering.
Keywords: Mutability landscapes; Enzyme engineering; biocatalysis, mutations, hotspots
BNW_Lieuwe.indd   16 31-08-20   15:17
17
Exploitation of Protein Mutability Landscapes for Enzyme Engineering
1.  Advantages of enzyme catalysis
Application of enzymes as catalysts in the production of chemicals has the potential 
of being a sustainable and ecient alternative to traditional catalysts used in organic 
synthesis. Enzymes are nature’s catalysts and therefore generally function under mild 
reaction conditions (i.e., ambient temperatures in aqueous solvent systems). Furthermore, 
enzymes are biodegradable, non-toxic, readily available, and their production is not 
dependent on any rare elements. ese features underline the sustainable potential of 
using enzymes as catalysts. Another important feature of enzymes is their excellent 
catalytic properties which can make them highly ecient catalysts. Enzymes are 
known for their high catalytic rates and excellent regio-, chemo- or stereoselectivity. 
Enantioselectivity is still a major challenge in traditional catalysis and is highly desirable 
for the production of pharmaceuticals. Finally, enzymes can be optimized for their 
application in industrial biocatalysis by means of protein engineering. Owing to these 
advantages, the number of applications for enzyme catalysts in the production of valuable 
chemicals, especially pharmaceuticals and agrochemicals, is increasing.[1-3]
2. Why is enzyme engineering required?
Typical goals of engineering projects in the eld of biocatalysis can be divided into 
three topics. e rst topic has a focus on the catalytic properties of enzymes and 
includes engineering projects which aim to improve catalytic activity, alter substrate 
scope or improve (enantio-)selectivity. As a result of engineering projects in this 
theme, there are now many examples of enzymes which carry out industrially relevant 
transformations, with practical turnover rates.[1-3] e second topic covers enzyme 
engineering projects which aim to improve enzyme stability. Enzymes can be unstable 
under process conditions, which may include high temperatures, extreme pH values, 
high substrate (and product) concentrations and/or the presence of organic solvents. 
Major improvements in enzyme stability can be achieved using enzyme engineering.[4] 
Alternatively, solvent engineering or enzyme immobilization can be used to address these 
stability issues. ese methods have recently been reviewed elsewhere.[4-7] e third topic 
in enzyme engineering is the generation of enzymes which catalyze unnatural chemical 
transformations. Creating enzymes with new enzymatic activities is currently one of 
the frontiers in biocatalysis and there are two main approaches to achieve this. Firstly, 
the de novo computational design of enzymes, which involves the computational design 
of an active site and placing it in a suitable protein scaold.[8-10] Enzyme engineering is 
required to improve the activity of the initial de novo designed protein to a practical 
1
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level. e second approach to create enzymes with new activities is to exploit the catalytic 
promiscuity of existing enzymes. Promiscuous activities are enzymatic activities other 
than the activity for which an enzyme has evolved and that are not part of the organism’s 
physiology.[11] It has been long recognized that promiscuous activities can serve as a 
starting point for natural evolution of new enzymatic functions.[12, 13] Using nature’s 
approach, enzyme engineering can be applied to improve promiscuous activities for the 
generation of novel biocatalysts for unnatural chemical transformations.[14]
3. Hotspot identication for enzyme engineering
Enzyme engineering can be viewed as an iterative procedure which starts with generating 
diversity in the wild-type (WT) enzyme and screening a collection of mutants for the 
desired properties. To eciently engineer enzymes, researchers try to identify hotspot 
positions in an enzyme where mutations are likely to be benecial.[15] Targeting these sites 
for combinatorial mutagenesis leads to relatively small libraries with a high percentage 
of positive hits. e identication of these hotspots requires extensive knowledge on 
the sequence-function relationships of an enzyme and the main ways to obtain this 
information is by analyzing the (crystal) structure of the enzyme, multi-sequence 
alignments (MSAs) of homologues proteins or empirical mutational data.
Hotspot identication based on the structure of an enzyme is the most commonly used 
method in enzyme engineering. Damborski and co-workers recently published an 
extensive review on in silico hotspot identication methods which are available as web 
tools.[16] e majority of these tools are structure-based and therefore require a crystal 
structure of the enzyme. e computational tools then identify hotspot positions, based 
on predicted protein-ligand interactions, binding pockets or residues present in access 
tunnels of enzymes with a buried active site. Computational tools for the identication 
of hotspots to improve enzyme stability are mainly based on crystallographic B-factors, 
although computational protein design and consensus methods are gaining momentum 
in this area.[4,16,17] Besides these in silico approaches, several experimental, semi-rational, 
structure-based enzyme engineering methods have been developed, which apply targeted 
site-saturation mutagenesis on active site residues. ese methods include the highly 
successful CASTing method and derivatives thereof.[3,18,19]
Homology-based hotspot identication tools require a MSA of homologues proteins 
to identify the evolutionary conservation of specic amino acid residues in a protein. 
High conservation scores suggest that a specic residue is important for the structure 
BNW_Lieuwe.indd   18 31-08-20   15:17
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or function of the protein, whereas low conservation suggests that this residue may be 
mutated without the loss of function. Targeting positions with mutational robustness, 
therefore, increases the chance of obtaining viable mutant enzymes and thereby increases 
the quality of the library.[16]
e third basis on which hotspot identication can be conducted is empirical data. 
is data can be generated by screening libraries which were created using random 
mutagenesis methods such as error prone PCR. e hotspots identied in these libraries 
can be targeted by combinatorial site-saturation mutagenesis.[20] e main advantage of 
this approach is that it does not require extensive prior knowledge of the target enzyme.
Obviously, there are tools available which combine information from all three sources. A 
successful example of this is the PROSAR method. Here, a collection of enzyme variants 
which carry multiple mutations per sequence are generated and empirically tested for 
the desired activity. e initial pool of enzyme variants covers mutations which are 
selected based on a combination of structural information, analysis of MSAs and random 
mutagenesis.[21] By statistical analysis of the screening results, the PROSAR soware tool 
then evaluates the contribution of each individual mutation in each enzyme variant with 
multiple mutations. e identied residue positions with benecial mutations are used 
for the subsequent rounds of diversication and screening. is cycle is repeated until 
the engineering goal is met.
4. Protein mutability landscapes
An interesting concept in enzyme engineering is the generation and use of mutability 
landscapes. For this type of analysis, a large number of protein variants are analyzed to 
determine the eect of each single amino acid substitution on enzyme activity, selectivity 
or stability, providing detailed maps of benecial, neutral and detrimental amino acids 
for each residue position and each enzyme property. e generation of mutability 
landscapes for multiple properties of one enzyme provides dierent landscapes, with 
the exciting opportunity to select mutations that are benecial for either one or several 
of these properties and neutral or detrimental for others. us, in contrast to other 
systematic mutagenesis approaches such as gene site-saturation mutagenesis (GSSM), 
mutability landscapes do not only provide information on benecial mutations but also 
on detrimental and neutral mutations. is gives valuable information on sequence-
function relationships by revealing regions in the enzyme with mutational robustness 
as well as functionally important residues and hotspot positions.
1
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e term ‘mutability landscape’ was rst used by Rost and co-workers, who developed 
the screening for non-acceptable polymorphisms (SNAP) algorithm to predict the eect 
of single amino acid substitutions in disease related proteins.[22] e predictions of this 
SNAP algorithm are based on information from both a MSA and structural features 
of the protein of interest.[23] Alternatively, the sorting intolerant from tolerant (SIFT) 
algorithm can be used to make similar predictions based on residue conservation.[24] 
Both methods predict whether an amino-acid substitution will be neutral or lead to a 
functional eect but do not distinguish between detrimental or benecial eects. is 
is sucient when merely looking at pathogenicity because both gain-of-function and 
loss-of-function-mutations can lead to disease. However, it is of limited use when this 
mutability landscape is generated for enzyme engineering purposes.
Hecht et al. argue that the lack of comprehensive experimental mutagenesis data 
seems a crucial problem for the development of better computational tools and that 
the generation of such experimental data is constrained by the amount of required 
resources.[22] Indeed, available data from experimental protein mutability landscapes is 
scarce and the majority of these available studies cover protein-protein interactions or 
protein-DNA interactions.[25-27] In the last few years, however, there have been several 
reports on experimental mutability landscapes of enzymes. Here we present an overview 
of the recent advances in experimental mutability landscapes of enzymes to illustrate 
how these mutability landscapes were generated and used to gain insight in sequence-
function relationships or exploited for enzyme engineering.
5. Generating mutability landscapes using a dened collection of 
single mutants
ere are two approaches for generating experimental protein mutability landscapes. 
e rst approach involves the characterization of a dened collection of single mutants 
and the second approach is called deep mutational scanning (Fig. 1). To construct 
a dened collection of mutant enzymes, which covers (nearly) all possible single 
amino acid substitutions of an enzyme, requires signicant eort and resources, but 
the characterization of the mutants can be relatively easy as it does not require any 
oversampling. erefore, the screening methods are not limited to a high-throughput 
assay, giving more exibility in the design of the assays and providing access to a broader 
range of analyses (e.g. HPLC, UV-spectroscopy). e following examples of mutability 
landscapes were generated using this approach.
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 Figure 1. General methods for generating mutability landscapes.
5.1. Protease activity and stability
e usage of ‘site evaluation libraries’ described in a patent of Estell and Aehle was 
basically the rst example where a mutability landscape of an enzyme was generated 
and applied in enzyme engineering.[28] e inventors used a dened collection of single 
mutants of a serine protease from Cellulomonas strain 69B4 (ASP), which covered at 
least 12 variants on each of its 189 residue positions. All members of this collection were 
screened for protease activity on three substrates (keratin, casein and succinyl-alanine-
alanine-proline-phenylalanine-p-nitroanilide), for thermostability and for stability in 
the presence of 0.06% dodecylbenzenesulfonate (LAS). e performance of each mutant 
was scored as the apparent change of free energy in the process of interest, relative to WT 
ASP (ΔΔGapp). is value was calculated using the following formula: ΔΔGapp = -RTln(Pvar/
Pwt), where Pvar is the performance value of the variant and Pwt is the performance value 
of WT ASP. erefore, negative ΔΔGapp values indicate improved performance of the 
1
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variant, relative to WT ASP. e majority (84% - 94%) of the 2851 analyzed single mutants 
performed worse compared to WT ASP based on activity or stability. Interestingly, 
5-10% of the positions in ASP contained mutations that were deleterious for all analyzed 
properties. As the residues at these positions were also highly conserved among 20 non-
redundant homologs of ASP, the authors concluded that these residues are required for the 
structural fold of the enzyme. Another remarkable nding was that most mutations which 
led to improved protease activity, where on positions located outside of the enzyme’s 
active site. For example, the closest residue position at which mutations led to improved 
protease activity on keratin (Arg-14) was 13 Å away from the catalytic Ser-137. erefore, 
targeted saturation mutagenesis on active site residues would most likely not have led to 
the identication of improved mutants for this reaction.
One unique advantage of this mutability landscape analysis is that it provides information 
on mutations which lead to the simultaneous improvement of multiple properties. 
For example, four positions were identied at which mutations led to both improved 
protease activity towards keratin and improved stability in the presence of LAS. ese 
four positions were simultaneously randomized and the quality of the resulting library 
was determined based on the performance of 64 randomly picked mutants in both 
the activity and the LAS stability assay. e average observed performance of these 
mutants exceeded the expected average performance of the library members, which was 
calculated based on the assumption of additive eects of single mutations at the four 
sites. is indicated that information from the mutability landscape of an enzyme can 
provide valuable guidance for enzyme engineering.
5.2.  Mutability landscapes for improved detergent stability
e large α/β-hydrolase fold superfamily includes a broad range of synthetically useful 
enzymes.[29] Fulton et al. generated complete mutability landscapes of Bacillus subtilus 
lipase A (BSLA), which is an α/β-hydrolase fold superfamily member, for stability in the 
presence of dierent detergents.[30] erefore, the authors constructed a dened collection 
of single mutants, covering each amino acid substitution at each residue position of 
BSLA. is collection was constructed by performing site-saturation mutagenesis at 
each of the 181 residue positions in BSLA. e resulting 181 libraries were subsequently 
used to transform E. coli cells. From each library, plasmid DNA was isolated from 102 
randomly picked colonies and sequenced to determine whether all 19 possible single 
mutants per residue position were present. Missing single mutants were separately 
constructed to ensure that the collection of mutants covered all possible 3439 single 
mutants of BSLA. Subsequently, the residual activity of each mutant was assessed aer 
incubation with varying concentrations of four detergents with dierent physicochemical 
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properties (i.e. cationic, anionic, zwitterionic and non-ionic). e enzymatic activity of 
the BSLA mutants was measured using the screening substrate p-nitrophenyl butyrate 
(1), which aer enzymatic hydrolysis yields p -nitrophenol (2) which can be detected 
using UV spectroscopy (Scheme 1a). By plotting the dierences in residual activity of 
each mutant relative to WT BSLA, the authors could identify residue positions at which 
mutations led to increased tolerance or increased sensitivity towards detergents. By 
comparing this data to the crystallographic B-factors of BSLA, the authors observed 
that only two of the ve regions in BSLA with high B-factors contained SDS tolerant 
variants, suggesting that B-factors are not a good predictor for hotspot positions which 
can be targeted to enhance detergent stability. Additionally, the authors observed that 
84% of the hotspots for detergent tolerance were located on surface-exposed sites and 
that mainly substitutions to aromatic or charged residues, along with cysteine, improved 
detergent tolerance. is prompted the authors to suggest an optimized mutagenesis 
strategy using degenerate codons to introduce only those amino acids at solvent exposed 
sides, for eciently improving the stability of other (BSLA) α/β-hydrolase fold enzymes.
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Scheme 1. Screening reactions used to generate mutability landscapes for enzymatic activity. a, 
e BSLA catalyzed hydrolysis of p-nitrophenyl butyrate (1) yielding p -nitrophenol (2) and butyric 
acid (3). b, e 4-OT catalyzed Michael-type addition of butanal (4) to trans-β-nitrostyrene (5), 
yielding chiral γ-nitroaldehyde 6. c, e Bgl3 glycoside-bond cleavage of uorescein di-(β-D-glu-
copyranoside) (7), yielding uorescein (8) and β-D-glucopyranoside (9).
1
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5.3.  New catalytic functions and enantioselectivity
Poelarends and co-workers recently reported the use of mutability landscapes of the 
promiscuous enzyme 4-oxalocrotonate tautomerase (4-OT) to guide the engineering 
of novel biocatalysts for Michael-type additions.[31] e enzyme 4-OT is extremely 
promiscuous and its small monomer size of only 62 residues makes it an ideal template 
for mutability-landscape guided enzyme engineering.[32] One of 4-OT’s promiscuous 
activities is the Michael-type addition of unmodied aldehydes to nitroalkenes yielding 
chiral γ-nitroaldehydes, which are valuable precursors for γ-aminobutyric acid (GABA)-
based pharmaceuticals.[33-35] To generate the mutability landscapes, a dened collection 
of 4-OT genes was constructed which encoded at least 15 of the 19 possible variants at 
each residue position. Each member of this collection was individually characterized 
for the level of soluble protein expression, tautomerase and ‘Michaelase’ activities, and 
enantioselectivity. e level of soluble protein expression was determined for each 
mutant by using quantitative densitometry on SDS gels. Aer the 4-OT concentrations 
in the cell free extracts were quantied, the cell-free extracts were used in the activity and 
enantioselectivity assessments. All the activities were related to the amount of soluble 
4-OT enzyme, yielding the specic activities of each mutant. An overview of the eect of 
each single mutant on both the tautomerase and ‘Michaelase’ activity (Fig. 2a) provides 
insight in the number of neutral amino acid substitutions, essential residues for one or 
both activities, and benecial mutations. e positions where mutations lead to improved 
‘Michaelase’ activity (His-6, Ala-33, Met-45 and Phe-50) were simultaneously varied in a 
focused library, which covered only those amino acid substitutions at each position that 
improved activity. is led to the identication of a triple mutant (H6M/A33E/F50V), 
which had an ~15-fold improvement in ‘Michaelase’ activity.
To screen for enantioselectivity, the authors assayed the enzymatic Michael-type addition 
of butanal (4) to trans-β-nitrostyrene (5) (Scheme 1b). Aer following the progress of the 
reaction with UV-spectroscopy, the reaction mixtures were cleared by ultraltration and 
directly injected on a RP-HPLC system with a chiral stationary phase. Each single mutant 
was individually analyzed in this way, which allowed for the determination of both the 
‘Michaelase’ activity and the enantiomeric ratio of the enzymatically produced 2-ethyl-
3-phenyl-4-nitrobutanal (6) (Scheme 1b). When the activity data is plotted versus the 
enantioselectivity data (Fig. 2b) it becomes apparent that single amino acid substitutions 
can have signicant eects on improving, inverting or losing the enantioselectivity. In the 
case of 4-OT, an inversion in enantioselectivity was required to produce precursors for 
the biologically most active enantiomer of the GABA-analogues. erefore, the authors 
made combinations of the single mutants which had the most pronounced inversion 
in enantioselectivity (H6I, M45Y and F50A) leading to the identication of 4-OT 
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M45Y/F50A which produced the 2S3R-enantiomer of 2-ethyl-3-phenyl-4-nitrobutanal 
(6) with a e.r. of 96:4. is double mutant also had inverted enantioselectivity in the 
acetaldehyde addition to various nitroalkenes compared to WT 4-OT, producing the 
pharmaceutically relevant enantiomers of GABA precursors in enantiomeric ratios up 
to 97:3. e Michaelase activity of M45Y/F50A was also improved relative to WT 4-OT, 
which was not surprising because the mutability landscape already indicated that single 
mutations at these positions led to improved activity (Fig. 2b). Structural analysis of the 
M45Y/F50A mutant revealed the opening of a hydrophobic pocket in the active site of 
4-OT which could accommodate the phenyl group of trans-β-nitrostyrene (5). It seems 
likely that this new binding pocket is related to the inverted enantioselectivity of M45Y/
F50A. e simultaneous improvement in activity and enantioselectivity underlines the 
usefulness of mutability landscapes in enzyme engineering.
Figure 2. Mutability landscape data derived from van der Meer et al.[31] A), mutational eects 
on 4-OT’s tautomerase activity, plotted versus the mutational eects on 4-OT’s promiscuous 
Michael-type addition activity. B), mutational eects on 4-OT’s enantioselectivity in the Mi-
chael-type addition reaction, plotted versus the mutational eects on 4-OT’s activity in the Mi-
chael-type addition reaction.
6. Generating mutability landscapes using deep mutational scanning
As mentioned above, it requires signicant eort and resources to generate a dened 
gene collection encoding all single mutants of an enzyme. is bottleneck can be 
circumvented by using deep mutational scanning. For this, diversity in the WT enzyme 
is created followed by high-throughput sorting of active mutants from inactive mutants 
1
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(e.g. by ow cytometry, microuidics, phage display or growth selection). is allows 
for the enrichment of active mutants. Conducting next-generation sequencing enables 
the comparison of the DNA read counts in the sorted library relative to the unsorted (or 
pre-selected) library (Fig. 1).[36,37] Using this approach, the enrichment factor (E-factor, 
which is given by the ratio of the DNA read counts of a specic variant in the sorted to 
the unsorted library) of each mutant can be determined and compared to the E-factor 
of the WT enzyme. A mutability landscape can be generated based on these E-factors, 
which maps the benecial, neutral and detrimental eects of (nearly) all single amino 
acid substitutions of an enzyme. However, to obtain full coverage a large oversampling is 
required, demanding high throughputs for both the functional sorting and sequencing. 
Several examples of mutability landscapes using deep mutational scanning to investigate 
protein-DNA or protein-protein interactions can be found in the literature. [25-27,36,37] 
Recently, the rst studies on the generation of mutability landscapes of enzymes by using 
deep mutational scanning have been published, which are discussed below.
6.1. Mutability landscape generation using microuidics
β-glucosidases are enzymes which cleave β-d-glucosidic bonds by hydrolysis, which can 
be an important step in the conversion of biomass into fermentable sugars.[38] Romero 
et al. have generated mutability landscapes of a β-glucosidase from Streptomyces sp. 
(Bgl3) using a deep mutational scanning approach in combination with a micro-uidic 
based sorting system.[39] For this, they generated a random mutant library of Bgl3 using 
error-prone PCR with an average of 3.8 mutations per Bgl3 gene. is library was rst 
analyzed using high-throughput sequencing to establish the DNA read counts in the 
unsorted library. Aer expressing this library in E. coli BL21(DE3), single E. coli cells 
were encapsulated in a micro droplet containing lysing agents and uorescein di-(β-
D-glucopyranoside) (7), which is a uorogenic substrate for Bgl3 (Scheme 1c). Micro 
droplets containing an active Bgl3 variant were sorted based on uorescence, using a 
microuidic device. is way the authors achieved a throughput of 100 s-1. DNA was 
retrieved from the sorted micro droplets and sequenced using Illumina sequencing. Aer 
analyzing 107 variants, the eects of the mutations were determined based on changes 
in the frequency of occurrence of each mutation before and aer the functional sorting. 
Because of the disadvantage of working with an error-prone library, mainly those amino-
acid substitutions which require one nucleotide mutation per codon were accessed in this 
study. erefore, only 31% of all possible single amino acid substitutions were analyzed. 
Nevertheless, the generated mutability landscape gave important insights in sequence-
function relationships of the enzyme. For example, two essential residues (Lys-461 and 
Asn-307), which are located outside of the enzyme’s active site, were identied in this 
study. Crystal structure analysis of Bgl3 revealed that Lys-461 is part of a network of salt 
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bridges, which suggests that this residue plays a role in structural stability of the enzyme. 
Asn-307 is in hydrogen bonding distance with Glu-178, which is the catalytic acid/base in 
Bgl3 (Scheme 2). It was therefore suggested that Asn-307 induced a crucial shi in the pKa 
of this catalytic residue. Single mutations that improve the thermostability of Bgl3 have 
been identied in a slightly modied microuidic screening protocol, which included a 
heat challenge (65°C for 10 min). Again, 107 enzyme variants were analyzed, revealing 
several single mutants with improved thermostability including mutant S325C. Further 
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Scheme 2. General mechanism of glucosidic-bond cleavage by Bgl3. Mechanism is derived from 
Zechel et al.[40]
6.2.  Mutability landscape generation using growth selection
Aminoglycoside-3’-phosphotransferase II (APH(3’)II) is a kinase involved in antibiotic 
resistance that catalyzes the phosphorylation of aminoglycoside antibiotics leading to 
their inactivation. Melnikov et al. performed a single-substitution mutational scan on 
APH(3’)II by analyzing the eect of these mutations on the enzyme’s activity and substrate 
specicity, using kanamycin and ve other aminoglycoside antibiotics.[41] For this, the 
genes coding for each single mutant were individually prepared using a microarray-
based DNA synthesis (MITE) approach. All synthesized genes were pooled in equimolar 
amounts and used to transform E. coli cells. ese cells were cultured in liquid medium 
in the presence of aminoglycoside antibiotics, thereby selecting for cells which express an 
active APH(3’)II mutant. Aer this selection, DNA was isolated from the surviving cells 
and sequenced using an Illumina sequencing approach to determine the frequency of 
occurrence of each mutant. By determining the dierence in abundance of each mutant 
before and aer selection, the authors could map the eect of all single amino acid 
substitutions on activity on six aminoglycoside antibiotics. Based on these maps, amino 
acid substitutions were identied which led to a shi in substrate specicity either towards 
kanamycin or towards one of the ve other tested aminoglycoside antibiotics. By making 
combinations of these specic amino acid substitutions, the authors engineered ve pairs 
of APH(3’)IIs which either favor or disfavor any of the tested antibiotics over kanamycin. 
1
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For example, Paro+ and Paro- is a pair of APH(3’)IIs, engineered to either favor or disfavor 
paromomycin over kanamycin. Paro+ showed unaltered activity for paromomycin 
(MIC= 2000-4000 µg/ml) relative to WT APH(3’)II but a decreased activity for kanamycin 
(MIC 31.3 µg/ml). Paro- had a decreased activity for paromomycin (MIC= 62.5 µg/ml) 
relative to WT APH(3’)II but unaltered activity towards kanamycin (MIC= 2000 µg/
ml) relative to WT APH(3’)II. is remarkable shi in substrate specicity underlines 
the applicability of mutability landscapes to identify hotspots for enzyme engineering.
6.3.  Mutability landscape generation using phage display
E3-ubiquitin ligases are enzymes which catalyze an ubiquitin transfer from E2-ubiquitin 
conjugating enzymes to lysines of substrate proteins. is ubiquitination promotes 
degradation of the substrate protein, which is a crucial process for homeostasis. Ube4b, 
for example, functions as an E3-ubiquitin ligase, which has been linked to cancer 
pathogenesis as it ubiquitinates the p53 tumor suppressor in vivo.[42] A mutability 
landscape for the activity of the Ube4b enzyme has been generated and analyzed in 
order to identify the molecular determinants that modulate the ligase activity of these 
E3 ligases.[43] A deep-mutational scanning approach was conducted on the U-box 
domain of Ube4b. is is the active domain of the enzyme which can perform an auto-
ubiquitination. Libraries with on average two random nucleotide mutations per gene 
were generated, sequenced and subsequently displayed on bacteriophages. Bacteriophages 
which display active (auto-ubiquitinated) U-box domains were then enriched using 
antibodies against (FLAG)-ubiquitin. Because these antibodies were immobilized on 
agarose beads, unbound bacteriophages could be washed away (Fig. 3). DNA was isolated 
from enriched bacteriophages and subsequently sequenced using Illumina technology. 
By comparing the DNA-read counts of each mutation before and aer the enrichment, an 
E-factor was calculated. In this way, 98,289 unique mutant enzymes were characterized, 
of which 932 single mutants. Mapping the E-factors of these single mutants revealed 
that some regions (e.g. loop 1,2 and helix 1) were less tolerant to mutations than other 
portions of the U-box domain. Interestingly, several single mutants could be identied 
from this mutability landscape with improved activity relative to WT. Combining these 
benecial single mutations had a synergistic eect and resulted in two double mutants 
(M1124V/N1142T and D1139N/N1142T) which each have a 22-fold enhanced ubiquitin 
ligase activity relative to the WT U-box domain. Mechanistic studies on these improved 
single and double mutants revealed that all benecial mutations either enhanced the 
ligase activity by improving binding of the U-box domain to the E2-ubiquitin complex 
or by improving allosteric activation of the E2-ubiquitin complex. is illustrates that 
benecial mutations can be useful both for the generation of superior enzymes and to 
provide useful insight in enzyme mechanisms.
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Figure 3. Enrichment procedure for bacteriophages displaying active (auto-ubiquitinated) U-box 
domains of Ube4b. Bacteriophages displaying inactive Ube4B U-box domains do not bind to 
anti-Flag-ubiquitin beads and are washed away. Only the bacteriophages which display active au-
to-ubiquitinated Ube4B U-box domains bind to the anti-Flag-ubiquitin beads and are sequenced.[43]
7. Summary and Outlook
Currently, most studies on enzyme mutability landscapes have focused on small enzymes 
(Table 1), which is related to the required costs and eort to generate a mutability 
landscape. When using a dened collection of single mutants, the bottleneck lays in the 
generation of this dened mutant gene collection. Currently, PCR-based site-directed 
mutagenesis techniques are mostly used for the generation of the mutants. Other more 
recently developed mutagenesis techniques include chemo-enzymatic methods (e.g. 
SeSaM),[44] micro-array based DNA synthesis (e.g. MIRE)[41] or nonsense suppressor 
t-RNA methods.[25] e development of these methods might reduce the required 
amount of eort and costs to generate a dened collection of single mutants. Moreover, 
because of the ever decreasing costs of commercially available synthetic DNA, the most 
economical way to obtain a dened collection of single mutants of an enzyme might be 
DNA synthesis.[45] In the case of deep-mutational scanning the bottleneck for generating 
mutability landscapes lays in the high-throughput sequencing and high-throughput 
screening. Both these techniques are rapidly evolving [36,37,46] which might facilitate the 
generation of mutability landscapes using deep mutational scanning.
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Protease X A, S, SS X 189 [28]
Lipase X A, S 181 [30]
Tautomerase / 
‘Michaelase’
X A, E, ES, SS X 62 [31]
Glucosidase X A, S 500 [39]
Kinase X A, SS X 263 [41]
Ligase X A X 102c [43]
a S, stability; A, activity; E, expression; ES, enantioselectivity; SS, substrate specicity. b e box 
is checked when combinatorial mutagenesis was conducted on hotspots which were identied in 
the mutability landscape. c Only the U-box domain of Ube4b was analyzed.
In conclusion, mutability landscapes are a powerful tool to identify “hotspots” at any 
place in the amino acid sequence of an enzyme. ese “hotspots” can be used as targets 
for combinatorial mutagenesis to yield superior enzymes with improved catalytic 
properties, stability or even new enzymatic activities. e generation of mutability 
landscapes for several properties of one enzyme (for example, stability and activity or 
activity and enantioselectivity) provides the unique opportunity to select mutations, 
which are benecial for either one or both these properties. Furthermore, mutability 
landscapes can be used to advance our understanding of sequence-function relationships 
in enzymes since they provide systematic information on neutral, benecial and 
detrimental amino acid substitutions. Both detrimental and benecial mutations can 
be extremely helpful to elucidate enzyme mechanisms. Neutral mutations are thought 
to have an important role in natural enzyme evolution, because they may result in 
‘neutral dri’.[47,48] Owing to these advantages, combined with the technical advances 
in high-throughput screening and DNA sequencing, we expect that mutability landscape 
analysis will become accessible for larger enzymes, and more commonly used for enzyme 
engineering in the coming years.
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Chiral γ-aminobutyric acid (GABA) analogues represent abundantly prescribed drugs, 
which are broadly applied as anticonvulsants, antidepressants and for the treatment 
of neuropathic pain. Here we report a one-pot two-step biocatalytic cascade route for 
synthesis of the pharmaceutically relevant enantiomers of γ-nitrobutyric acids, starting 
from simple precursors (acetaldehyde and nitroalkenes), using a tailor-made highly 
enantioselective articial ‘Michaelase’ (4-oxalocrotonate tautomerase mutant L8Y/
M45Y/F50A), an aldehyde dehydrogenase with a broad non-natural substrate scope, 
and a cofactor recycling system. We also report a three-step chemoenzymatic cascade 
route for the ecient chemical reduction of enzymatically prepared γ-nitrobutyric acids 
into GABA analogues in one pot, achieving high enantiopurity (e.r. up to 99:1) and high 
overall yields (up to 70%). is chemoenzymatic methodology oers a step-economic 
alternative route to important pharmaceutically active GABA analogues, and highlights 
the exciting opportunities available for combining chemocatalysts, natural enzymes, 
and designed articial biocatalysts in multistep syntheses.
Keywords:
Systems biocatalysis, cascades, ‘Michaelase’, γ-aminobutyric acids, γ-nitrobutyric acids, 
enzyme engineering, pharmaceuticals
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Introduction
Analogues of γ-aminobutyric acid (GABA, Figure 1) represent abundantly prescribed 
drugs, which are broadly applied as anticonvulsants, antidepressants and for the 
treatment of neuropathic pain. With an increasing world population and life expectancy, 
the demand for GABA analogues is expected to even further increase. e ecient 
asymmetric synthesis of pharmaceutically active GABA analogues has therefore 
attracted enormous attention. With current synthesis routes oen involving kinetic 
resolutions1-3, there is a need to investigate alternative asymmetric synthesis routes that 
are potentially greener, more sustainable, and more step-economic. In this regard, the 
use of a systems (bio)catalysis approach4-8 in which dierent catalysts are combined to 
construct reaction cascades for ecient synthesis of GABA analogues is an attractive 
idea. is approach aims to minimize the number of reaction steps and improve the 
‘pot-economy’ of the process9.
We envisioned that pharmaceutically active GABA analogues, such as pregabalin, 
phenibut, baclofen and uorophenibut, could be prepared via one-pot three-step 
(chemo)enzymatic cascade reactions, using simple and inexpensive starting materials 
and avoiding (de-)protecting steps and intermediate purications (Figure 1). For 
establishing the required C-C bond stereochemistry, the asymmetric Michael-type 
addition of acetaldehyde (1) to nitroalkenes 2a-d is of high interest. is would give 
convenient access to chiral γ-nitroaldehydes 3a-d, which in two steps (oxidation of 3a-d 
into 4a-d followed by reduction of 4a-d into 5a-d) can be converted into the desired 
GABA analogues.
e asymmetric Michael-type addition of 1 to 2a-d is certainly not trivial. Multiple 
organocatalytic approaches to obtain enantioenriched γ-nitroaldehydes have been 
reported, mainly using small peptide- and proline-based organocatalysts10-13. However, 
examples including acetaldehyde as donor substrate are scarce and a high catalyst 
loading in organic solvent is typically applied. erefore, there is great interest in 
the development of biocatalytic procedures for the enantioselective synthesis of 
γ-nitroaldehydes. However, enzymes that naturally catalyze these required carbon-
carbon bond-forming Michael-type additions are not known to be present in nature. 
In fact, only a few enzymes are known to be able to catalyze any type of C-C bond-
forming Michael-type addition14,15. Interestingly, Hilvert and co-workers published the 
elegant enzymatic synthesis of γ-nitroketones, but not γ-nitroaldehydes, by both acetone 
addition to nitroalkenes and nitroalkane addition to conjugated ketones using a highly 
engineered computationally designed retroaldolase16. We have previously reported 
2
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that 4-oxalocrotonate tautomerase (4-OT) can promiscuously catalyze the addition of 
small aldehydes, most notably the highly reactive acetaldehyde, to various aliphatic and 
aromatic nitroalkenes17-20. Analogous to proline-based organocatalysts, the 4-OT enzyme 
utilizes an N-terminal proline (Pro-1) as key catalytic residue in promiscuous aldol 
condensations21,22 and Michael-type additions19, most likely via enamine catalysis22,23. 
By using mutability-landscape guided enzyme engineering24, a mutant of 4-OT (4-OT 
M45Y/F50A) was generated that showed inverted enantioselectivity in acetaldehyde 
additions to nitroalkenes25, allowing the enzymatic synthesis of the pharmaceutically 
relevant enantiomers of γ-nitroaldehydes 3a-d. However, the enantioselectivity of 4-OT 
M45Y/F50A is too low for biocatalytic application, providing the desired γ-nitroaldehyde 
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Figure 1. Chemoenzymatic cascade synthesis of pharmaceutically active GABA analogues. A) 
Envisioned (chemo)enzymatic cascade synthesis of pharmaceutically active GABA analogues. 
Abbreviations: 4-OT*, newly engineered 4-OT variant that functions as a highly enantioselective 
articial ‘Michaelase’; ALDH, aldehyde dehydrogenase; NR, nitroreductase. B) Structures of 
GABA and its analogues pregabalin, phenibut, baclofen and uorophenibut.
Here, we report the development of a tailor-made articial ‘Michaelase’, which 
exhibits improved enantioselectivity, activity and cosolvent stability compared to the 
parental enzyme 4-OT M45Y/F50A, for additions of 1 to nitroalkenes 2a-d yielding 
γ-nitroaldehydes 3a-d with outstanding enantiopurity. is articial ‘Michaelase’ was 
combined with a natural aldehyde dehydrogenase and a cofactor recycling NADH-
oxidase to give a one-pot two-step reaction cascade for the synthesis of γ-nitrobutyric 
acids 4a-d in high yields and with excellent enantiomeric excess. Finally, the reaction 
cascade was further extended by the inclusion of nickel boride, promoting the conversion 
of enzymatically prepared 4a-d into the desired GABA analogues 5a-d, which resulted in 
a one-pot three-step chemoenzymatic reaction cascade (Figure 1A). Given that all steps 
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were performed under aqueous conditions with high conversions, the desired GABA 
analogues 5a-d were obtained in good isolated yields of up to 70% and with excellent 
enantiomer ratio (e.r.) values of up to 99:1. is new methodology oers a step-economic 
alternative route to important pharmaceutically active GABA analogues, and highlights 
the exciting opportunities available for combining chemocatalysts, natural enzymes, 
and designed articial biocatalysts in multistep syntheses of valuable chemical products.
Experimental Methods
Library Screening
Aer transformation with 4-OT I2X/L8X/M45Y/F50A library DNA, individual E. coli 
BL21(DE3) colonies were used to inoculate 2x 1.25 ml LB supplemented with 100 µg/
ml ampicillin and 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) in 96-deep 
well plates (Greiner Bio-one, 96-well Masterblock). e plates were sealed with sterile 
gas-permeable seals (Greiner Bio-one, BREATHseal) and incubated at 37 °C, overnight 
shaking at 250 rpm. Aer the incubation, the plates were centrifuged (2232 x g, 8 min). 
e supernatant was discarded and the individual pellets were lysed by resuspension in 
350 µl BugBuster (Novagen) supplemented with 25 U/ml benzonase (Novagen). e lysis 
was continued for 20 min at room temperature under vigorous shaking. e lysates were 
cleared by centrifugation (2232 x g, 55 min, 4 °C) aer which the Cell Free Extract (CFE) 
was obtained. e nal reaction mixture for monitoring the addition of 1 to 2a consisted 
of the following: CFE (40% v/v), 150 mM 1, 5 mM 2a, DMSO (5% v/v) in 20 mM sodium 
phosphate buer pH 6.5, 500 µl nal volume. e reactions were performed in 96-deep 
well plates sealed by ultraviolet transparent plate seals (VIEWseal, Greiner Bio-One) 
at room temperature. Aer 50 min the reaction was stopped by extraction with 300 µl 
toluene, which caused the proteins to precipitate. e organic layer was separated from 
the water layer by centrifugation (2232 x g, 20 min). e plates containing the water and 
organic layer were incubated at -80 °C for 30 min to freeze the water layer and hence 
preventing accidental uptake of part of the water layer. An aliquot of 50 µl from the 
organic layer was transferred to a GC vial by a robotic pipetting station. For analysis of 
the amount and enantiopurity of the enzymatic product 3a, 8 µl of the organic layer was 
injected on a gas chromatograph using an Astec CHIRALDEX G-TA column, isocratic 
125 °C (carrier gas He, r1.69 ml/min). Flame ionization detection; retention time S-3a: 
25.6 min, retention time R-3a 26.9 min. e assignment of the absolute conguration 
of product 3a was based on earlier reported data17,25.
2




All semi-preparative scale experiments were based on previously reported reaction 
conditions17,25. Instead of DMSO, ethanol was used as a co-solvent, since the desired 
products 3a-d were obtained at the highest enantiopurity using 4-OT L8Y/M45Y/F50A 
in combination with ethanol as the co-solvent. For the enzymatic synthesis of 3a, the 
reaction mixture consisted of the following: 5.0 mg 2a (3 mM), 6.5 mg 4-OT L8Y/M45Y/
F50A (75 µM, 2.5 mol% compared to 2a), 2.56 ml ethanol (20% v/v) in 20 mM sodium 
phosphate buer pH 6.5 to a nal volume of 12.8 mL. e reaction was performed in 
a 25 ml Erlenmeyer ask sealed with a rubber stopper. e reaction was initiated by 
the addition of 108 µl of 1 (150 mM) and incubated at room temperature. At timely 
intervals a sample was withdrawn from the reaction mixture and the reaction progress 
was monitored by following the depletion in absorbance at 249 nm corresponding to 
the concentration of substrate 2a17. Aer the measurement, the sample was combined 
with the reaction mixture. Aer 50 min the reaction was nished and the reaction 
mixture was extracted 3x with 10 ml toluene. e organic layers were combined, washed 
with brine and dried with anhydrous Na2SO4. e dried organic layer was concentrated 
in vacuo, yielding product 3a without any further purication (4.2 mg, 63% isolated 
yield). e enantiopurity and absolute conguration was determined by GC with a chiral 
stationary phase (see library screening).
For the enzymatic synthesis of 3b-d, the reaction mixture consisted of the following: 
nitroalkene (17.9 mg 2b, 2 mM; 14.3 mg 2c, 1.3 mM; or 20.1 mg 2d, 2 mM), 11.5 mg 
4-OT L8Y/M45Y/F50A (28 µM, 1.4 mol% compared to 2b and 2d, 2.15 mol% compared 
to 2c), ethanol (12 ml, 20% (v/v) for 2b and 2d and 18 ml, 30% (v/v) for 2c) in 20 mM 
sodium phosphate buer pH 6.5 to a nal volume of 60 ml. e reaction was performed 
in a 100 ml Erlenmeyer ask sealed with a rubber stopper. e reaction was initiated 
by the addition of 169 µl 1 (50 mM) and incubated at room temperature. At timely 
intervals a sample was withdrawn from the reaction mixture and the reaction progress 
was monitored by following the depletion in absorbance (λmax of 2b and 2c at 320 nm, 
λmax of 2d at 322 nm). Aer the measurement, the sample was combined with the reaction 
mixture. When the reaction was nished, the reaction mixture was extracted with 3x 40 
ml ethyl acetate. e organic layers were combined, washed with brine and dried with 
anhydrous Na2SO4. e dried organic layer was concentrated in vacuo, yielding 3b-d 
without any further purication (3b 20.1 mg, 87% yield; 3c 17.2 mg, 97% yield; and 3d 
24.0 mg, 94% yield). e aldehyde functionality of 3b and 3c was derivatized to a cyclic 
acetal (see supporting methods). e enantiopurity of 3b-d was determined by reverse 
phase HPLC using a chiralpak AD-RH column (150 mm x 4.6 mm, Daicel) (MeCN/
water 70:30 for 3b, MeCN/water 62:38 for 3c and MeCN/water 30:70 for 3d, 25 °C, 0.5 
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ml/min ow rate). Detection at 220 nm, retention time R-3b: 8.3 min, S-3b 10.8 min; 
R-3c: 29 min, S-3c 37 min; R-3d: 39 min and S-3d 41 min. e absolute conguration 
was determined by literature comparison17.
Two-Step Enzymatic Cascade Synthesis
e reaction mixture contained 2a (22 mg, 3 mM), 4-OT L8Y/M45Y/F50A (5 mol% 
compared to 2a), 5 ml ethanol (10% v/v) in 0.1 M sodium phosphate buer (pH 7.3) to a 
nal volume of 50 mL. e reaction was initiated by the addition of 50 mM of 1 (2.5 mL 
from a freshly prepared 1 M stock solution) and the reaction mixture was incubated at 
room temperature. At timely intervals a sample was withdrawn from the reaction mixture 
and the reaction progress was monitored by following the depletion in absorbance at 
249 nm corresponding to the concentration of substrate 2a17. Aer the measurement the 
sample was combined with the reaction mixture. Aer 20 min, the reaction was nished 
(full conversion of 2a into 3a) and then to this PRO-ALDH(003) (0.5 mg/ml), PRO-
NOX(009) (1 mg/ml) and NAD+ (8 mM) were added. We used this step-wise cascade 
approach because PRO-ALDH(003) also showed activity towards starting substrate 1. 
Favorably, the enzyme showed ~3-fold higher activity towards substrate 3a (at 3 mM) 
than towards 1 (at 50 mM). Using this methodology, complete oxidation of 3a into 4a was 
achieved with the formation of less than 10 mM acetate as by-product from 1. Aer the 
PRO-ALDH(003)-catalyzed oxidation reaction was completed, the reaction was stopped 
by acidifying the reaction mixture to pH 5. e reaction mixture was extracted with 3x 
50 ml ethyl acetate. e organic layers were combined, washed with brine and dried with 
anhydrous Na2SO4. e dried organic layer was concentrated in vacuo and the product 
was puried by silica gel column chromatography (hexane/ethylacetate 4:1) to obtain 
4a (18 mg, 64% yield). e acid functionality of 4a was derivatized to the corresponding 
methyl ester (see supporting methods). e same reaction procedures were followed 
for the synthesis of 4b-4d. e enantiopurity of derivatized 4a was determined by GC 
using a chiral Astec CHIRALDEX G-TA column, 100 °C to 140 °C at a rate of 4 °C/min, 
then 140 °C to 160 °C at a rate of 2 °C/min and nally held at 160 °C. Flame ionization 
detection, retention time R-4a: 16 min; S-3c: 17 min. e enantiopurity of derivatized 
4b-d was analyzed by reverse phase HPLC using a chiral column (Chiralpak-ID, 150 
mm x 4.6 mm, Daicel®) (MeCN/water 30:70, 25 °C, 1 ml/min ow rate). Detection at 
210 nm, retention time R-4b: 22.6 min, S-4b: 24.5 min; R-4c: 19.4 min, S-4c: 24.4 min; 
R-4d: 23.5 min, S-4d: 26.6 min.
ree-Step Chemoenzymatic Cascade Synthesis
e reaction mixture contained nitoalkene (3 mM of 2a and 4 mM of 2b-d), 4-OT L8Y/
M45Y/F50A (28-32 mg; 5 mol% compared to 2a-2d), ethanol (10% v/v) in 0.1 M NaH2PO4 
2
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buer (pH 7.3) to a nal volume of 25 ml. e reaction was initiated by the addition of 50 
mM of 1 (1.25 ml from a freshly prepared 1 M stock solution in 0.1 M NaH2PO4 buer 
pH 7.3) and the reaction mixture was incubated at room temperature. At timely intervals, 
a sample was withdrawn from the reaction mixture and the reaction progress was 
monitored by following the depletion in absorbance corresponding to the concentration 
of nitroalkene (see above). Aer the measurement the sample was combined with the 
reaction mixture. Aer the completion of the reaction, PRO-ALD(003) (0.5 mg/ml), 
PRO-NOX(009) (1 mg/ml) and NAD+ (0.5 mM) were added to the reaction mixture. 
Aer 30 min, the reaction was quenched by acidifying the reaction mixture using 5 
M HCl until the pH dropped to 3. To this mixture, NiCl2.6H2O (40 mM) and NaBH4 
(40 mM) were added at 0 °C, and stirring was continued for 24 h at room temperature. 
e reaction mixture was ltered through a celite pad and the ltrate concentrated 
in vacuo, aer which the resulting concentrated mixture was acidied to pH 3-4. e 
acidied reaction mixture was loaded on a column packed with cation exchange resin 
(5g of Dowex® 50WX8 hydrogen form). Aer washing with deionized water (4 column 
volumes), the product was eluted out with 0.5 - 1 M ammonia solution (4 column 
volumes). e ninhydrin-positive fractions were collected, combined and lyophilized 
to yield the desired products 5a-5d. Products 5a-d were derivatized to diastereomers 
using sodium 2,4-dinitro-5-uorophenyl-L-valine amide (see supporting methods) 
and their enantiopurity was determined using reverse phase HPLC on a C18 column 
(Kinetex 5u EVO C18 100A, 150 mm x 4.6 mm, Phenomenex®) at 25 °C (1 ml/min ow 
rate). e mobile phase was a 60:40 (v/v) mixture of aqueous buer (0.2% triethylamine, 
pH adjusted to 3.5 with dilute orthophosphoric acid) and MeCN. Detection at 340 nm, 
retention time S-5a: 16.1 min, R-5a: 21.4 min; R-5b: 10.9 min, S-5b: 12.1 min; R-5c: 17.2 
min, S-5c: 20.2 min; R-5d: 12.3 min, S-5d: 13.6 min.
Results
Eect of Cosolvents on the Enzymatic Michael-Type Addition Reaction
e previously reported 4-OT mutant M45Y/F50A25 exhibits inverted enantioselectivity 
when compared to wild-type 4-OT, allowing the enzymatic synthesis of the 
pharmaceutically relevant enantiomers of γ-nitroaldehydes 3a-d (Figure 1). However, 
the enantioselectivity of 4-OT M45Y/F50A is too low for biocatalytic application, 
with for instance the production of 3a with an e.r. of 90:10 and 3c with an e.r. of only 
62:3825. To improve the enantioselectivity of the 4-OT M45Y/F50A catalyzed Michael-
type additions, we initially focused our eorts on solvent engineering. Indeed, the 
use of dierent solvent systems has been reported to have a substantial eect on the 
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enantioselectivity of dierent enzyme catalyzed reactions26,27. We selected the 4-OT 
catalyzed addition of 1 to 2a to test the eect of co-solvents on enantioselectivity, 
because the optical purity of product 3a can be straightforwardly analyzed by gas 
chromatography. Although the enzyme was still active at concentrations of up to 
40% (v/v) DMSO, increasing the DMSO concentration had a detrimental eect on the 
enantioselectivity of the 4-OT M45Y/F50A-catalyzed reaction (Figure 2). A similar 
loss of enantioselectivity was observed when short-chain alcohols such as ethanol or 
methanol were used as co-solvent. Notably, ethanol and methanol concentrations of 
>20% (v/v) led to enzyme precipitation, which indicates a destabilizing eect of the 
co-solvent on the biocatalyst. Using aqueous solutions of glyceline and ethaline (deep-
eutectic solvents) led to inactivation of the enzyme at all tested concentrations (10-60%, 
v/v). Diols, however, could be used in high concentrations without observing inactivation 
and with a positive eect on the enantioselectivity (Figure 2). For example, using up to 
60% (v/v) ethylene glycol, 1,3-propanediol or 1,4-butanediol did not aect the enzymatic 
activity and the e.r. of product 3a increased up to 95:5.
Figure 2. Eect of cosolvents on the enantioselectivity of the enzymatic Michael-type addition 
reaction. Enantiopurity of 3a (as the percentage of the S-enantiomer) in the 4-OT M45Y/F50A 
catalyzed addition of 1 to 2a performed in the presence of increasing concentrations of dierent 
cosolvents.
2
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Engineering of a Highly Enantioselective Articial ‘Michaelase’
Although solvent engineering slightly improved the enantioselectivity of the addition 
of 1 to 2a catalyzed by 4-OT M45Y/F50A, at best a product e.r. of 95:5 was achieved. 
erefore, protein engineering was required to further enhance the enantioselectivity 
of this reaction. To guide our engineering eorts, we used the available crystal structure 
of 4-OT M45Y/F50A in complex with nitrostyrene 2b (PDB: 5CLO)25. is structure 
suggests that the substrate may bind in two distinct orientations relative to Pro-1, 
diering by a rotation of ~180 degrees around the longitudinal axis of the substrate 
molecule. One substrate orientation is consistent with the formation of the R enantiomer 
of the product, whereas the other is consistent with formation of the S enantiomer. We 
reasoned that by reducing the rotational freedom of the substrate in the active site and/or 
repositioning of Pro-1 relative to the substrate, the enantioselectivity of M45Y/F50A may 
be improved. erefore, we selected position Leu-8, the side chain of which is involved 
in formation of the binding pocket for the substrate’s R-group (Figure 1), and position 
Ile-2, which is located next to Pro-1, for site-saturation mutagenesis28. Accordingly, a 
focused library was constructed by randomizing positions Ile-2 and Leu-8 using NNK 
degeneracy, yielding library I2X/L8X/M45Y/F50A. As the model reaction for activity and 
enantioselectivity screening, the addition of 1 to 2a was chosen because the quantity and 
optical purity of product 3a can be easily analyzed by gas chromatography. We reasoned 
that if mutants displaying enhanced activity and enantioselectivity were to be found, 
then they could be tested for their ability to facilitate the enantioselective addition of 
acetaldehyde to aromatic nitroalkenes as well.
e library was transformed into Escherichia coli cells, and screened by evaluating 
960 transformants. is resulted in the identication of two quadruple mutants (I2W/
L8Y/M45Y/F50A and I2M/L8Y/M45Y/F50A) with signicantly improved activity and 
enantioselectivity. ese mutant enzymes were puried to homogeneity and assayed for 
their ability to catalyze the addition of 1 to 2a. Mutants I2W/L8Y/M45Y/F50A and I2M/
L8Y/M45Y/F50A both displayed excellent enantioselectivity, providing product S-3a 
with an e.r. of 99:1 (Table S1), and enhanced activity (4- and 5-fold, respectively) when 
compared to that of M45Y/F50A (Figure 3a). Since both quadruple mutants contain the 
L8Y mutation, the triple mutant L8Y/M45Y/F50A was constructed to test the importance 
of the mutation at position Ile-2. In addition, the triple mutant L8F/M45Y/F50A was 
constructed to test if a structurally similar residue at position Leu-8 might result in 
better catalytic properties. Interestingly, mutants L8Y/M45Y/F50A and L8F/M45Y/F50A 
exhibited excellent enantioselectivity in the addition reaction yielding S-3a with an e.r. 
of 99:1 (Table S1). To our delight, the catalytic activity of mutant L8Y/M45Y/F50A for the 
addition of 1 to 2a was considerably improved (6-fold) compared to that of the starting 
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mutant M45Y/F50A and higher than those of the quadruple mutants I2M/L8Y/M45Y/
F50A and I2W/L8Y/M45Y/F50A (Figure 3a). e activity of mutant L8F/M45Y/F50A 
was slightly lower than that of L8Y/M45Y/F50A. Satisfyingly, mutant L8Y/M45Y/F50A 
also displayed higher activity (3.5-fold) for the addition of 1 to the aromatic nitroalkene 
2c when compared to that of mutant M45Y/F50A (Figure 3b).
Coincidentally, when compared to mutant M45Y/F50A, mutant L8Y/M45Y/F50A 
also proved to be much more stable in the presence of the desirable cosolvent ethanol, 
tolerating concentrations of up to 30% (v/v) without losing activity or enantioselectivity. 
In fact, the enantioselectivity of the L8Y/M45Y/F50A catalyzed addition of 1 to 2a in 
the presence of 25% (v/v) ethanol was exceptional, yielding optically pure S-3a (the 
pregabalin precursor) with an e.r. of >99:1 (Table S1). On the other hand, mutant 
L8F/M45Y/F50A was rather unstable in the presence of ethanol, with signicantly 
reduced activity already at an ethanol concentration of 10% (v/v). Because the L8Y/
M45Y/F50A mutant showed the highest catalytic activity and enantioselectivity, and 
because it tolerates relatively high concentrations of the cosolvent ethanol without loss 
of performance, it was selected for further study.
Figure 3. Progress curves of Michael-type additions catalyzed by dierent 4-OT variants. (a) 
Addition of 1 (150 mM) to 2a (5 mM) in 20 mM sodium phosphate buer (pH 6.5) and 5% (v/v) 
DMSO. Dierent 4-OT mutants were used as a catalyst at a concentration of 100 µM. YA: 4-OT 
M45Y/F50A, FYA: 4-OT L8F/M45Y/F50A, WYYA: 4-OT I2W/L8Y/M45Y/F50A, MYYA: 4-OT 
I2M/L8Y/M45Y/F50A, YYA: 4-OT L8Y/M45Y/F50A. (b) Addition of 1 (65 mM) to 2c (1.3 mM) in 
20 mM sodium phosphate buer (pH 6.5) and 45% (v/v) DMSO. Dierent 4-OT mutants were used 
as a catalyst at a concentration of 18 µM. YA: 4-OT M45Y/F50A, YYA: 4-OT L8Y/M45Y/F50A.
2
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e synthetic usefulness of mutant L8Y/M45Y/F50A was further investigated in semi-
preparative scale experiments with nitroalkene acceptors 2a-d (Table 1). Ethanol 
was used as a cosolvent in all reactions because in 20-30% (v/v) ethanol excellent 
enantioselectivity was observed for the enzymatic additions. Under optimized 
conditions, products 3a-d could be synthesized with good isolated yields (63-97 %) and 
excellent enantioselectivity (e.r. up to >99:1). In all cases, the pharmaceutically relevant 
enantiomer of the γ-nitroaldehyde was synthesized [(S)-3a and (R)-3b-d]. ese results 
demonstrate the potential of this newly engineered articial ‘Michaelase’, which displays 
enhanced activity, improved enantioselectivity and better ethanol stability compared 
to the parent enzyme, for the asymmetric synthesis of optically pure γ-nitroaldehydes, 
which are important precursors for the valuable pharmaceuticals pregabalin, phenibut, 
baclofen and uorophenibut.
Structural Basis for the Enhanced Enantioselectivity
To obtain insight into how the active site of 4-OT L8Y/M45Y/F50A is remodelled to 
facilitate the highly enantioselective Michael-type addition reactions, we determined 
its crystal structure at 1.9 Å resolution (Table S2). e overall hexameric structure of 
4-OT L8Y/M45Y/F50A is very similar to that of wild-type 4-OT (PDB entry: 4X19)23 
and of mutant M45Y/F50A (PDB entry: 5CLN)25, with Cα-backbone root-mean-square-
deviations of 0.38 Å and 0.69 Å, respectively. A more detailed structural comparison 
of 4-OT L8Y/M45Y/F50A and the parental enzyme 4-OT M45Y/F50A with bound 
nitrostyrene (PDB entry: 5CLO)25 shows that the extra mutation (L8Y) in the triple 
mutant results in a slight shi of residues 5-17, comprising the last residues of strand β1, 
the following loop, and the N-terminal residues of helix α1 (maximum shi is 1.4 Å). In 
addition, residues 46-48 comprising the loop/310-helix aer strand β2 show a maximum 
shi of 2.2 Å. Residues Tyr-45 and Ala-50 line the active site pocket, their side chains 
having a conformation very similar to that observed in the M45Y/F50A mutant. Notably, 
two conformations of Tyr-45 were observed. In one conformation, the side chain of 
Tyr-45 is rotated towards the substrate binding pocket. Overlaying this conformation 
with the structure of M45Y/F50A in complex with nitrostyrene (2b) would result in a 
clash between the aromatic ring of 2b and Tyr-45, suggesting that this is not the active 
conformation. In the second conformation, the side chain of Tyr-45 is ipped to the 
back of the active site, making H-bond interactions with His-6, similar as is observed 
in the structure of M45Y/F50A.
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Table 1. 4-OT L8Y/M45Y/F50A catalyzed Michael-type additions of 1 to 2a-d yielding 3a-da.
1 2 a : R = i s o b u t y l
2 b : R = P h
2 c : R = p - C l - C 6 H4
2 d : R = p - F - C 6 H4
3 a : R = i s o b u t y l
3 b : R = P h
3 c : R = p - C l - C 6 H4
3 d : R = p - F - C 6 H4











( S ) - 3 a
50 20% EtOH 63 >99:1
2 NO2
O
( R ) - 3 b
80 20% EtOH 87 98:2
3 NO2
O
C l ( R ) - 3 c
55 30% EtOH 97 >99:1
4 NO2
O
F ( R ) - 3 d
140 20% EtOH 94 >99:1
a Assay conditions: reaction mixtures consisted of 150 mM 1 (synthesis of 3a), or 50 mM 1 
(synthesis of 3b-d), 3 mM 2a, 1.3 mM 2c or 2 mM 2b and 2d in 20 mM sodium phosphate buer, 
pH 6.5. e reaction volume was 12.8 mL (synthesis of 3a) or 60 mL (synthesis of 3b-d). 1.4 mol% 
of 4-OT (compared to concentration nitroalkene) was used, except for entry 1 (2.5 mol%) and 
entry 3 (2.15 mol%). 
b For 3a, the e. r. was determined by GC with a chiral stationary phase. For 3b and 3c, the 
enzymatic product was rst converted into the corresponding ethylene glycol acetal, of which 
the e. r. was determined by HPLC with a chiral stationary phase. For 3d, the e.r. was directly 
determined by HPLC with a chiral stationary phase. e absolute conguration was determined 
by comparison to literature data17,25.
2
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Most importantly, at the interface of each dimer of the L8Y/M45Y/F50A mutant, the Tyr-8 
side chain lies “above” the hydrophobic pocket that binds the aromatic ring of 2b in the 
M45Y/F50A mutant (Figure 4a). While the pocket has become narrower due to the extra 
L8Y mutation, the comparison with the M45Y/F50A structure indicates that it remains 
capable to accommodate 2b, with the aromatic rings of Tyr-8 and the substrate forming a 
parallel displaced pi-pi stacking interaction (Figure 4b). e narrower substrate binding 
pocket is expected to be less tolerant towards accommodating the alternate binding mode 
of 2b, which would give the opposite enantiomer of the corresponding product, because 
the substrate has little freedom to adjust its conformation and orientation to minimize 
unfavorable close contacts. ese results indicate that the enhanced enantioselectivity 
of the L8Y/M45Y/F50A mutant is not due to major structural changes but is related to 
the replacement of Leu-8 by a larger tyrosine residue, resulting in a narrower substrate 
binding pocket that prevents the substrate to bind in two distinct orientations relative to 
Pro-1. us, the reduction in size of the substrate binding pocket explains the excellent 
enantioselectivity of the 4-OT L8Y/M45Y/F50A mutant.
Figure 4. Crystal structure of the newly engineered 4-OT L8Y/M45Y/F50A mutant. (a) Overlay 
of the crystal structures of mutant M45Y/F50A with bound nitrostyrene (2b, in light grey color, 
PDB entry: 5CLO) and mutant L8Y/M45Y/F50A (in orange color, this work). e extra L8Y mu-
tation of the triple mutant has the tyrosine side chain lying above a hydrophobic pocket where 
nitrostyrene (2b) is bound in the double mutant, close to the catalytic proline residue (Pro-1). 
(b) A close-up view at a similar orientation, with the surface representation of the L8Y/M45Y/
F50A mutant added, showing that nitrostyrene (2b) would snugly t in the hydrophobic pocket.
One-Pot Two-Step Enzymatic Cascade Synthesis of γ-Nitrobutyric Acids.
Having constructed an articial ‘Michaelase’ that is highly enantioselective for the 
addition of acetaldehyde (1) to nitroalkenes 2a-d, yielding γ-nitroaldehydes (S)-3a and 
(R)-3b-d (Table 1), we focused our attention on the development of a two-step enzymatic 
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cascade process for the synthesis of γ-nitrobutyric acids 4a-d, which are more stable 
and practical GABA analogue precursors than the corresponding γ-nitroaldehydes. e 
synthesis of these compounds requires the coupling of the newly developed ‘Michaelase’ 
with an appropriate aldehyde oxidase or aldehyde dehydrogenase (Table 2). Notably, 
using an oxidase would result in the formation of hydrogen peroxide as a by-product, 
which could unfavourably react with the aldehyde substrates and enzyme catalysts, 
necessitating an additional step for its removal. erefore, an aldehyde dehydrogenase 
with a broad non-natural substrate scope, PRO-ALDH(003) available from Prozomix 
Ltd., was used. Initial experiments showed that PRO-ALDH(003) was dependent on either 
NAD+ or NADP+ and could accept both (R)-3a and (S)-3a as substrates. For cofactor 
regeneration, we used an NADH oxidase, PRO-NOX(009) available from Prozomix Ltd., 
which converts NADH to NAD+ using O2 and producing H2O. A water-forming NOX 
enzyme is particularly suited to include in the envisioned cascade synthesis, as it does not 
employ substrates or generate products that complicate subsequent work-up, resulting 
in increased purity and yield of 4a-d. Using our newly engineered articial ‘Michaelase’ 
4-OT L8Y/M45Y/F50A in combination with PRO-ALDH(003) and PRO-NOX(009), we 
developed a one-pot two-step biocatalytic cascade to synthesize the desired product 
(S)-4a in 64% isolated yield and with an excellent e.r. of 99:1 (Table 2, entry 1). Using 
similar conditions, also (R)-4b-d could be synthesized in good isolated yield (67-70%) 
and with excellent e.r. values of up to 99:1 (Table 2, entries 2-4).
Interestingly, the modularity of this enzymatic cascade approach and the ability of 
PRO-ALDH(003) to accept both enantiomers of 3a-d as substrates, also allowed for 
the synthesis of the opposite enantiomers of γ-nitrobutyric acids 4a-d. To this end, we 
replaced 4-OT L8Y/M45Y/F50A by the previously engineered enantiocomplementary 
4-OT variant A33D, which produces the opposite enantiomers of 3a-d25. Under 
optimized conditions and using the appropriate combination of enzymes in one pot, 
the desired products (R)-4a and (S)-4b-d were obtained with excellent e.r. values (99:1) 
and in 62-74% isolated yield (Table 2, entries 5-8).
2
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e n a n t i o c o m p l e m e n t a r y
4 - OT v a r i a n t
1 0 0 m M Na H2P O4 , p H 7 . 3
1 0 % E t OH2 a : R = i s o b u t y l2 b : R = P h
2 c : R = p - C l - C 6 H4
2 d : R = p - F - C 6 H4
1
P R O- A L D H( 0 0 3 )
NA D + NA D H























( S ) - 4 a
L8Y/M45Y/




( R ) - 4 b
L8Y/M45Y/





( R ) - 4 c
L8Y/M45Y/





( R ) - 4 d
L8Y/M45Y/





( R ) - 4 a




( S ) - 4 b
A33D 40 5 67 99:1
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e n a n t i o c o m p l e m e n t a r y
4 - OT v a r i a n t
1 0 0 m M Na H2P O4 , p H 7 . 3
1 0 % E t OH2 a : R = i s o b u t y l2 b : R = P h
2 c : R = p - C l - C 6 H4
2 d : R = p - F - C 6 H4
1
P R O- A L D H( 0 0 3 )
NA D + NA D H























( S ) - 4 c





( S ) - 4 d
A33D 30 5 74 99:1
a Michael-type addition of 1 to 2a-d catalyzed by 4-OT L8Y/M45Y/F50A or 4-OT A33D to form 
either S-3a and R-3b-d or R-3a and S-3b-d respectively, followed by aldehyde oxidation catalyzed 
by PRO-ALDH(003), using PRO-NOX(009) for cofactor recycling, to form either S-4a and R-4b-d 
or R-4a and S-4b-d. e reaction mixtures consisted of 50 mM 1, 3 mM 2a or 4 mM 2b-d in 
100 mM sodium phosphate buer pH 7.3 and 10% (v/v) ethanol. 5 mol% of 4-OT (compared to 
concentration nitroalkene) was used, except for entry 6 (1.5 mol%) and entry 7 (3 mol%). PRO-
ALDH(003) was added to a nal concentration of 0.5 mg/mL, PRO-NOX(009) was added to a 
nal concentration of 1 mg/mL. e concentration NAD+ was 8 mM (4a) or 10 mM (4b-d). e 
amounts of applied cofactor were adjusted such that short reaction times and high conversions 
were achieved. b Monitored by UV spectroscopy; c Monitored by HPLC. d Products 4a-d were 
esteried and the e.r. was determined by GC or HPLC with a chiral stationary phase.
One-Pot ree-Step Chemoenzymatic Cascade Synthesis of γ-Aminobutyric Acids. 
Having developed a modular one-pot two-step enzymatic cascade for the production 
of both enantiomers of γ-nitrobutyric acids 4a-d, we focused our attention on the 
extension of this cascade by including a third step, converting 4a-d into the desired 
pharmaceutically active γ-aminobutyric acids 5a-d. To the best of our knowledge, 
no enzymes have been reported that can catalyze the full reduction of aliphatic nitro 
groups, such as those present in 4a-d, to the corresponding amines29. While several 
2
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procedures for the chemical reduction of nitro groups have been reported, most of these 
use organic solvents and are not suitable to be executed in aqueous solutions. To prevent 
the necessity of intermediate purication of 4a-d, we selected nickel boride as catalyst 
(NiCl2.6H2O in combination with NaBH4), because this system has been reported to 
catalyze the reduction of nitro groups in aqueous solutions30,31. Pleasingly, when using 
10 equivalents of nickel boride (NaBH4/NiCl2.6H2O) the complete reduction of 4a-d into 
5a-d in aqueous buer at pH 3 was achieved.
Having established that nickel boride can be used to set up a three-step chemoenzymatic 
cascade reaction, 4-OT L8Y/M45Y/F50A, PRO-ALDH(003), PRO-NOX(009) and NaBH4/
NiCl2.6H2O were combined in one pot. is chemoenzymatic cascade proved to be 
ecient, converting the simple starting materials 1 and 2a into the desired product (S)-5a 
with an isolated yield of 55% and an excellent e.r. of 98:2 (Table 3, entry 1). Similarly, this 
one-pot three-step reaction cascade could also be used to eciently synthesize (R)-5b-d 
in good isolated yields (65-70%) and with excellent e.r. values of 99:1 (Table 3, entries 2-4). 
us, access to the pharmaceuticals pregabalin, phenibut, baclofen and uorophenibut 
has been achieved using this newly developed one-pot, three-step chemoenzymatic 
cascade process.
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4 - OT L 8 Y / M 4 5 Y / F 5 0 A
1 0 0 m M Na H2P O4 , p H 7 . 3
1 0 % E t OH2 a : R = i s o b u t y l
2 b : R = P h
2 c : R = p - C l - C 6 H4
2 d : R = p - F - C 6 H4
1
P R O- A L D H( 0 0 3 )
NA D + NA D H






S - 3 a
R - 3 b
R - 3 c
R - 3 d
S - 4 a
R - 4 b
R - 4 c
R - 4 d
S - 5a ( p r e g a b a l i n )
R - 5b ( p h e n i b u t )
R - 5c ( b a c l o f e n )
R - 5d ( f l u o r o p h e n i b u t )
Ni C l 2 / Na B H4
1 0 0 m M Na H2P O4 , p H 3
Entry Product
Reaction time









( S ) - 5a




( R ) - 5b





( R ) - 5c




F ( R ) - 5d
25 30 24 68 99:1
a Michael-type addition of 1 to 2a-d catalyzed by 4-OT L8Y/M45Y/F50A to form S-3a and R-3b-d, 
followed by aldehyde oxidation catalyzed by PRO-ALDH(003), using PRO-NOX(009) for cofactor 
recycling, to form S-4a and R-4b-d, followed by nitro reduction catalyzed by nickel boride to 
form S-5a and R-5b-d. e reaction mixtures consisted of 50 mM 1, 3 mM 2a or 4 mM 2b-d in 
100 mM sodium phosphate buer pH 7.3 and 10% (v/v) ethanol. 5 mol% of 4-OT (compared to 
concentration of nitroalkene) was used; PRO-ALDH(003) was added to a nal concentration of 
0.5 mg/mL; PRO-NOX(009) was added to a nal concentration of 1 mg/mL; 0.5 mM of NAD+ 
was added; 40 mM of NiCl2 and 40 mM of NaBH4 were used. Because of the poor stability of 
nickel boride in aqueous buer, a 10-fold excess of this reagent (40 mM versus 3-4 mM 2a-d) is 
required to achieve high conversion. 
b Monitored by UV spectroscopy. 
c Monitored by HPLC. 
d Monitored by TLC. 
e Puried by cation exchange chromatography. 
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f Products 5a - 5d were derivatized using Nα-(2,4-dinitro-5-uorophenyl)-L-valinamide 
and the e.r. of the corresponding diastereomers was determined by HPLC with an achiral 
stationary phase. Notably, the e.r. of product 5a is likely to be 99:1; however, because a 
minor contaminant from the derivatizing agent has the same retention time as the R 
enantiomer of product 5a, the e.r. for product 5a is cautiously reported as 98:2 consistent 
with the observed peaks in the HPLC chromatogram.
Discussion
e use of dierent enzymes to build reaction cascades for ecient synthesis of valuable 
chemical products is an emerging concept in biocatalysis4-7. is approach aims to 
minimize the number of reaction steps, prevent the necessity of isolation of intermediate 
products and improve the ‘pot-economy’ of the process9. Using such a systems biocatalysis 
strategy, we have successfully demonstrated a one-pot two-step biocatalytic cascade 
reaction for the synthesis of the pharmaceutically relevant enantiomers of γ-nitrobutyric 
acids starting from simple achiral precursors (acetaldehyde and nitroalkenes). is 
synthetic route highlights a highly enantioselective carbon–carbon bond-forming step 
catalyzed by a newly engineered articial ‘Michaelase’, 4-OT L8Y/M45Y/F50A, which 
has no known biological counterpart. is tailor-made enzyme shows non-natural 
substrate promiscuity, accepting acetaldehyde for enantioselective addition to various 
nitroalkenes. e modularity of this two-step cascade reaction was demonstrated by 
using a previously engineered enantiocomplementary 4-OT mutant, 4-OT A33D25, to 
synthesize the opposite enantiomers of the γ-nitrobutyric acids. We also developed a 
three-step chemoenzymatic cascade route for the conversion of enzymatically prepared 
γ-nitrobutyric acids by chemical reduction into the corresponding γ-aminobutyric 
acids in one pot. Given that the ecient large-scale process for the manufacture of 
pregabalin (5a) by Pzer is based on a lipase-catalysed kinetic resolution with ex-situ 
enantiomer recycling32, our one-pot asymmetric chemoenzymatic cascade synthesis 
oers an alternative route to pharmaceutically active γ-aminobutyric acid products, as 
exemplied by the enantioselective synthesis of pregabalin (3 steps, 55% yield), phenibut 
(3 steps, 70% yield), baclofen (3 steps, 65% yield) and uorophenibut (3 steps, 68% yield). 
is shows the exciting opportunities available for combining chemocatalysts, natural 
enzymes, and designed articial biocatalysts in multistep syntheses5. It is anticipated 
that such a rapid synthesis strategy, which avoids (de-)protecting steps and intermediate 
purications, could be exibly extended to various other targets, for example by using 
aldehyde donors with dierent chain length or by starting from structurally distinct 
nitroalkenes.
BNW_Lieuwe.indd   54 31-08-20   15:18
55
Enantioselective Synthesis of Pharmaceutically Active γ-Aminobutyric Acids
e key step of the developed cascade synthesis is the enantioselective Michael addition 
of acetaldehyde to a nitroalkene catalyzed by an engineered 4-OT variant (mutant L8Y/
M45Y/F50A). e development of this highly enantioselective 4-OT variant was achieved 
by using an engineering strategy that involves simultaneous randomization at two sites 
(Ile-2 and Leu-8, Figure 4) lining the substrate binding pocket of 4-OT M45Y/F50A, a 
double mutant previously designed for inverting the stereoselectivity to that required 
for GABA precursor synthesis.25 e major benet of this structure-guided engineering 
strategy lies in the reduction of the sequence space that has to be covered in order to 
identify valuable mutants.28 Screening of 960 transformants, which is only a relatively 
small fraction of clones with respect to statistical requirements for signicant coverage 
of possible combinations in a double-site SSM library with NNK codons, yielded two 
quadruple mutants (I2W/L8Y/M45Y/F50A and I2M/L8Y/M45Y/F50A) with signicantly 
improved activity and the desired high enantioselectivity. e best performing triple 
mutant, L8Y/M45Y/F50A, was deductively constructed from these quadruple mutants. 
Notably, this triple mutant must have been included in the double-site SSM library, but 
apparently was not identied due to insucient screening. From this result it can be 
concluded that a single-site SSM strategy at both positions would have been an even more 
ecient engineering strategy, with only the need for screening of ~200 transformants 
with acceptable statistical coverage of possible mutants. In summary, we provide 
evidence that three amino acid substitutions (L8Y/M45Y/F50A) are sucient to invert 
and dramatically enhance the enantioselectivity of 4-OT for the Michael addition of 
acetaldehyde to various nitroalkenes.
A structural comparison of 4-OT M45Y/F50A complexed with a nitroalkene substrate25 
and unliganded 4-OT L8Y/M45Y/F50A suggested that the new triple mutant has a 
narrower binding pocket for the nitroalkene substrate (Figure 4). is reduction in 
size of the substrate binding pocket may prevent the nitroalkene substrate to bind 
in two distinct orientations relative to Pro-1, potentially explaining the enhanced 
enantioselectivity. However, the possibility that the observed nitroalkene substrate 
orientation is not relevant for the catalytic bond-forming event can not be excluded, 
because the covalent enzyme-bound enamine intermediate, which is formed between 
Pro-1 and acetaldehyde,23 may inuence the binding orientation of the nitroalkene 
substrate and the trajectory of the nucleophilic addition.
e currently employed amounts (1.4–5.0 mol%) of 4-OT L8Y/M45Y/F50A are lower 
and reactions times of ≤30 min are generally shorter than in the few conventional 
organocatalytic methodologies for identical type of Michael reactions.12,33,34 Moreover, 
we take advantage of the water solubility of the enzyme to achieve the reactions in 
2
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environmentally friendly aqueous buer and not in organic solvent. Nevertheless, the 
relatively high amounts of the 4-OT L8Y/M45Y/F50A enzyme employed, required 
to ensure short reaction times to outcompete non-enzymatic water addition to 
nitroalkene substrates 2a-d, might pose a possible constraint on the use of our developed 
chemoenzymatic cascade synthesis for large‐scale transformations. To address this 
issue, we currently run protein engineering studies with the aim to further enhance 
the unnatural ‘Michaelase’ activities of 4‐OT L8Y/M45Y/F50A, which would allow lower 
catalyst loadings.
While all three steps of the cascade reaction were performed under aqueous conditions 
with high conversions, the chemical reduction step requires 10 equivalents of nickel 
boride and has to be performed at acidic pH, which is not directly compatible with 
the enzymatic steps that require neutral pH. It will be interesting to investigate 
whether the chemical reduction step can be replaced by an enzymatic step, converting 
the γ-nitrobutyric acids 4a-d into GABA analogues 5a-d. However, such an entirely 
enzymatic cascade route for the straightforward synthesis of pharmaceutically active 
GABA analogues awaits the discovery or engineering of an appropriate nitroreductase 
capable of completely reducing the aliphatic nitro group of 4a-d to the amine group [at 
the expense of NAD(P)H] in a controlled and ecient fashion, without formation of 
unstable, reactive intermediates that lower the yield of the desired amino acid product. 
Although increasingly investigated, reported nitroreductases prefer nitroaromatic 
substrates and oen catalyze only partial reduction of nitro groups to the reactive 
nitroso or hydroxylamino products29. We have initiated studies aimed at exploring a 
large collection of putative nitroreductases, as well as engineered variants thereof, for 
their ability to eciently reduce γ-nitrobutyric acids 4a-d into γ-aminobutyric acids 
5a-d. As such, our work sets the stage for further development of ‘articial metabolisms’ 
for the greener, more sustainable and step-economic synthesis of an important class of 
pharmaceuticals.
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e 4-OT I2X/L8X/M45Y/F50A library was constructed by Quikchange mutagenesis. 
e following primers were used: Fw 5’-GGA GAT ATA CAT ATG CCT NNK GCC 
CAG ATC CAC ATC NNK GAA GGC CGC AGC G-3’ and Rv 5’-C GCT GCG GCC 
TTC MNN GAT GTG GAT CTG GGC MNN AGG CAT ATG TAT ATC TCC-3’. e 
mutated codons are indicated in bold. An amount of 40 ng of pJexpress 414 plasmid 
DNA containing the 4-OT M45Y/F50A gene was used as template1. e PCR reaction 
was conducted using Phusion polymerase (New England Biolabs) in 1x HF buer (New 
England Biolabs) in 50 µl reaction volume. e following PCR program was used: 98 
°C, 10 min (initial denaturation), followed by 18 cycles of 95 °C for 30 s, 55 °C for 
1 min, 68 °C for 4 min and a nal elongation step of 68 °C for 10 min. e reaction 
mixtures were 2x diluted with water followed by the addition of 1 µl FastDigest DpnI 
(ermoFisher Scientic) to digest the template DNA. Reaction mixtures were placed 
at 37 °C for 2 h, followed by a DpnI denaturing step of 80 °C for 10 min. An initial 
transformation in Escherichia coli Dh5α cells was performed and the plasmid DNA 
of individual colonies was isolated and sequenced to conrm the library quality. To 
collect the library DNA, four parallel transformations were performed using 50 µl of 
10-beta competent E. coli cells (High eciency, New England Biolabs) and 5 µl of the 
PCR reaction mixture. Transformants were selected on LB-agar plates supplemented 
with 100 µg/ml ampicillin. About 8000 colonies were resuspended in 10 mM sodium 
phosphate buer and plasmid DNA was isolated and subsequently used to transform E. 
coli BL21(DE3) cells for expression of the 4-OT mutants.
Production and purication of enzymes
e enzyme 4-OT M45Y/F50A was puried according to an earlier described purication 
procedure2. Mutant enzymes 4-OT I2M/L8Y/M45Y/F50A, 4-OT I2W/L8Y/M45Y/
F50A, 4-OT L8F/M45Y/F50A and 4-OT L8Y/M45Y/F50A were puried according to 
a modied protocol. Accordingly, the cell pellets were resuspended in 10 mM TRIS 
buer pH 8 (instead of 10 mM sodium phosphate buer). Aer loading on the DEAE-
sepharose column, the column was washed 2x with 8 ml 10 mM TRIS buer pH 8. 
e 4-OT enzyme was eluted with 3x 8 ml of 10 mM sodium phosphate buer pH 
7.3. Typically, the second and third elution fraction would contain pure 4-OT (>95% 
purity as determined by SDS-PAGE). Fractions containing pure 4-OT enzyme were 
combined and concentrated using a vivaspin centrifugal concentrator (Sartorius, 5000 
2
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MWCO). Aer concentration to ~3 ml, the sample was two times dialtrated with 20 ml 
of 10 mM sodium phosphate buer pH 7.3 to remove any traces of the TRIS buer. e 
concentration of puried 4-OT was determined by the Waddell method3. e puried 
4-OT was aliquoted, ash frozen in liquid nitrogen and stored at -80 °C until further use. 
All puried 4-OT mutants were analyzed by electron spray ionization mass spectrometry 
to conrm the correct mass of the protein. PRO-ALDH(003) and PRO-NOX(009) were 
provided as crude cell-free extracts by Prozomix Ltd, and used without any further 
purication.
Progress curves of the enzyme-catalyzed reactions
To monitor the progress of the enzymatic addition of 1 to 2a, the reaction mixtures 
consisted of the following: 5 mM 2a, DMSO (5% v/v), 100 µM 4-OT (2 mol% compared 
to 2a) in 20 mM sodium phosphate buer pH 6.5, 500 µl nal volume. e reaction was 
initiated by the addition of 1 to a nal concentration of 150 mM (from a freshly prepared 
1.5 M stock solution in 20 mM sodium phosphate buer pH 6.5). Every 8 min a sample 
was withdrawn from the reaction mixture and a UV-VIS spectrum was measured from 
200 to 500 nm. Aer the measurement, the sample was returned to the reaction mixture. 
e progress curve was constructed based on the depletion in absorbance at 249 nm, 
which corresponds to the λmax of substrate 2a
4. Aer 88 minutes, the reaction mixtures 
were extracted with 500 µl toluene. e organic layer was separated from the aqueous 
layer by centrifugation. A sample from the organic layer was transferred to a GC vial 
and analyzed by GC with a chiral stationary phase (see library screening). No product 
3a could be identied for the control reaction without enzyme.
To monitor the progress of the enzymatic addition of 1 to 2c, the reaction mixtures 
consisted of the following: 1.3 mM 2c, DMSO (45% v/v), 18 µM 4-OT (1.4 mol% compared 
to 2c) in 20 mM sodium phosphate buer pH 6.5, 500 µl nal volume. e reaction was 
initiated by the addition of 1 to a nal concentration of 65 mM (from a freshly prepared 
650 mM stock solution in sodium phosphate buer pH 6.5). Every 8 min a sample was 
withdrawn from the reaction mixture and a UV-VIS spectrum was measured from 200 
to 500 nm. Aer the measurement, the sample was returned to the reaction mixture. 
e progress curve was constructed based on the depletion in absorbance at 320 nm, 
which corresponds to the λmax of substrate 2c
4.
Crystallization and data collection
e newly engineered articial Michaelase (4-OT L8Y/M45Y/F50A) was crystallized by 
hanging drop vapour diusion at 293 K. Drops consisted of equal volumes of protein 
solution (14.5 mg/ml) in 10 mM sodium phosphate buer, pH 7.3 and 18% (w/v) PEG 
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3350, 0.2 M sodium formate, 0.1 M Bis-Tris propane-HCl, pH 7.0. Rod-like crystals 
appeared within a few days and were cryoprotected using 24% (w/v) PEG 3350, 16% (v/v) 
glycerol, 50 mM sodium formate, 50 mM Bis-Tris propane-HCl, pH 6.5. Diraction data 
were collected at beamline P11 of DESY (Hamburg, Germany) and indexed, integrated 
and scaled using XDS5. Statistics are given in Table S2.
Structure determination and renement
e structure of 4-OT L8Y/M45Y/F50A, containing three hexamers (chains A-F, G-L 
and M-R) in the asymmetric unit of the P 212121 cell, was determined by molecular 
replacement using PHASER6 with the wild-type 4-OT structure (PDB entry: 4X19)7 
as a search model. Crystallographic renement was carried out with Refmac8 using 
non-crystallographic symmetry restraints, and alternated with map inspection and 
manual rebuilding in Coot9. Renement statistics and model quality are given in Table 
S2. Structural gures were prepared with PyMOL (e PyMOL Molecular Graphics 
System, Version 2.0 Schrödinger, LLC). Atomic coordinates and structure factors have 
been deposited at the Protein Data Bank with entry 6FPS.
Solvent screening
e eect of increasing concentrations of dierent co-solvents on the enantioselectivity 
of 4-OT M45Y/F50A for the addition of 1 to 2a was investigated. Small scale reactions 
were set up consisting of the following: 325 µg 4-OT M45Y/F50A (160 µM), 3 mM 
2a, 50 mM 1, and co-solvent in 20 mM sodium phosphate buer pH 5.5, 300 µl nal 
volume. e reactions were performed in a 1 mm quartz cuvette. e following co-
solvents were used: DMSO, ethanol, methanol, isobutanol, PEG400, 1,4-butanediol, 
1,3-propanediol, ethylene glycol, glyceline, and ethaline in concentrations ranging from 
1% to 70%. e decrease in absorbance at 249 nm, corresponding to the concentration 
of 2a, was followed over time. In case 4-OT M45Y/F50A precipitated during the course 
of the reaction, the reaction mixture was discarded. Aer the reaction was nished, the 
reaction mixture was extracted with 700 µl toluene. e organic layer was collected and 
concentrated by applying a N2 ow. A sample of the remaining organic layer was analyzed 
by GC to determine the enantiopurity of the enzymatic product 3a. e following GC 
program was used: gradual temperature increase: 40 °C to 120 °C at 10 °C per min. 
Gradual temperature increase 120 °C to 140 °C at 0.5 °C per min. Gradual temperature 
decrease 140 °C to 40 °C at 10 °C per min. Flame ionization detection: Retention time 
S-enantiomer: 30.4 min, retention time R-enantiomer 31.3 min. e assignment of the 
absolute conguration was based on earlier reported data1,4.
2
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Synthesis of racemic references
Synthesis of racemic γ-nitrobutyraldehydes
e racemic γ-nitrobutyraldehydes 3a-d, which served as reference compounds for 
analyses by HPLC and GC on a chiral stationary phase, were synthesized according to 
literature procedures4.
Synthesis of racemic γ-nitrobutyric acids (4a-d)
e racemic γ-nitrobutyric acids 4a-d were synthesized from the corresponding 
racemic γ-nitrobutyraldehydes 3a-d according to literature procedures10. e racemic 
γ-nitrobutraldehyde 3a (0.5 mmol) was dissolved in 3 ml of tert-butanol:water (3:1) 
and cooled to 0°C. To this NaH2PO4·2H2O (1 mmol), 2-methyl-2-butene (2 mmol) and 
NaClO2 (6.96 g, 1.5 mmol) were added and the mixture was stirred for 30 min. e 
reaction mixture was quenched with a saturated NH4Cl solution and extracted with 
EtOAc. e organic layer was dried over anhydrous MgSO4, concentrated in vacuo and 
the crude reaction product was puried by silica gel column chromatography using 
petroleum ether:EtOAc (8:2) to get racemic 4a. e same procedure was followed for 
the synthesis of 4b- 4d.
Synthesis of racemic γ-aminobutyric acids (5a-d)
Racemic γ-aminobutyric acids 5a and 5c were commercially available. Racemic 5b and 
5d were synthesized from the corresponding racemic γ-nitrobutyric acids (4b and 4d) 
according to literature procedures11. Racemic 4b (0.1 mmol) was dissolved in 10% ethanol 
(3 ml) and cooled to 0°C. To this NiCl2·6H2O (1 mmol), followed by NaBH4 (1 mmol) was 
added carefully. e reaction mixture was stirred at room temperature for 24 h. Aer 
complete conversion, the reaction mixture was ltered through celite pad and the ltrate 
was concentrated in vacuo. e resulting concentrated mixture was acidied to pH 3-4 
and then loaded on a column packed with cation exchange resin (5 g of Dowex® 50WX8 
hydrogen form). Aer washing with deionized water (4 column volumes), the product 
was eluted out with 0.5 M (4 column volumes) - 1 M ammonia solution (4 column 
volumes). e ninhydrin-positive fractions were collected, combined and lyophilized to 
yield racemic product 5b. Racemic 5d was synthesized by following the same procedure.
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Product derivatization for determination of enantiomeric excess and 
reaction progress
Derivatization of 3b and 3c for enantiomeric excess determination
e aldehyde functionality of 3b was derivatized to a cyclic acetal according to a literature 
procedure4,12. e aldehyde functionality of 3c was also derivatized to the cyclic acetal. 
To a solution of 100 mg (0.44 mmol) racemic 3c in 16 ml DCM (anhydrous) and 0.51 g 
(8.2 mmol) ethylene glycol (anhydrous), 15 mg of paratoluene sulfonic acid was added. 
e reaction was stirred overnight at room temperature. Aer silica column purication 
the cyclic acetal was obtained (91 mg, 76% yield).
1H NMR (500 MHz, Chloroform-d) δ 7.30 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.5 Hz, 2H), 
4.76 (dd, J = 12.7, 6.1 Hz, 1H), 4.73 (dd, J = 6.2, 3.2 Hz, 0H), 4.55 (dd, J = 12.6, 9.4 Hz, 
1H), 3.99 – 3.93 (m, 1H), 3.85 – 3.79 (m, 1H), 3.79 – 3.72 (m, 1H), 2.08 (ddd, J = 14.2, 7.7, 
3.2 Hz, 1H), 2.00 – 1.94 (m, 1H).
13C NMR (126 MHz, CDCl3) δ 137.97, 133.68, 129.30, 128.93, 102.21, 80.26, 65.12, 65.05, 
39.43, 37.27.
Derivatization for HPLC analysis of reaction progress13
For the cascade reactions, a sample (50 µl) from the reaction mixture was taken 
at constant time intervals and mixed with 50 µL of derivatizing agent, which 
contains O-benzylhydroxylamine hydrochloride 40 mg mL–1; 0.25 mmol mL–1 in 
pyridine:methanol:water (9:9:2). Aer incubation for 30 min at room temperature, the 
sample was centrifuged at 13,000 rpm for 10 min and then the supernatant was analyzed 
by reverse phase HPLC using a C18 column (Kinetex 5u EVO C18 100A, 150 mm x 4.6 
mm, Phenomenex®). Mobile phase A was water with 0.1% TFA and mobile phase B was 
ACN with 0.1% TFA. e detailed mobile phase gradient was as follows: 0 min, 5% B; 
0.01–6 min, 8-35% B; 6–14 min, 35–85% B; 14–15.5 min, 85–90% B; 15.5–16.5 min 90–8% 
B and 16.5–20 min, 5% B, while the ow rate was 1 ml/min.
Derivatization of 4a-d for enantiomeric excess determination
e compound 4a (0.1 mmol) was dissolved in dichloromethane (1 ml) and methanol 
(0.2 ml), and cooled down to 0 °C. To this cooled solution, EDC.HCl (0.15 mmol) was 
added, followed by DMAP (0.01 mmol). Aer 1 h, the reaction mixture was quenched 
with saturated NH4Cl, extracted with diethyl ether and the organic layer was dried 
over anhydrous Na2SO4. e dried organic layer was concentrated in vacuo and the 
crude product was puried by silica gel column chromatography (hexane/ethylacetate 
2
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9:1) to yield the methyl ester of 4a (75% yield). e same procedure was followed for 
derivatization of 4b-d.
Derivatization of 5a-d for enantiomeric excess determination
γ-Aminobutyric acids 5a-d were derivatized to diastereomers using sodium 2,4-dinitro-
5-uorophenyl-L-valine amide14. To a solution of 5a in water (0.1 ml, 1 mg/ml), a freshly 
prepared solution of sodium 2,4-dinitro-5-uorophenyl-L-valine amide in MeCN/
water 10:90 (0.1 ml, 10 mg/ml) was added. To this triethylamine (2.5 µl) was added and 
the sample was vortexed at high speed. Aer 10 min incubation at room temperature, 
the sample was directly analyzed by HPLC. e same procedure was followed for 
derivatization of 5b-d.
BNW_Lieuwe.indd   66 31-08-20   15:18
67
Enantioselective Synthesis of Pharmaceutically Active γ-Aminobutyric Acids
Supporting Tables





1 2 a 3 a
Entry 4-OT mutant Co-solvent Product e.r.b Abs. Conf.c
1 M45Y/F50A 5 % DMSO 90:10 S
2 I2W/L8Y/M45Y/F50A 5 % DMSO 99:1 S
3 I2M/L8Y/M45Y/F50A 5 % DMSO 99:1 S
4 L8F/M45Y/F50A 5 % DMSO 99:1 S
5 L8Y/M45Y/F50A 5 % DMSO 99:1 S
6 L8Y/M45Y/F50A 25 % EtOH >99:1 S
a Assay conditions: e reaction mixture consisted of 150 mM 1, 5 mM 2a, and 100 µM of 
biocatalyst in 20 mM sodium phosphate buer pH 6.5, 300 µl reaction volume. 
b Determined by GC with a chiral stationary phase. 
c Determined by literature comparison1,4.
Table S2. Crystallographic data.
PDB entry 6FPS
Data collection
Space group P 212121
Cell dimensions a, b, c (Å) 90.0, 99.5, 118.3




< I/σ > 14.2 (1.5)
Completeness (%) * 100.0 (100.0)
Redundancy * 8.1(7.7)
Renement
Resolution (Å) 46-1.90 (1.93-1.90)
Unique observations * 80195 (4096)




Ligand molecules phosphate ion (1), glycerol (1)
Average B-factor protein (Å2) 39.3
Root mean square deviations
 Bond lengths (Å) 0.015
 Bond angles (o) 1.64
Ramachandran
 Favored (%) 99.9
 Allowed (%) 0.1
 Outliers (%) 0.0
* values in brackets refer to the highest resolution shell
2




GC chromatograms of products from small scale reactions
Figure S1. GC chromatograms of racemic or enzymatically obtained 3a in small scale reactions. 
e experimental conditions and product e.r. values are listed in Table S1.
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Figure S1. Continued.
2
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UV absorbance spectra monitoring the 4-OT L8Y/M45Y/F50A catalyzed addition 
of 1 to 2a-d
Figure S2. UV spectra showing the conversion of 2a catalyzed by 4-OT L8Y/M45Y/F50A in 20 
mM sodium phosphate buer, pH 6.5, 20% ethanol.
Figure S3. UV spectra showing the conversion of 2b catalyzed by 4-OT L8Y/M45Y/F50A in 20 
mM sodium phosphate buer, pH 6.5, 20% ethanol.
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Figure S4. UV spectra showing the conversion of 2c catalyzed by 4-OT L8Y/M45Y/F50A in 20 
mM sodium phosphate buer, pH 6.5, 30% ethanol.
Figure S5. UV spectra showing the conversion of 2d catalyzed by 4-OT L8Y/M45Y/F50A in 20 
mM sodium phosphate buer, pH 6.5, 20% ethanol.
2
BNW_Lieuwe.indd   71 31-08-20   15:18
72
Chapter 2
1H NMR spectra of enzymatically obtained 3a-d
Figure S6. 1H NMR spectrum of enzymatically prepared (S)-5-methyl-3-(nitromethyl)hexanal 
(3a) (400 MHz, CDCl3).
Figure S7. 1H NMR spectrum of enzymatically prepared (R)-4-nitro-3-phenylbutanal (3b) (400 
MHz, CDCl3).
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Figure S8. 1H NMR spectrum of enzymatically prepared (R)-3-(4-chlorophenyl)-4-nitrobutanal 
(3c) (400 MHz, CDCl3).
Figure S9. 1H NMR spectrum of enzymatically prepared (R)-3-(4-uorophenyl)-4-nitrobutanal 
(3d) (400 MHz, CDCl3).
2
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HPLC and GC chromatograms for enantiomeric excess determination of 3a-d
Figure S10. GC chromatograms of racemic and enzymatically obtained 3a.
Figure S11. HPLC chromatograms of racemic and enzymatically obtained derivatized 3b.
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 Figure S12. HPLC chromatograms of racemic and enzymatically obtained derivatized 3c.
Figure S13. HPLC chromatograms of racemic and enzymatically obtained 3d.
2
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UV spectra and HPLC chromatograms of the one-pot synthesis of 4a-d
Figure S14. UV spectra showing the conversion of 2a by 4-OT L8Y/M45Y/F50A in the rst step 
of the enzymatic cascade.
Figure S15. HPLC chromatograms showing the conversion of 4-OT L8Y/M45Y/F50A synthesized 
3a by PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality 
was derivatized to the corresponding (O)-benzyl oxime.
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Figure S16. UV spectra showing the conversion of 2b by 4-OT L8Y/M45Y/F50A in the rst step 
of the enzymatic cascade.
Figure S17. HPLC chromatograms showing the conversion of 4-OT L8Y/M45Y/F50A synthesized 
3b by PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality 
was derivatized to the corresponding (O)-benzyl oxime.
2
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Figure S18. UV spectra showing the conversion of 2c by 4-OT L8Y/M45Y/F50A in the rst step 
of the enzymatic cascade.
Figure S19. HPLC chromatograms showing the conversion of 4-OT L8Y/M45Y/F50A synthesized 
3c by PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality 
was derivatized to the corresponding (O)-benzyl oxime.
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Figure S20. UV spectra showing the conversion of 2d by 4-OT L8Y/M45Y/F50A in the rst step 
of the enzymatic cascade.
Figure S21. HPLC chromatograms showing the conversion of 4-OT L8Y/M45Y/F50A synthesized 
3d by PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality 
was derivatized to the corresponding (O)-benzyl oxime.
2
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Figure S22. UV spectra showing the conversion of 2a by 4-OT A33D in the rst step of the 
enzymatic cascade.
Figure S23. HPLC chromatograms showing the conversion of 4-OT A33D synthesized 3a by 
PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality was 
derivatized to the corresponding (O)-benzyl oxime.
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Figure S24. UV spectra showing the conversion of 2b by 4-OT A33D in the rst step of the 
enzymatic cascade.
Figure S25. HPLC chromatograms showing the conversion of 4-OT A33D synthesized 3b by 
PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality was 
derivatized to the corresponding (O)-benzyl oxime.
2
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Figure S26. UV spectra showing the conversion of 2c by 4-OT A33D in the rst step of the 
enzymatic cascade.
Figure S27. HPLC chromatograms showing the conversion of 4-OT A33D synthesized 3c by 
PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality was 
derivatized to the corresponding (O)-benzyl oxime.
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Figure S28. UV spectra showing the conversion of 2d by 4-OT A33D in the rst step of the 
enzymatic cascade.
Figure S29. HPLC chromatograms showing the conversion of 4-OT A33D synthesized 3d by 
PRO-ALDH(003) in the second step of the enzymatic cascade. e aldehyde functionality was 
derivatized to the corresponding (O)-benzyl oxime.
2
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1H NMR spectra of enzymatically obtained 4a-d
Figure S30. 1H NMR spectrum of (S)-5-methyl-3-(nitromethyl)hexanoic acid (4a) obtained by 
4-OT L8Y/M45Y/F50A and PRO-ALDH(003) (400 MHz, CDCl3).
Figure S31. 1H NMR spectrum of (R)-4-nitro-3-phenylbutanoic acid (4b) obtained by 4-OT L8Y/
M45Y/F50A and PRO-ALDH(003) (400 MHz, CDCl3).
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Figure S32. 1H NMR spectrum of (R)-3-(4-chlorophenyl)-4-nitrobutanoic acid (4c) obtained by 
4-OT L8Y/M45Y/F50A and PRO-ALDH(003) (400 MHz, CDCl3).
Figure S33. 1H NMR spectrum of (R)-3-(4-uorophenyl)-4-nitrobutanoic acid (4d) obtained by 
4-OT L8Y/M45Y/F50A and PRO-ALDH(003) (400 MHz, CDCl3).
2
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 Figure S34. 1H NMR spectrum of (R)-5-methyl-3-(nitromethyl)hexanoic acid (4a) obtained by 
4-OT A33D and PRO-ALDH(003) (400 MHz, CDCl3).
Figure S35. 1H NMR spectrum of (S)-4-nitro-3-phenylbutanoic acid (4b) obtained by 4-OT A33D 
and PRO-ALDH(003) (400 MHz, CDCl3).
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Figure S36. 1H NMR spectrum of (S)-3-(4-chlorophenyl)-4-nitrobutanoic acid (4c) obtained by 
4-OT A33D and PRO-ALDH(003) (400 MHz, CDCl3).
Figure S37. 1H NMR spectrum of (S)-3-(4-uorophenyl)-4-nitrobutanoic acid (4d) obtained by 
4-OT A33D and PRO-ALDH(003) (400 MHz, CDCl3).
2
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1H NMR spectra of racemic derivatized 4a-d
Figure S38. 1H NMR spectrum of racemic methyl 5-methyl-3-(nitromethyl)hexanoate (400 MHz, 
CDCl3).
Figure S39. 1H NMR spectrum of racemic methyl 4-nitro-3-phenylbutanoate (400 MHz, CDCl3).
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Figure S40. 1H NMR spectrum of racemic methyl 3-(4-chlorophenyl)-4-nitrobutanoate (400 
MHz, CDCl3).
Figure S41. 1H NMR spectrum of racemic methyl 3-(4-uorophenyl)-4-nitrobutanoate (400 MHz, 
CDCl3).
2
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HPLC and GC chromatograms for enantiomeric excess determination of 
derivatized 4a-d
Figure S42. GC chromatograms of racemic and enzymatically obtained derivatized 4a.
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 Figure S43. HPLC chromatograms of racemic or enzymatically obtained derivatized 4b.
2
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Figure S44. HPLC chromatograms of racemic and enzymatically obtained derivatized 4c.
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Figure S45. HPLC chromatograms of racemic and enzymatically obtained derivatized 4d.
2
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1H NMR spectra of chemoenzymatically obtained 5a-d
Figure S46. 1H NMR spectrum of chemoenzymatically prepared (S)-Pregabalin (5a) (400 MHz, 
D2O and NaOD).
Figure S47. 1H NMR spectrum of chemoenzymatically prepared (R)-Phenibut (5b) (400 MHz, 
D2O and NaOD).
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Figure S48. 1H NMR spectrum of chemoenzymatically prepared (R)-Baclofen (5c) (400 MHz, 
D2O and NaOD).
Figure S49. 1H NMR spectrum of chemoenzymatically prepared uorophenibut (5d) (400 MHz, 
D2O and NaOD).
2
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HPLC chromatograms for enantiomeric excess determination of derivatized 5a-d
Figure S50. HPLC chromatograms of racemic and chemoenzymatically obtained derivatized 5a.
Figure S51. HPLC chromatograms of racemic and chemoenzymatically obtained derivatized 5b.
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 Figure S52. HPLC chromatograms of racemic and chemoenzymatically obtained derivatized 5c.
Figure S53. HPLC chromatograms of racemic and chemoenzymatically obtained derivatized 5d.
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Enzymes have evolved to function under aqueous conditions and may not exhibit 
features essential for biocatalytic application, such as the ability to function in high 
concentrations of an organic solvent. Consequently, protein engineering is oen 
required to tune an enzyme for catalysis in non-aqueous solvents. In this study, we have 
used a collection of nearly all single mutants of 4-oxalocrotonate tautomerase, which 
promiscuously catalyzes synthetically useful Michael-type additions of acetaldehyde 
to various nitroolens, to investigate the eect of each mutation on the  ability of 
this enzyme to retain its ‘Michaelase’ activity in elevated concentrations of ethanol. 
Examination of this mutability landscape allowed the identication of two hotspot 
positions, Ser-30 and Ala-33, at which mutations are benecial for catalysis in high 
ethanol concentrations. e ‘hotspot’ position Ala-33 was then randomized in a highly 
enantioselective, but ethanol-sensitive 4-OT variant (L8F/M45Y/F50A) to generate an 
improved enzyme variant (L8F/A33I/M45Y/F50A) that showed great ethanol stability 
and eciently catalyzes the enantioselective addition of acetaldehyde to nitrostyrene 
in 40% ethanol (permitting high substrate loading) to give the desired γ-nitroaldehyde 
product in excellent isolated yield (89%) and enantiopurity (ee = 98%). e presented 
work demonstrates the power of mutability-landscape-guided enzyme engineering for 
ecient biocatalysis in non-aqueous solvents.
Keywords
Enzyme engineering; biocatalysis; solvents; mutability landscape; Michael addition
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Introduction
e enzyme 4-oxalocrotonate tautomerase (4-OT) from Pseudomonas putida mt-2 
catalyzes the tautomerization of 2-hydroxy-2,4-hexadienedioate (1) to 2-oxo-3-
hexenedioate (2) as part of a metabolic pathway for the degradation of aromatic 
hydrocarbons (Scheme 1A).[1,2] In addition, 4-OT can promiscuously catalyze several 
C-C bond-forming reactions, including Michael-type additions and aldol condensations, 
yielding precursors for important classes of pharmaceuticals.[3–7] For instance, the 
4-OT catalyzed Michael-type addition of acetaldehyde (3) to nitroalkenes 4a and 4b 
yields γ-nitroaldehydes 5a and 5b, important precursors for the γ-aminobutyric acid 
analogues phenibut (R-6a) and pregabalin (S-6b), respectively (Scheme 1B).[5] Hence, 
several enzyme engineering studies have been performed to improve the activity and 
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Scheme 1. A) Tautomerization reaction naturally catalyzed by 4-OT. B) Michael-type addition of 
acetaldehyde (3) to nitroalkenes 4a and 4b, promiscuously catalyzed by 4-OT. Products 5a and 
5b are precursors for phenibut (R-6a) and pregabalin (S-6b), respectively.
Solubilization of substrates 4a and 4b requires the use of cosolvents. Since enzymes 
have evolved to function under aqueous conditions, high concentrations of cosolvents 
can signicantly aect their catalytic performance and eventually result in enzyme 
precipitation.[10] In this study, we used a collection of nearly all single-mutant variants 
of 4-OT to investigate the eect of each mutation on the ability of the enzyme to retain 
its ‘Michaelase’ activity in elevated concentrations of ethanol. Ethanol was selected as 
cosolvent because it is readily accessible from biorenewable sources and can also function 
as a precursor for 3.[11] Randomization of the identied ‘hotspot’ position Ala-33 in 
the context of a previously engineered highly enantioselective, but ethanol-sensitive, 
3
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4-OT variant (L8F/M45Y/F50A) aorded an improved enzyme variant (4-OT L8F/A33I/
M45Y/F50A) with high ethanol stability, allowing ecient and enantioselective Michael-
type addition reactions in 40% (v/v) ethanol. As such, our work provides an interesting 
example of how targeted mutagenesis of a single amino acid can radically modify the 
cosolvent stability of an enzyme, allowing ecient catalysis in high concentrations of 
ethanol.
Results
In order to identify ‘hotspot’ positions of 4-OT at which mutations are benecial for 
catalysis in high concentrations of ethanol, a dened collection of 1040 single-mutant 
variants of 4-OT[8] was screened using cell-free extracts (CFEs) prepared from cultures 
each expressing a dierent 4-OT mutant. e Michael-type addition of 3 to 4a was 
used as a model reaction in screening owing to the marked absorbance of 4a at 320 
nm. Control experiments demonstrated no signicant dierence between the eect 
of ethanol on the reaction catalyzed by puried 4-OT or 4-OT present in CFE (Figure 
S1). e ‘Michaelase’ activity of each single-mutant variant of 4-OT was measured 
using either 5% or 25% ethanol as cosolvent and the remaining activity at 25% ethanol, 
compared to that at 5% ethanol, was graphically represented in a mutability landscape 
for solvent tolerance (Figure 1). Increasing the concentration of ethanol from 5% to 25% 
reduced the ‘Michaelase’ activity of wild-type 4-OT by approximately 50% (Figures 1 
and 2A). Interestingly, analysis of the ethanol-tolerance mutability landscape revealed 
two ‘hotspot’ positions, Ser-30 and Ala-33, at which single mutations resulted in enzyme 
variants that showed more than 70% residual ‘Michaelase’ activity at 25% ethanol (Figure 
1). Notably, the crystal structure of wild-type 4-OT does not provide an immediate 
explanation for the improved ethanol tolerance caused by mutations at these two 
positions (Figure S2), illustrating the importance of mutability-landscape navigation 
to identify functional ‘hotspot’ positions. ree single mutants, 4-OT S30C, S30Y and 
A33D, which showed high ethanol tolerance, were puried and the eect of ethanol and 
other cosolvents on the ‘Michaelase’ activity was tested (Figure 2). Interestingly, 4-OT 
S30C, S30Y and A33D also showed tolerance towards other cosolvents such as DMSO 
and isopropanol, suggesting that these mutations convey general cosolvent resistance. 
Notably, while the 4-OT variants perform well up to 40% DMSO, visible protein 
precipitation with concomitant loss of activity was observed at DMSO concentrations 
≥50% (v/v).
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Figure 1. Ethanol-tolerance mutability landscape of 4-OT.  e horizontal axis of the data matrix 
represents the residue positions of 4-OT.  e vertical axis represents all 20 canonical amino acids. 
 e wild-type amino acid at each position is indicated with a bold square. White squares indicate 
that this mutant is not present in the collection.  e color of the square indicates the residual 
‘Michaelase’ activity of a speci c single-mutant variant of 4-OT for the addition of 3 to 4a in 25% 
ethanol, compared to that in 5% ethanol. Grey boxes indicate that the ‘Michaelase’ activity was 
too low to determine the remaining activity.
Figure 2. Michael-type addition of 3 to 4a catalyzed by puri ed wild-type 4-OT or 4-OT mutants 
in the presence of di erent cosolvent concentrations. A) ethanol, B) methanol, C) 1,3-propane-
diol, D) DMSO, E) isopropanol, F) tert-butanol.  e activity of each mutant is normalized to the 
activity in the presence of 5% cosolvent.
We next investigated if we could use the information from the solvent-tolerance mutability 
landscape to engineer a previously constructed highly enantioselective 4-OT variant, L8F/
M45Y/F50A (4-OT FYA),[9] to function in high concentrations of ethanol. As single mutants 
3
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at ‘hotspot’ position Ala-33 generally exhibited higher ‘Michaelase’ activity than those at 
‘hotspot’ position Ser-30, we focused our mutagenesis strategy on position Ala-33.[8] In the 
context of 4-OT FYA, residue Ala-33 was mutated to all possible amino acids and the nineteen 
enzyme variants were expressed and puried to homogeneity. Initially, we tested all variants 
for visible precipitation upon incubation (1 h) of the enzyme with increasing concentrations 
of ethanol (up to 50%). e parental enzyme 4-OT FYA rapidly precipitated when incubated 
with ethanol concentrations equal to or greater than 10% (Figure 3D). Interestingly, enzyme 
variants with isoleucine (A33I/FYA), leucine (A33L/FYA) or valine (A33V/FYA) at position 
33 could tolerate up to 50% ethanol without any visible protein precipitation aer 1 hour of 
incubation. Notably, substitution of Ala-33 to aspartate, glutamate or cysteine in the context 
of 4-OT FYA also strongly improved the stability of the enzyme in high concentrations of 
ethanol, tolerating up to 40% ethanol without visible protein precipitation.
Next, we tested the activity and enantioselectivity of these six quadruple mutants in 
the presence of 5%, 30% or 50% ethanol. e Michael-type addition of 3 to 4b was used 
as model reaction because the optical purity of product 5b can easily be analyzed by gas 
chromatography. All six quadruple mutants proved to be highly enantioselective giving nearly 
enantiopure product 5b, and, importantly, increasing ethanol concentrations do not negatively 
aect enzyme enantioselectivity (Table 1). In the presence of 30% ethanol, the reactions with 
the six quadruple mutants were completed within 35-70 min, whereas the reaction with the 
parental enzyme (4-OT FYA) showed no conversion due to rapid protein precipitated (Table 1).
Table 1. Biocatalytic addition of 3 to 4b catalyzed by 4-OT mutants in dierent ethanol 
concentrations.[a]
5% v/v ethanol 30% v/v ethanol 50% v/v ethanol





FYA 98 (S) 40 -[d] -[d] -[d] -[d]
A33D/FYA 98 (S) 50 98 (S) 70 92 (S) > 360[e]
A33E/FYA 96 (S) 30 96 (S) 60 98 (S) > 360[e]
A33C/FYA 98 (S) 55 98 (S) 70 -[d] -[d]
A33I/FYA 98 (S) 30 98 (S) 35 98 (S) 90
A33L/FYA 98 (S) 35 98 (S) 50 96 (S) 180
A33V/FYA 98 (S) 35 98 (S) 45 98 (S) 120
[a] Assay conditions: 3 mM 4b, 100 mM 3, 73 µM 4-OT, 20 mM NaH2PO4 (pH 7.3), 0.3 mL reaction 
volume [b] Determined by GC using a chiral stationary phase; the absolute conguration was 
determined by literature comparison[8,9] [c] Reaction progress was monitored by following the 
depletion in absorbance at 249 nm. [d] No data due to protein precipitation. [e] Reaction was not 
nished aer 360 min.
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e best mutant, 4-OT A33I/FYA, catalyzed the Michael-type addition reaction practically 
as ecient in 40% ethanol as in 10% ethanol (Figure 3B). Moreover, pre-incubation of 4-OT 
A33I/FYA in 50% ethanol for 10 h resulted in only 25% loss of activity (Figure 3A). On the 
contrary, the parental enzyme (4-OT FYA) rapidly lost its activity upon incubation in 10% 
ethanol (Figure 3A, B). Interestingly, an increase in the T50
60 of approximately 6 °C was 
observed for 4-OT A33I/FYA compared to 4-OT FYA, indicating that 4-OT A33I/FYA is also 
somewhat more thermostable than 4-OT FYA (Figure 3C). Finally, to further demonstrate 
the synthetic usefulness of 4-OT A33I/FYA, a semi-preparative scale reaction was performed, 
using 40% ethanol as cosolvent, which allowed for the solubilization of 15 mM 4a. Using 
a 6.7-fold excess of 3 over 4a, the reaction was nished within 200 min. Product R-5a was 
obtained in excellent isolated yield (89%) and enantiopurity (ee = 98%) (Figures S3 and S4). 
Taken together, these results demonstrate that 4-OT can be engineered to eciently catalyze 
enantioselective Michael-type reactions in ethanol concentrations up to 40%.
Figure 3. Characterization of 4-OT A33I/FYA (FIYA). A) Enzyme activity for the Michael-type addition 
of 3 to 4a aer pre-incubation (1, 2, 4, 6, 8 or 10 h) in the presence of 10, 30 or 50% ethanol. e data is 
normalized to the activity of the enzyme without pre-incubation. B) Progress curves of 4-OT A33I/FYA- 
and 4-OT FYA-catalyzed Michael-type additions in the presence of dierent ethanol concentrations. C) 
Temperature-induced inactivation proles of 4-OT A33I/FYA and 4-OT FYA. e enzyme activity aer 
incubation for 60 min at 30 °C was set as 100%. D) Photograph of cuvettes in which 4-OT FYA (190 µg/
mL, top ve cuvettes) and 4-OT A33I/FYA (190 µg/mL, bottom ve cuvettes) were incubated for 1 h in 
20 mM NaH2PO4 buer (pH 7.3) containing 10%, 20%, 30%, 40% or 50% (v/v) ethanol (cuvette 1 to 5, 
respectively, from le to right). 4-OT FYA shows rapid precipitation in buer containing >10% ethanol.
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Enzymes are highly attractive catalysts for organic synthesis because of their unparalleled 
enantio-, regio- and chemoselectivity. Given that enzymes have evolved to operate 
in the mild aqueous environment of the cell, they are usually not t for preparative 
biocatalysis in the presence of high concentrations of organic cosolvents required for 
substrate solubilization.[10] A solution to this problem is the engineering of enzymes 
to improve their cosolvent tolerance. Rational enzyme engineering towards increased 
cosolvent tolerance is still very challenging due to our relatively poor understanding 
of the interactions between enzymes and solvent molecules.[12–14] Currently employed 
rational engineering strategies include stabilization of exible regions, introduction of 
new cysteine bridges and modication of access tunnels.[14–17]
An important strategy to guide enzyme-engineering eorts is to make use of mutability 
landscapes.[18–21] By screening a large collection of nearly all single mutants of an enzyme, 
important information is obtained on single mutations or residue positions that inuence 
a desired characteristic of the enzyme. Here we have applied mutability-landscape guided 
enzyme engineering to improve the ethanol tolerance of 4-OT. Screening of a collection 
of nearly all single-mutant variants of 4-OT revealed that mutations at particularly 
positions Ser-30 and Ala-33 resulted in improved ethanol tolerance. Interestingly, a 
previously reported 4-OT variant with 3.5-fold increased ‘Michaelase’ activity, 4-OT 
A33D, also showed improved ethanol tolerance.[8] We used the information from the 
ethanol-tolerance mutability landscape to further engineer a previously constructed 
highly enantioselective 4-OT variant (FYA) that exhibits poor ethanol stability. All 
19 possible variants at position Ala-33 in the context of 4-OT FYA were constructed, 
expressed and puried. Remarkably, from this small, focused set of quadruple mutants, 
six mutants showed strongly improved ethanol tolerance. It is interesting to note that 
all six variants, including 4-OT A33D/FYA, are highly enantioselective towards the 
synthesis of S-5b, similar to the parental mutant 4-OT FYA.[9] Conversely, the single 
mutant 4-OT A33D markedly improved the enantioselectivity towards the opposite 
enantiomer R-5b.[8]
Incubation of the best mutant, 4-OT A33I/FYA, for 10 h in the presence of 50% ethanol 
resulted in only 25% loss of activity, whereas the parental enzyme 4-OT FYA lost all its 
activity upon incubation for 1 h in 10% ethanol. 4-OT A33I/FYA also showed an increase 
in thermostability compared to 4-OT FYA, an eect that has also been observed for other 
enzymes that have been engineered towards increased solvent tolerance.[22,23] We further 
show that 4-OT A33I/FYA can be used to eciently catalyze the Michael-type addition 
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of 3 to 4a in the presence of 40% ethanol, which permitted the use of a higher substrate 
loading (up to 15 mM 4a). Product R-5a could be obtained in good isolated yield (89%) 
and with excellent enantiopurity (ee = 98%).
In conclusion, our results demonstrate the power of mutability landscapes to guide 
engineering eorts to improve the cosolvent tolerance of enzymes. By specically 
targeting the identied ‘hotspot’ position Ala-33, we could engineer an ethanol-sensitive 
mutant, 4-OT FYA, into a highly ethanol-resistant mutant 4-OT A33I/FYA. Further 
tuning of 4-OT A33I/FYA might lead to new synthetic opportunities in almost neat 
organic solvents.
Experimental section
Production of cell-free extract. Cell-free extracts (CFE) of 4-OT single mutants were 
prepared according to a reported procedure.[8]
Construction of the ethanol-tolerance mutability landscape. e CFEs prepared from 
cells producing 4-OT single-mutant variants were used in two reactions, containing 
either 5% or 25% v/v ethanol. e following reaction conditions were used: CFE (20% 
v/v), 3 (50 mM), 4a (0.5 mM) in 20 mM NaH2PO4 buer (pH 7.3), 100 µL nal volume. 
e reactions were performed in 96-well microtiter plates (MTP) (UV-star µclear, Greiner 
Bio-one), covered with UV-transparent plate seals (VIEWsealTM, Greiner Bio-one). To 
ensure proper mixing of the reagents, the plate was shaken (60 s at 500 rpm) immediately 
aer all reaction components were added. e reaction progress was monitored in a 
plate reader by measuring the depletion in absorbance at 320 nm, corresponding to the 
concentration of 4a, for 60 min with a 60 s data interval. e slope of the linear part of 
the curve was determined for both the reactions. e remaining enzymatic activity was 
determined by dividing the slope of the reaction in 25% v/v ethanol by the slope of the 
reaction in 5% v/v ethanol.
4-OT purication. e purication of 4-OT single mutants[24] and 4-OT quadruple 
mutants[9] are based on previously reported procedures. All puried proteins were >90% 
pure as assessed by SDS-PAGE. All puried mutants were analyzed by electron spray 
ionization (ESI) mass spectrometry to conrm the correct mass of the enzyme. e 
puried protein was ash-frozen in liquid nitrogen and stored at -80 °C until further use.
3
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UV-spectroscopic assay for the enzymatic activity of 4-OT single mutants in dierent 
organic solvents. e enzymatic activities of the 4-OT mutants and wild-type 4-OT was 
monitored by following the decrease in absorbance at 320 nm, which corresponds to the 
depletion of 4a. Puried enzyme (150 µg, 73 µM) was incubated in a 1 mm cuvette with 
3 (50 mM) and 4a (2 mM) in 20 mM NaH2PO4 (pH 7.3; 0.3 mL nal volume).
Construction of nineteen Ala-33 mutants of 4-OT L8F/M45Y/F50A. Ala-33 
was randomized by Quikchange technology using the gene encoding 4-OT 
L8F/M45Y/F50A cloned in the pET20b vector as the template. The following 
two primers were used: 5’-GCTCCCTGGATNNKCCGCTGACCAG-3’ and 
5’-CTGGTCAGCGGMNNATCCAGGGAGC-3’. Aer transformation of the DNA into 
E. coli cells, random colonies were picked from an agar plate, and the mutant 4-OT 
genes were sequenced by Macrogen Europe (Meibergdreef 31, 1105AZ, Amsterdam, the 
Netherlands) until all of the 19 quadruple mutants were obtained.
Activity assays of the six best quadruple mutants. e enzymatic activities of the 
4-OT quadruple mutants and 4-OT L8F/M45Y/F50A were monitored by following the 
decrease in absorbance at 249 nm, which corresponds to the depletion of 4b. Puried 
enzyme (150 µg, 73 µM) was incubated in a 1 mm cuvette with 3 (100 mM) and 4b 
(3 mM) in 20 mM NaH2PO4 buer (pH 7.3; 0.3 mL nal volume). Aer the reactions 
were completed, product 5b was extracted with ethyl acetate (400 µL) and analyzed 
by gas chromatography using an Astec CHIRALDEX G-TA column, isocratic 125 °C. 
Retention time S-5b: 25.6 min, retention time R-5b: 26.9. e assignment of the absolute 
conguration was based on earlier reported data.[9]
Determination of T50
60. 4-OT L8F/M45Y/F50A and 4-OT L8F/A33I/M45Y/F50A (50 
µL of 2 mg/mL in 20 mM NaH2PO4, pH 7.3) were incubated in 0.2-mL PCR tubes 
at temperatures ranging from 30 °C to 90 °C for 60 min in a thermal cycler. Aer 
incubation, the enzymes were cooled on ice for 10 min followed by equilibration at 25 
°C for 10 min. Samples were centrifuged to remove any precipitated protein. e residual 
‘Michaelase’ activity for the addition of 3 to 4a was tested in a plate reader. Following 
conditions were used: 25 µL of enzyme supernatant, 50 mM 3, 0.5 mM 4a, 5% v/v ethanol 
in 20 mM NaH2PO4 buer (pH 7.3), 100 µl nal volume. e ‘Michaelase’ activities were 
normalized to that obtained aer 60 min incubation at 30 °C.
Stability of 4-OT L8F/M45Y/F50A and 4-OT L8F/A33I/M45Y/F50A upon incubation 
with increasing ethanol concentrations. 4-OT L8F/M45Y/F50A and 4-OT L8F/A33I/
M45Y/F50A (1 mL of 1.5 mg/mL in 20 mM NaH2PO4, pH 7.3) were incubated in 20 mM 
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NaH2PO4 buer (pH 7.3) containing 10%, 30% or 50% v/v ethanol in a water bath of 25 
°C. Aliquots of enzyme (80 µL) were taken at dierent time intervals and centrifuged to 
remove any aggregated protein. 50 µL of the supernatant was used to test the residual 
enzymatic activity. e reaction mixture consisted of the following: 3 (50 mM), 4a (2 
mM, from a 40 mM stock solution in 100% (v/v) ethanol) in 20 mM NaH2PO4 buer (pH 
7.3), 0.3 mL nal volume. Depletion of 4a was monitored by following the decrease in 
absorbance at 320 nm in time. e activities were normalized to the activity measured 
without incubation of the enzyme.
Semi-preparative scale synthesis. To a 50 mL round bottom ask was added: 6 mL 
ethanol, 112 µL 3, 12 mL buer (20 mM NaH2PO4, pH 6.5) containing 4-OT L8F/A33I/
M45Y/F50A. e reaction was initiated by the addition of 2 mL ethanol containing 
150 mM 4a. e nal concentrations were: 3 (100 mM), 4a (15 mM), 4-OT L8F/A33I/
M45Y/F50A (75 µM, based on monomer concentration), and 40% (v/v) ethanol in 
20 mM NaH2PO4 buer (pH 6.5). e reaction progress was monitored using UV-
spectrophotometric analysis. At timely intervals, a sample of 30 µL was collected 
from the reaction mixture and diluted to 300 µL with 20 mM NaH2PO4 buer and a 
full spectrum from 200 nm to 500 nm was recorded. Aer 200 min, the reaction was 
nished. e reaction mixture was extracted 3x with ethyl acetate. e combined organic 
layers were washed with brine and dried over anhydrous Na2SO4. e organic layer 
was concentrated in vacuo, yielding 5a without any further purication (51.5 mg, 89% 
yield). e aldehyde functionality of 5a was derivatized to a cyclic acetal according to 
a reported procedure[5]. e enantiopurity of derivatized 5a was determined by reverse 
phase HPLC using a chiralpak AD-RH column (150 mm x 4.6 mm, Daicel) MeCN/water 
70:30. Retention time R-5a: 7.8 min, S-5a: 10.8 min.
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Figure S1. Activity of puried wild-type 4-OT and wild-type 4-OT in cell free extract for the 
Michael-type addition of 3 to 4a in the presence of dierent ethanol concentrations.
Figure S2. Crystal structure of wild-type 4-OT (PDB: 4X1C). In light grey, a single monomer of 
4-OT is indicated. Residues Pro-1, Ser-30 and Ala-33 are indicated as stick representation.
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Figure S3. 1H NMR spectrum of enzymatically obtained 5a (4-nitro-3-phenylbutanal). 1H NMR 
(500 MHz, Chloroform-d) δ 9.71 (s, 1H), 7.37 – 7.33 (m, 2H), 7.31 – 7.27 (m, 1H), 7.25 – 7.21 (m, 
2H), 4.68 (dd, J = 12.5, 7.2 Hz, 1H), 4.62 (dd, J = 12.5, 7.6 Hz, 1H), 4.08 (p, J = 7.3 Hz, 1H), 3.01 – 
2.96 (m, 1H), 2.96 – 2.90 (m, 1H).
Figure S4. HPLC chromatograms of derivatized racemic (A) and enzymatically (B) obtained 5a.
3
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e ecient engineering of iminium biocatalysis has drawn considerable attention, with 
many applications in pharmaceutical synthesis. Here we report a tailor-made iminium-
activated colorimetric “turn-on” probe, specically designed as a pre-screening tool to 
facilitate engineering of iminium biocatalysis. Upon complexation of the probe with 
the catalytic Pro-1 residue of the model enzyme 4-oxalocrotonate tautomerase (4-
OT), a brightly colored merocyanine-dye-type structure is formed. 4-OT mutants that 
formed this brightly colored species upon incubation with the probe proved to have 
substantial activity for the iminium-based Michael-type addition of nitromethane to 
cinnamaldehyde, whereas mutants that showed no staining by the probe exhibited no 
or very low-level ‘Michaelase’ activity. is system was exploited in a solid-phase pre-
screening assay termed as Activated Iminium Colony Staining (AICS) to enrich libraries 
for active mutants. AICS pre-screening reduced the screening eort up to 20-fold. Aer 
two rounds of directed evolution, two articial ‘Michaelases’ were identied with up to 
39-fold improvement in activity for the addition of nitromethane to cinnamaldehyde, 
yielding the target γ-nitroaldehyde product with excellent isolated yield (up to 95%) and 
enantiopurity (up to >99% ee). e colorimetric activation of the “turn-on” probe could 
be extended to the class I aldolase 2-deoxy-D-ribose 5-phosphate aldolase, implicating 
a broader application of AICS in engineering iminium biocatalysis.
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Introduction
Iminium-based catalysts are among the most versatile catalysts, nding applications in 
a myriad of C-C bond-forming transformations1. Many of these transformations lead to 
the formation of one or more asymmetric carbon atoms. Hence, researchers have focused 
on the discovery and engineering of iminium-based enzymes that could be applied 
as biocatalysts2–4. Unfortunately, nature’s repertoire of iminium-based carboligases is 
limited. is has motivated researchers to supplement natural iminium-based biocatalysts 
with articial biocatalysts, either obtained by computational design5,6 or inspired by 
natural scaolds7,8. Regardless of the source of the biocatalyst, enzyme engineering 
is oen required to improve the catalytic rate, enantioselectivity or stability. In the 
Hilvert-laboratory, the computationally designed retroaldolase RA95.0 was engineered 
toward Michael-type additions9, aldol reactions10,11, knoevenagel condensations12 and 
Henry condensations13. In our group, we have focused on the engineering of a natural 
tautomerase, 4-oxalocrotonate tautomerase (4-OT). By exploiting the nucleophilic 
character of the key catalytic residue Pro-1, we have engineered 4-OT towards several 
enamine or iminium mediated C-C bond-forming reactions, including Michael-type 
additions and aldol reactions14–18.
Despite large steps that have been made in techniques to construct small smart libraries, 
typically only a small fraction of the mutants within a library display the desired 
improved characteristic19–21. Especially improving the catalytic rate is challenging, as it 
is dicult to predict how mutations inuence the catalytic machinery of the enzyme. 
As a consequence, the screening of mutants is still considered to be the bottleneck in 
enzyme engineering20.
Ultrahigh-roughput screening techniques, such as Fluorescence-Activated Cell 
Sorting (FACS)22 and Fluorescence-Activated Droplet Sorting (FADS)23,24, have enabled 
the screening of very large mutant libraries to enrich these libraries for active mutants. 
e resulting enriched libraries are small enough that they can be screened using lower 
throughput screening techniques such as 96-well assays, or HPLC/GC-based assays 
to identify individual mutants with the desired characteristic. e eectiveness of 
this approach was elegantly demonstrated by the FADS-based directed evolution of 
retroaldolase RA95.5-8, improving the catalytic eciency >20-fold11,25. However, these 
techniques require specialized equipment and non-trivial reaction setup.
Here we present a simple pre-screening technique based on the iminium-activated 
colorimetric “turn-on” probe 1b to pre-screen large 4-OT mutant libraries for improved 
4
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activity towards the iminium-mediated Michael-type addition of 2 to 1a (Figure 1). e 
principle behind the pre-screening technique is based on the iminium-species that is 
selectively formed between 1b and Pro-1 of 4-OT (Figure 1). is structure resembles a 
merocyanine dye and results in a new relatively batochromic absorption peak that can easily 
be observed by the naked eye. is staining is not, or to a much lesser extent, observed in 
many inactive mutants which allows for those mutants to be excluded from subsequent 
screenings. We applied this technique in a solid-phase pre-selection assay that was termed as 
Activated Iminium Colony Staining (AICS). AICS pre-screening reduced screening eorts 
up to 20-fold and allowed for the screening of large mutant libraries. Aer 2 rounds of 
directed evolution we could improve the ‘Michaelase’ activity of 4-OT for the addition of 
2 to 1a up to 39-fold. We show that the principle behind AICS can be extended to other 
iminium-based biocatalysts like the class I aldolase DERA, which potentially paves the road 
for the engineering of novel biocatalysts for iminium-mediated C-C bond-forming reactions.
Figure 1. 4-OT catalyzed Michael-type addition, Brooker’s merocyanine and the reaction 
between Pro-1 of 4-OT and cinnamaldehydes. (a) 4-OT catalyzed Michael-type addition of 2 
to 1a. Product R-3 is a precursor for Phenibut. (b) Resonance forms of Brooker’s merocyanine. 
(c) “Turn-on” probes 1b and 1c reacting with Pro-1 of 4-OT, forming a zwitterionic resonating 
species. (d) Compounds 1a, 1d and 1e reacting with Pro-1 of 4-OT, forming a species without 
zwitterionic resonance.
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Results
Identication of a selective “turn-on” probe for 4-OT
Recently, it was shown that Pro-1 of 4-OT can react with 1a to form complex 5a, a 
catalytic intermediate in the Michael-type addition of 2 to 1a yielding 318. Analogously, 
we hypothesized that 1b and 1c could react with Pro-1 of 4-OT to form 5b and 5c, 
respectively, structures that bear chemical resemblance to Brooker’s merocyanine (4) 
(Figure 1). Compound 4 is a member of the diverse class of merocyanine dyes, which 
are characterized by an electron donating N-atom connected via a streptopolymethine 
chain to an electron withdrawing carbonyl group26,27. As a consequence, merocyanine 
dyes possess a neutral and a zwitterionic resonance form, and have a relatively high 
λmax. As compound 1b nor 1c nor free 4-OT bear this characteristic chemical scaold, 
incubation of 1b and 1c with 4-OT is expected to induce the formation of complexes 5b 
and 5c respectively, each having a new relatively batochromic absorption peak.
To test this hypothesis, 1b and 1c were chemically synthesized (Figure S1). As a control, 
we synthesized compounds 1d and 1e that, like substrate 1a, should not be able to form 
merocyanine dye-type structures upon condensation with Pro-1 of 4-OT because they 
lack an o-OH or p-OH group (Figure 1d). For testing we used 4-OT M45T/F50A, a 
well-studied 4-OT mutant that was constructed for the synthesis of 1a via the aldol 
condensation of acetaldehyde with benzaldehyde15. Gratifyingly, upon incubation of 1b 
or 1c with 4-OT M45T/F50A, the color of the solution changed within a few seconds 
(Figure 2). Spectroscopic analysis revealed the appearance of a novel absorption peak at 
516 nm for 1b and 478 nm for 1c, whereas incubation of 4-OT M45T/F50A with 1d and 
1e did not reveal any new absorption peaks (Figure 2). Especially the bright red species 
that was formed upon incubation of 1b with 4-OT M45T/F50A could clearly be seen by 
the naked eye, which made 1b a powerful “turn on” probe for 4-OT. A single-site binding 
relationship between 1b and 4-OT M45T/F50A was observed, with an estimated KD of 
0.119 ± 0.0055 mM, which indicates that binding of 1b to 4-OT is site specic (Figure S2).
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Figure 2. Absorption spectra of 1b-e in the presence and absence of 4-OT M45T/F50A. (a) 
Absorption spectrum of 1b with and without 4-OT M45T/F50A. (b) Absorption spectrum of 
1c with and without 4-OT M45T/F50A. (c) Absorption spectrum of 1d with and without 4-OT 
M45T/F50A. (d) Absorption spectrum of 1e with and without 4-OT M45T/F50A. Conditions: 
2.5% DMSO, 20 mM sodium phosphate (pH 7.3), 1 mM 1b-e, 50 µM 4-OT M45T/F50A, 1 cm 
quartz cuvets.
To gain further evidence for the formation of complex 5b, 4-OT M45T/F50A was 
incubated with 1b for 15 minutes, followed by the addition of NaCNBH3 to reduce 
any iminium species and covalently trap the interaction of the probe and the protein. 
Subsequent analysis by ESI-MS showed a mass consistent with that of 4-OT M45T/F50A 
modied with a single molecule of 1b (Figure S3). Control reactions with 4-OT M45T/
F50A incubated with only 1b or only NaCNBH3 did not show any modication. e 
labeled 4-OT was digested with the endoproteinase Glu-C and the resulting peptides 
were analyzed by ESI-MS, revealing labeling of 1b on the peptide fragment Pro-1 to Glu-9 
(Figure S4). As Pro-1 is the only likely candidate on this peptide to form an iminium 
species with 1b, Pro-1 was reckoned as the site of labeling.
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Interestingly, incubation of 1b with the enzyme 2-deoxy-D-ribose 5-phosphate aldolase 
(DERA), a well-studied class I aldolase4,28, also resulted in an increase in absorbance at 
516 nm (Figure S5), implicating a broader applicability of probe 1b.
Mutants with improved ‘Michaelase’ activity show strong staining with 1b
Having developed a selective “turn-on” probe for 4-OT, we were interested in applying 
this system to aid our directed evolution eorts. erefore the eect of mutations of 
4-OT on the staining with 1b was investigated. Cells producing a dened set of 53 single 
mutants, covering nearly all single mutants at positions 6, 45 and 50 were grown in a 
deep 96-well plate. ese positions were selected because mutations at these positions 
have shown to inuence the activity of 4-OT for several promiscuous reactions14–16,18. 
Incubation of cells producing the 53 single mutants with 1b demonstrated that single 
mutations can signicantly aect the staining with 1b (Figure S6). Most notably, single 
mutants 4-OT F50A, F50I and F50V showed strong staining upon incubation with 1b. 
Interestingly, these three mutants were previously found in a screen for mutants with 
enhanced activity for the Michael-type addition of 2 to 1a, forming 318. ese results 
prompted us to investigate if 1b could be used as a pre-screening tool to enrich libraries 
for mutants with activity towards the Michael-type addition of 2 to 1a yielding 3, a 
precursor for phenibut, an important gamma-aminobutyric acid (GABA) analogue.
Activated Iminium Colony Staining-based directed evolution of 4-OT
To improve the ‘Michaelase’ activity of 4-OT for the addition of 2 to 1a, we started by 
constructing a triple-site NNK-library. We randomized the active site residues Gln-4, 
Leu-8 and Met-45 in the context of 4-OT F50A, the reported best mutant for this 
reaction18, yielding library Q4X/L8X/M45X/F50A. e addition of 0.2% lactose to agar 
plates induced the expression of 4-OT in freshly transformed cells, without any eect on 
the transformation eciency. A solution of 0.75% agarose containing 1b was poured on 
the agar plate and was allowed to solidify. Within 1 minute, ~5% of the colonies stained 
bright red and could be distinguished from other colonies by the naked eye.
A total of 1472 stained colonies were picked and screened for improved activity for the 
addition of 2 to 1a. Several mutants with improved activity were identied. Almost all 
mutants harbored the M45I mutation, without any obvious additive eect of mutations 
at position 4 and 8. Hence, double mutant 4-OT M45I/F50A was constructed which 
showed a 20-fold improvement in activity compared to 4-OT F50A, using optimized 
reaction conditions (Figure 3).
4
BNW_Lieuwe.indd   123 31-08-20   15:18
124
Chapter 4
Figure 3. Activity for the Michael-type addition of 2 to 1a catalyzed by dierent 4-OT mutants. 
(a) Progress curve of the Michael-type addition of 2 to 1a catalyzed by dierent 4-OT mutants. 
(b) Initial rate of the Michael-type addition of 2 to 1a catalyzed by dierent 4-OT mutants. e 
data is presented as fold increase compared to the initial rate of starting mutant 4-OT F50A. Assay 
conditions: 5% ethanol, 20 mM HEPES (pH 6.5), 1 mM 1a, 100 mM 2, 50 mM sodium formate.
In a second round of directed evolution two libraries, 2-20_IA and 21-40_IA, were 
constructed containing a single random mutation from position 2-20 and 21-40 respectively 
in the context of 4-OT M45I/F50A. No mutations were introduced in the C-terminal 
part of 4-OT (position 41-62) as this region is highly important for stabilization of the 
hexameric structure29. e library was transformed into Escherichia coli cells, and colonies 
were stained using the AICS assay (Figure 4). Comparing the activity of 92 stained colonies 
with 92 unstained colonies of library 21-40_IA demonstrated the high sensitivity of AICS 
pre-screening, as 32% of the stained mutants showed activity comparable or higher than 
the parental mutant 4-OT M45I/F50A, whereas all of the unstained mutants showed no 
activity or less than 50% of the activity of the parental mutant 4-OT M45I/F50A (Figure 5).
Figure 4. Agar plates 10 s (le) and 4 min (right) aer performing the AICS assay. Transformants 
of Library 21-40_IA were stained with the AICS assay as described in the experimental section.
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From each library, 368 stained colonies were picked and screened for improved activity 
for the addition of 2 to 1a. Although library 2-20_IA yielded many active mutants, 
unfortunately none were signicantly more active than parental mutant 4-OT M45I/
F50A. Gratifyingly, library 21-40_IA yielded 2 improved triple mutants: 4-OT S37E/
M45I/F50A and 4-OT A33E/M45I/F50A with 29-fold and 39-fold improved activity 
compared to 4-OT F50A, respectively (Figure 3). e synthetic usefulness of the 
newly engineered mutants 4-OT S37E/M45I/F50A and 4-OT A33E/M45I/F50A was 
demonstrated in semi-preparative scale Michael-type addition reactions using substrates 
1a and 2. Target product R-3 could be obtained in good to excellent isolated yield (up to 
95%) and with excellent enantiopurity (up to >99% enantiomeric excess, ee) (Table S1, 
Figures S7-S11). Given that only a small number of colonies were assayed, these results 
demonstrate the power of using the AICS pre-screening tool for rapid engineering of 
iminium biocatalysis.
Figure 5. Activity for the Michael-type addition of 2 to 1a catalyzed by CFEs of 92 stained and 
92 unstained colonies. Colonies from cells that were freshly transformed with library 21-40_IA 
were stained using the AICS procedure. In total 92 stained colonies and 92 unstained colonies 
were picked, grown overnight and the CFE was assayed for ‘Michaelase’ activity using substrates 
2 and 1a. e ’Michaelase’ activity was measured in a platereader by following the depletion of 
1a at 290 nm. Assay conditions: 5% ethanol, 30% CFE, 0.5 mM 1a, 100 mM 2, 50 mM sodium 
formate. Analysis of CFEs of unstained colonies by SDS PAGE showed that 8 out of 16 show sig-
nicant 4-OT expression, indicating that the AICS procedure can eciently be used to eliminate 
colonies not producing enzyme or producing enzyme with low-level activity.
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e use and development of novel, higher throughput screening systems has drawn 
considerable attention30. As screening of large mutant libraries is oen limiting enzyme 
engineering eorts, systems that reduce screening eorts, or allow for higher throughput 
of screening, have signicantly attributed to the success of enzyme engineering 
studies25,31,32. e design of novel smart (pre-)screening techniques is therefore expected 
to have a strong impact. We wanted to contribute to this eld by designing a smart 
iminium-based “turn on” probe that could be used to remove a considerable part of 
4-OT mutants with no or low activity from large mutant libraries.
Although there are a few reports on “turn-on” probes that make use of an activated lysine 
in the acceptor protein33–35, these studies focused on non-catalytic proteins. Instead, we 
aimed to design the rst iminium-activated “turn-on” probe for an enzyme, exploiting 
the characteristic nucleophilic N-terminal proline of 4-OT. In the past we showed that 
1a binds specically to Pro-1 of 4-OT, forming 5a (Figure 1d)18. Hence, we designed 
“turn-on” probes 1b and 1c, which are close mimics of substrate 1a. Incubation of 1b 
and 1c with 4-OT M45T/F50A resulted in the formation of a novel relatively batochromic 
absorption peak characteristic of merocyanine dyes. Especially incubation of “turn-on” 
probe 1b with 4-OT M45T/F50A induced a remarkable spectroscopic shi that could 
easily be observed by the naked eye. Labeling studies further supported our hypothesis 
that Pro-1 of 4-OT reacts with 1b to form merocyanine dye 5b. Note that substrate 1a 
and analogues 1d and 1e, which were prepared as controls, can not form merocyanine 
dye-type structures upon condensation with Pro-1 of 4-OT because they lack an o-OH 
or p-OH group (Figure 1d).
Merocyanine dye 5b is very similar to 5a, a key catalytic intermediate for the Michael-
type addition of 2 to 1a. erefore we investigated if there is a correlation between 
4-OT single mutants that upon incubation with probe 1b show strong staining and 
4-OT single mutants with improved ‘Michaelase’ activity. Indeed, we found that, from a 
subset of 4-OT single mutants, specically mutants with enhanced ‘Michaelase’ activity 
showed strong staining upon incubation with 1b. is inspired us to use “turn-on” probe 
1b as a pre-screening tool in the engineering of improved articial ‘Michaelases’. We 
developed the AICS technique, a colorimetric solid-phase pre-screening procedure based 
on selective staining of colonies producing an active 4-OT mutant with 1b, and used 
it to enrich large libraries for active 4-OT mutants. e developed AICS pre-screening 
technique proved to be highly eective, reducing the screening eort for a single round 
of directed evolution up to 20-fold. In addition, the sensitivity of AICS pre-screening 
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proved to be very high, as from a subset of 92 unstained colonies all showed less than 
50% activity compared to the parental mutant.
Aer two rounds of directed evolution two triple mutants, 4-OT S37E/M45I/F50A and 
4-OT A33E/M45I/F50A, were identied with a 29-fold and 39-fold improvement in 
activity compared to starting mutant 4-OT F50A. Semi-preparative scale reactions of the 
Michael-type addition of 2 to 1a catalyzed by 4-OT S37E/M45I/F50A and 4-OT A33E/
M45I/F50A resulted in isolation of target product R-3 with excellent yield (up to 95%) 
and enantiopurity (ee up to >99%).
e developed AICS pre-screening technique provides a novel application of “turn-on” 
probes, adding to the usage of “turn-on” probes as tools for non-invasive tissue imaging 
or colorimetric pH sensors36–38. Contrary to many reported colorimetric assays (e.g. 39–42), 
AICS does not rely on a (coupled) chemical reaction producing a chromogenic product, 
but instead solely relies on a conjugate formed between the probe and the enzyme. As 
such, AICS is very quick and nicely complements available reported colorimetric assays.
It would be interesting to investigate the application of AICS to a broader range of 
iminium biocatalysts, as preliminary results indicate that “turn-on” probe 1b was also 
activated by the lysine-dependent aldolase DERA. e further development of “turn-on” 
probes as tools for enzyme engineering potentially opens up new possibilities for the 
ecient engineering of novel classes of iminium-based biocatalysts.
Experimental Section
Spectrophotometric analysis of 1b-e incubated with puried 4-OT
A stock solution of 40 mM 1b-e was prepared in 100% DMSO. 25 µL was added to a 
solution of 20 mM sodium phosphate buer (pH 7.3) with and without 50 µM 4-OT 
M45T/F50A, 1 mL nal volume. e mixture was transferred to a 1 cm quartz cuvet and 
a spectrum from 350 – 800 nm was recorded. To analyze the binding behavior of 1b to 
4-OT M45T/F50A a binding curve was constructed. 1b (4 mM – 0 mM, 2-fold dilution 
series in 20 mM sodium phosphate pH 7.3, 5% DMSO) was incubated with 4-OT M45T/
F50A (50 µM) for 15 minutes (300 µL nal volume). e mixtures were transferred to 1 
mm quartz cuvets and the absorbance at 516 nm was recorded and plotted against the 
concentration of 1b. e experiment was performed in triplo. SigmaPlot was used to t 
the data against the one-site saturation model and to calculate the apparent KD value 
(Figure S2).
4
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Covalent labeling of 1b to 4-OT
To gain further evidence for the formation of 5b, 4 mM of 1b was incubated with 150 µM 
4-OT M45T/F50A in 10 mM sodium phosphate (pH 7.3), 5% DMSO at room temperature, 
500 µL total volume. Aer 15 minutes, 167 µL 100 mM NaCNBH3 in H2O was added 
to reduce any iminium species. e reaction was incubated at room temperature for 30 
minutes. e buer was exchanged to 10 mM ammonium formate in H2O using a pre-
packed PD-10 sephadex G-25 gelltration column. A sample of the collected enzyme was 
analyzed by ESI-MS (Figure S3). From the remaining fraction, 36 µL was digested with 
GluC (New England BioLabs, 4 µL from a 100 ng/µL) in a total volume of 80 µL for 24 
h at 37 °C using the supplied buer. A sample from the digested mixture was analyzed 
by ESI-MS. As controls, a reaction without 1b and a reaction without the addition of 
NaCNBH3 (no reduction) were included. In both cases no modied 4-OT could be 
detected by ESI-MS (Figure S3 and S4).
Staining of 4-OT single mutants with 1b
From a reported set of 4-OT single mutants16, BL21 DE3 glycerol stocks of all single 
mutants with a mutation at position 6, 45 or 50 were used to inoculate 1 mL of LB 
medium supplemented with ampicillin (100 µg/mL) and IPTG (100 µM) and grown 
overnight at 37 °C in 96-deep well plates (Greiner Bio-one, 96-well Masterblock), 
covered with sterile gas-permeable seals (Greiner Bio-one, BREATHseal). e cells 
were harvested by centrifugation and the supernatant was removed. e cell pellets 
were re-suspended in 200 µL 20 mM sodium phosphate buer (pH 7.3) and 50 µL was 
transferred to a round bottom 96-well plate (96 well U-bottom, Greiner Bio-One). To 
this 2.5 µL of 40 mM 1b in 100% DMSO was added. e cells were allowed to settle on 
the bottom of the 96-well plate.
Cloning and mutagenesis
Triple-site library 4-OT Q4X/L8X/M45X/F50A was constructed by PCR with degener-
ate primers. e rst part of the 4-OT gene was amplied using the following primers: 
5’-GGAGATATACATATGCCTATTGCCNNKATCCACATCNNKGAAGGCCGCAG-
CGACG-3’ and 5’- CAGGGAGCGCGAGATGGCC-3’. In bold are indicated the mutated 
codons Gln-4 and Leu-8. Met-45 was randomized using primers 5’-GTGATTATCAC-
GGAGNNKGCCAAGGGCCAC-3’ and 5’-GTGGCCCTTGGCMNNCTCCGTGA-
TAATCAC-3’ by means of quikchange technology. DNA of 4-OT F50A was used as a 
template. In bold is indicated the mutated codon Met-45. e second part of 4-OT was 
amplied from the quikchange product using the following primers: 5’- GGCCATCTC-
GCGCTCCCTG-3’ and 5’-GCTAGGGGGATCCTCAGCGTCTGACCTTGCTGGC-
CAGTTCGCCGCC-3’, using the quikchange product as template. e amplied parts 
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of the 4-OT gene were combined by overlap extension PCR and further amplied using 
primers 5’-TTGAAGGAGATATACATATGCCT-3’ and 5’-GCTAGGGGGATCCTCAG-
CG-3’. An empty pET20b backbone was generated by amplication of a pET20b plasmid 
using the following primers: 5’-TGGGCAATAGGCATATGTATATCTCCTTCTTA-
AAGTTAAAC-3’ and 5’-AAGGTCAGACGCTGAGGATCCGAATTCGAGCTCCG-3’. 
e assembled 4-OT gene and the empty pET20b backbone were puried and digested 
with restriction enzymes NdeI, BamHI and DpnI. e empty pET20b backbone was 
dephosphorylated using alkaline phosphatase. e digested DNA products were puried 
and ligated by T4 DNA ligase. e ligation mixture was puried and used to electro-
porate electrocompetent E. coli Dh5α cells. Aer 1 h of outgrowth with SOC medium 
a small sample of the transformed dh5α cells was spread on an agar plate to determine 
transformation eciency. e remainder of the transformation mixture was added to 5 
mL LB medium, supplemented with ampicillin (100 µg/mL) and grown overnight. e 
overnight culture was harvested and the plasmids were isolated and used to transform 
BL21 DE3 cells.
For the construction of library 2-20_IA a previously reported set of nearly all single 
mutants was used16. From a glycerol stock, each DH10B culture that carried a plasmid 
harboring a 4-OT gene with a mutation at position 2-20 was separately grown overnight 
in 300 µL LB medium supplemented with ampicillin (100 µg/mL). From all individual 
cultures 100 µL was mixed together. From a sample of this mixed culture plasmid DNA 
was isolated to obtain a library of 4-OT genes with a random single mutation at posi-
tion 2-20. e second part of the 4-OT gene was amplied using the following primers: 
‘5-GATTATCACGGAGATTGCCAAGGGCCACGCCGGCATCGGCGGCG-3’ and 
5’-GCTAGGGGGATCCTCAGCG-3’. In bold are indicated the mutated residues Ile-45 
and Ala-50. Using the library of 4-OT genes with a random single mutation at position 
2-20 as a template, the rst part of the 4-OT gene was amplied using the following 
primers: ‘5-TTGAAGGAGATATACATATGCCT-3’ and 5’-CGCCGCCGATGCCG-
GCGTGGCCCTTGGCAATCTCCGTGATAATC-3’. Using overlap extension PCR a 
full length 4-OT gene was obtained containing a random mutation at position 2-20, 
combined with the M45I and F50A mutation. e full length 4-OT gene was digested, 
ligated and cloned into the pET20b plasmid according to the procedure described for 
the construction of the Q4X/L8X/M45X/F50A library, to obtain library 2-20_IA. e 
same procedure was followed for the construction of library 21-40_IA, using the single 
mutants with a mutation at position 21-40.
4
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Expression and purication of enzymes
All 4-OT mutants were expressed and puried according to a reported procedure7. DERA 
with C-terminal His-tag was expressed and puried from E. coli using the pET20b(+) 
expression system. A colony of freshly transformed BL21 DE3 cells was used to inoculate 
5 mL of LB medium supplemented with 100 µg/mL ampicillin and grown for 8 h at 37 
°C. is starter culture was used to innoculate 100 mL of LB medium supplemented 
with ampicillin (100 µg/mL) and lactose (0.2% w/v). e cells were incubated at 30 °C 
overnight at 200 rpm shaking. Cells were harvested by centrifugation, re-suspended in 
30 mL 20 mM potassium phosphate buer (pH 7.0) and lysed by sonication. e lysate 
was cleared by centrifugation and transferred to a clean tube. Ni-sepharose (0.5 mL) was 
added to the lysate and incubated for 4 °C under slow rotation for 30 min. e lysate 
with Ni-sepharose was loaded on a column, washed with 8 mL of 20 mM potassium 
phosphate buer (pH 7.0), followed by 8 mL of 20 mM potassium phosphate buer 
(pH 7.0) containing 30 mM imidazole. Final elution was performed with 2.5 mL of 20 
mM potassium phosphate buer (pH 7.0) containing 250 mM imidazole (>95% purity 
as assessed by SDS PAGE). e buer was exchanged to 20 mM potassium phosphate 
buer (pH 7.0) using a pre-packed PD-10 sephadex G-25 gelltration column. e 
concentration of puried enzyme was determined by the Waddell method43. DERA 
K167L was puried according to the same protocol. Puried DERA and DERA K167L 
were immediately aer purication used in subsequent experiments.
Activated Iminium Colony Staining (AICS)
BL21 DE3 cells were transformed with library DNA and plated on LB agar plates 
supplemented with ampicillin (100 µg/mL) and lactose (0.2% w/v). Colonies were grown 
for ~16 h at 37 °C, aer which the agar plate was stored at room temperature. A solution 
of 1.5% agarose in H2O was prepared by heating in a microwave, and the solution was 
kept at 60 °C. A second solution of 1 mM 1b dissolved in 20 mM sodium phosphate 
(pH 7.3) was lter sterilized and stored at room temperate. 7 mL of the 1.5% agarose 
solution was mixed with 7 mL of the solution containing 1 mM 1b in 20 mM sodium 
phosphate and immediately aer mixing poured on the agar plate. Typically, aer 10 
seconds staining of the rst colonies was observed. e plate was incubated at room 
temperature for 5 minutes to complete the staining and allow the agarose to solidify. e 
staining is stable for at least several hours. For screening of library 2-20_IA and 21-40_IA 
the concentration of 1b in the second solution was reduced to 0.5 mM to increase the 
stringency of selection.
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Library screening
Colonies that showed clear staining aer the AICS assay were picked with sterile tooth 
picks and were used to inoculate 1 mL of LB medium supplemented with ampicillin 
(100 µg/mL) and lactose (0.2 % w/v) in 96-deep well plates (Greiner Bio-one, 96-well 
Masterblock). Two wells in the 96-deep well plate were used to inoculate the parental 
mutant (4-OT F50A or 4-OT M45I/F50A). e plates were sealed with sterile gas-
permeable seals (Greiner Bio-one, BREATHseal) and incubated at 37 °C, with overnight 
shaking at 250 rpm. 80 µL of the culture was mixed with 20 µL of a sterile solution of 
80% glycerol in H2O and stored at -80 °C for later reference. e remainder of the culture 
was centrifuged. e supernatant was discarded and the pellets were re-suspended with 
200 µL BugBuster (Novagen) supplemented with 15 U/mL benzonase (Novagen). Aer 
20 minutes of incubation at room temperature the lysates were cleared by centrifugation 
aer which the CFE was obtained. For the screening of library 2-20_IA and 21-40_IA, 
prior to centrifugation the lysed cells were diluted with 200 µL of sterile H2O. For the 
screening of library Q4X/L8X/M45X/F50A, the nal reaction mixture for monitoring 
the addition of 2 to 1a consisted of 40% CFE, 25 mM 2, 250 µM 1a, 5% ethanol in 20 
mM HEPES pH 6.5, 100 µL nal volume. For the screening of library 2-20_IA and 
21-40_IA, the nal reaction mixture for monitoring the addition of 2 to 1a consisted of 
30% CFE, 100 mM 2, 1 mM 1a, 50 mM sodium formate, 5% ethanol in 20 mM HEPES 
pH 6.5, 100 µL nal volume. Sodium formate was added to the reaction mixture, as 
this was found to positively aect the catalytic rate of 4-OT M45I/F50A. e reaction 
was performed in a 96-well plate (Greiner Bio-one, UV-star F-bottom microplate) and 
reaction progress was followed in a platereader by following the depletion in absorbance 
at 290 nm. For the screening of library 2-20_IA and 21-40_IA the initial absorbance 
was too high for the platereader, so the time point at which the absorbance went below 
the absorbance threshold of the platereader was used as reference point for activity. 
For the comparison of activity of 92 stained mutants to 92 unstained mutants, the 
same procedure as described for library 21-40_IA was followed. However, the reaction 
mixtures consisted of 0.5 mM 1a instead of 1 mM 1a.
Progress curves of the enzymatic reactions
For monitoring the progress of the enzymatic addition of 2 to 1a the following reaction 
setup was used. To a solution of ethanol, 1a and 2 in 20 mM HEPES (pH 6.5) puried 
4-OT F50A, 4-OT M45I/F50A, 4-OT S37E/M45I/F50A or 4-OT A33E/M45I/F50A was 
added. e nal reaction mixture consisted of the following: 5% ethanol, 20 mM HEPES 
(pH 6.5), 1 mM 1a, 100 mM 2, 50 mM sodium formate, 20 µM 4-OT. e reaction 
mixtures were transferred to 1 mm quartz cuvets and the absorption at 290 nm was 
recorded every 20 seconds.
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Semi-preparative scale experiments were performed using 4-OT S37E/M45I/F50A and 
4-OT A33E/M45I/F50A as biocatalysts. e reaction mixtures consisted of the following: 
5 mL ethanol (5% v/v), 20 mg 1a, 25 mM 2, 50 mM sodium formate, 20 mM HEPES (pH 
6.5), 7.5 µM enzyme, 100 mL nal volume. At timely intervals a sample was withdrawn 
from the reaction mixture and the reaction progress was monitored by following the 
depletion in absorbance at 290 nm. Aer 10.5 h for 4-OT S37E/M45I/F50A and 7.5 h 
for 4-OT A33E/M45I/F50A the reaction was nished and the reaction mixture was 
extracted 3x with 20 mL ethyl acetate. e combined organic layers were washed with 
brine and dried over anhydrous Na2SO4. For the reaction catalyzed by S37E/M45I/F50A, 
the organic layer was concentrated in vacuo, yielding 3 (27.8 mg, 95% isolated yield). 
For the 4-OT A33E/M45I/F50A catalyzed reaction the organic layer was concentrated 
in vacuo and the product was puried by silica gel column chromatography (hexane/
ethyl acetate 4:1) to obtain 3 (16.0 mg, 55% yield).
Condensation of 1b to DERA and to 4-OT
e condensation of 1b with DERA and 4-OT was monitored in time by following the 
absorbance at 516 nm. For the condensation with DERA and DERA K167L, a 2x stock 
solution was prepared consisting of the following: 20 mM potassium phosphate (pH 
7.0), 10% DMSO and 8 mM 1b. 500 µL of the stock solution was mixed in a 1 cm quartz 
cuvet with 500 µL of 200 µM DERA or DERA K167L (5.54 mg/mL) in 20 mM potassium 
phosphate (pH 7.0). Immediately aer mixing the absorbance at 516 nm was measured 
every 0.5 s for 190 seconds. For 4-OT, a 2x stock solution was prepared consisting of 
the following: 20 mM HEPES (pH6.5), 10% ethanol and 0.6 mM 1b. 500 µL of the stock 
solution was mixed in a 1 cm quartz cuvet with 500 µL of 100 µM 4-OT in 20 mM HEPES 
pH 6.5. Immediately aer mixing the absorbance at 516 nm was measured every 0.1 s 
for 190 seconds.
Derivatization of 3 for enantiomeric excess determination
e aldehyde functionality of 3 was derivatized to a cyclic acetal according to a literature 
procedure44,45. e enantiopurity of derivatized 3 was analyzed by reverse phase HPLC 
using a column with a chiral stationary phase (chiralpak AD-RH, 150 mm x 4.6 mm, 
Daicel). Detection at 220 nm, retention time R-3: 8.8 min, S-3: 12.2 min. e absolute 
conguration was determined by literature comparison16.
BNW_Lieuwe.indd   132 31-08-20   15:18
133
A Colorimetric “Turn-on” Probe for Engineering of Iminium Biocatalysis
Associated Content
Supporting Information
Synthesis of starting materials and reference compounds, additional Tables and Figures 
including ESI-MS, NMR, HPLC and UV-VIS spectra.
Acknowledgement
We acknowledge nancial support from the Netherlands Organization of Scientic 
Research (ECHO grant 713.015.003 and VICI grant 724.016.002), the European Research 
Council (PoC grant 713483), and the European Union’s Horizon 2020 Research and 
Innovation Programme under grant agreement No 635595 (CarbaZymes). We thank M.P. 
de Vries for his assistance in performing the electrospray ionization mass spectrometry 
experiments.
Author contributions
L.B. performed 4-OT labeling experiments, developed the AICS screening assay, and 
performed experiments with DERA. L.B. and M.C. performed the screening of mutant 
libraries. M.S. synthesized cinnamaldehyde derivatives. G.J.P. supervised scientic work. 
All authors contributed to writing of the manuscript.
Competing nancial interests
e authors declare no competing nancial interests
4




1. Claraz, A.; Siitonen, J. H.; Pihko, P. M. Iminium Catalysis (n?→?Π*). In Lewis Base Catalysis 
in Organic Synthesis; Vedejs, E.; Denmark, S.E., Eds.; Wiley-VCH: Weinheim, Germany, 
2016; pp 805–856.
2. Samland, A. K.; Rale, M.; Sprenger, G. A.; Fessner, W.-D. e Transaldolase Family: New 
Synthetic Opportunities from an Ancient Enzyme Scaold. ChemBioChem 2011, 12 (10), 
1454–1474.
3. Clapés, P.; Garrabou, X. Current Trends in Asymmetric Synthesis with Aldolases. Adv. 
Synth. Catal. 2011, 353 (13), 2263–2283, https://doi.org/10.1002/adsc.201100236.
4. Fei, H.; Zheng, C.; Liu, X.; Li, Q. An Industrially Applied Biocatalyst: 2-Deoxy-d-Ribose-5- 
Phosphate Aldolase. Process Biochem. 2017, 63, 55–59.
5. Jiang, L.; Altho, E. A.; Clemente, F. R.; Doyle, L.; Röthlisberger, D.; Zanghellini, A.; 
Gallaher, J. L.; Betker, J. L.; Tanaka, F.; Barbas, III, C. F.; Hilvert, D.; Houk, K. N.; Stoddard, 
B. L.; Baker, D. De Novo Computational Design of Retro-Aldol Enzymes. Science 2008, 319 
(5868), 1387 – 1391.
6. Altho, E. A.; Wang, L.; Jiang, L.; Giger, L.; Lassila, J. K.; Wang, Z.; Smith, M.; Hari, S.; 
Kast, P.; Herschlag, D.; Hilvert, D.; Baker, D. Robust Design and Optimization of Retroaldol 
Enzymes. Protein Sci. 2012, 21 (5), 717–726.
7. Zandvoort, E.; Baas, B.; Quax, W. J.; Poelarends, G. J. Systematic Screening for Catalytic 
Promiscuity in 4-Oxalocrotonate Tautomerase: Enamine Formation and Aldolase Activity. 
ChemBioChem 2011, 12 (4), 602–609.
8. Poddar, H.; Rahimi, M.; Geertsema, E. M.; unnissen, A. M. W. H.; Poelarends, G. J. 
Evidence for the Formation of an Enamine Species during Aldol and Michael-Type Addition 
Reactions Promiscuously Catalyzed by 4-Oxalocrotonate Tautomerase. ChemBioChem 2015, 
16 (5), 738-741.
9. Garrabou, X.; Beck, T.; Hilvert, D. A Promiscuous De Novo Retro-Aldolase Catalyzes 
Asymmetric Michael Additions via Schi Base Intermediates. Angew. Chemie, Int. Ed. 2015, 
54 (19), 5609–5612.
10. Giger, L.; Caner, S.; Obexer, R.; Kast, P.; Baker, D.; Ban, N.; Hilvert, D. Evolution of a 
Designed Retro-Aldolase Leads to Complete Active Site Remodeling. Nat. Chem. Biol. 2013, 
9, 494–498.
11. Obexer, R.; Godina, A.; Garrabou, X.; Mittl, P. R. E.; Baker, D.; Griths, A. D.; Hilvert, D. 
Emergence of a Catalytic Tetrad during Evolution of a Highly Active Articial Aldolase. 
Nat. Chem. 2017, 9 (1), 50–56.
12. Garrabou, X.; Wicky, B. I. M.; Hilvert, D. Fast Knoevenagel Condensations Catalyzed by an 
Articial Schi-Base-Forming Enzyme. J. Am. Chem. Soc. 2016, 138 (22), 6972–6974.
13. Garrabou, X.; MacDonald, D. S.; Hilvert, D. Chemoselective Henry Condensations Catalyzed 
by Articial Carboligases. Chem. - Eur. J. 2017, 23 (25), 6001–6003.
BNW_Lieuwe.indd   134 31-08-20   15:18
135
A Colorimetric “Turn-on” Probe for Engineering of Iminium Biocatalysis
14. Rahimi, M.; van der Meer, J.Y.; Geertsema, E. M.; Poelarends, G. J. Engineering a 
Promiscuous Tautomerase into a More Ecient Aldolase for Self-Condensations of Linear 
Aliphatic Aldehydes. ChemBioChem 2017, 18 (14), 1435–1441.
15. Rahimi, M.; van der Meer, J.Y.; Geertsema, E. M; Poddar, H.; Baas, B. J.; Poelarends, G. 
J. Mutations Closer to the Active Site Improve the Promiscuous Aldolase Activity of 4‐
Oxalocrotonate Tautomerase More Eectively than Distant Mutations. ChemBioChem 2016, 
17 (13).
16. van der Meer, J.Y.; Poddar, H.; Baas, B.J.; Miao, Y.; Rahimi, M.; Kunzendorf, A.; van Merkerk, 
R.; Tepper, P. G.; Geertsema, E. M.; unnissen, A.M. W. H.; Quax, W. J.; Poelarends, G. J. 
Using Mutability Landscapes of a Promiscuous Tautomerase to Guide the Engineering of 
Enantioselective Michaelases. Nat. Commun. 2016, 7, 10911.
17. Biewenga, L.; Saravanan, T.; Kunzendorf, A.; van der Meer, J.Y.; Pijning, T.; Tepper, P. G.; 
van Merkerk, R.; Charnock, S. J.; unnissen, A.M. W. H.; Poelarends, G. J. Enantioselective 
Synthesis of Pharmaceutically Active γ-Aminobutyric Acids Using a Tailor-Made Articial 
Michaelase in One-Pot Cascade Reactions. ACS Catal. 2019, 9 (2), 1503–1513.
18. Guo, C.; Saifuddin, M.; Saravanan, T.; Shari, M.; Poelarends, G. J. Biocatalytic Asymmetric 
Michael Additions of Nitromethane to α,β-Unsaturated Aldehydes via Enzyme-Bound 
Iminium Ion Intermediates. ACS Catal. 2019, 9 (5), 4369–4373.
19. Goldsmith, M.; Tawk, D. S. Enzyme Engineering by Targeted Libraries. In Methods in 
Protein Design; Keating, A. E., Ed.; Academic Press, 2013; Vol. 523, pp 257–283.
20. Acevedo-Rocha, C.G.; Ferla, M.; Reetz, M.T. Directed Evolution of Proteins Based on 
Mutational Scanning. In Methods in Protein Engineering; Bornscheuer U., Höhne M., eds.; 
Humana Press, New York, 2018; Vol. 1685, pp 87-128.
21. van der Meer, J. Y.; Biewenga, L.; Poelarends, G. J. e Generation and Exploitation of 
Protein Mutability Landscapes for Enzyme Engineering. ChemBioChem 2016, 17 (19), 
1792–1799.
22. Yang, G.; Withers, S. G. Ultrahigh-roughput FACS-Based Screening for Directed Enzyme 
Evolution. ChemBioChem 2009, 10 (17), 2704–2715.
23. Baret, J.C.; Miller, O. J.; Taly, V.; Ryckelynck, M.; El-Harrak, A.; Frenz, L.; Rick, C.; Samuels, 
M. L.; Hutchison, J. B.; Agresti, J. J.; Link, D. R.; Weitz, D. A.; Griths, A. D. Fluorescence-
Activated Droplet Sorting (FADS): Ecient Microuidic Cell Sorting Based on Enzymatic 
Activity. Lab Chip 2009, 9 (13), 1850–1858.
24. Mair, P.; Gielen, F.; Hollfelder, F. Exploring Sequence Space in Search of Functional Enzymes 
Using Microuidic Droplets. Curr. Opin. Chem. Biol. 2017, 37, 137–144.
25. Obexer, R.; Pott, M.; Zeymer, C.; Griths, A. D.; Hilvert, D. Ecient Laboratory Evolution 
of Computationally Designed Enzymes with Low Starting Activities Using Fluorescence-
Activated Droplet Sorting. Protein Eng. Des. Sel. 2016, 29 (9), 355–366.
26. Kulinich, A. V.; Ishchenko, A. A. Merocyanine Dyes: Synthesis, Structure, Properties and 
Applications. Russ. Chem. Rev. 2009, 78 (2), 141–164.
27. Mishra, A.; Behera, R. K.; Behera, P. K.; Mishra, B. K.; Behera, G. B. Cyanines during the 
1990s: A Review. Chem. Rev. 2000, 100 (6), 1973–2012.
4
BNW_Lieuwe.indd   135 31-08-20   15:18
136
Chapter 4
28. Haridas, M.; Abdelraheem, E. M. M.; Hanefeld, U. 2-Deoxy-d-Ribose-5-Phosphate Aldolase 
(DERA): Applications and Modications. Appl. Microbiol. Biotechnol. 2018, 102 (23), 9959–
9971.
29. Whitman, C. P. e 4-Oxalocrotonate Tautomerase Family of Enzymes: How Nature Makes 
New Enzymes Using a β-α-β Structural Motif. Arch. Biochem. Biophys. 2002, 402 (1), 1–13.
30. Mugge, C.; Kourist, R. Practical Considerations Regarding the Choice of the Best High-
roughput Assay. In Protein engineering methods and protocols; Bornscheuer, U. T., Hohne, 
M., Eds.; Humana Press: New York, 2018; pp 189–208.
31. Aharoni, A.; ieme, K.; Chiu, C. P. C.; Buchini, S.; Lairson, L. L.; Chen, H.; Strynadka, N. 
C. J.; Wakarchuk, W. W.; Withers, S. G. High-roughput Screening Methodology for the 
Directed Evolution of Glycosyltransferases. Nat. Methods 2006, 3 (8), 609–614.
32. Lauchli, R.; Rabe, K. S.; Kalbarczyk, K. Z.; Tata, A.; Heel, T.; Kitto, R. Z.; Arnold, F. H. High-
roughput Screening for Terpene-Synthase-Cyclization Activity and Directed Evolution 
of a Terpene Synthase. Angew. Chemie Int. Ed. 2013, 52 (21), 5571–5574.
33. Wang, W.; Nossoni, Z.; Berbasova, T.; Watson, C. T.; Yapici, I.; Lee, K. S. S.; Vasileiou, C.; 
Geiger, J. H.; Borhan, B. Tuning the Electronic Absorption of Protein-Embedded All-Trans-
Retinal. Science 2012, 338 (6112), 1340 – 1343.
34. Crist, R. M.; Vasileiou, C.; Rabago-Smith, M.; Geiger, J. H.; Borhan, B. Engineering a 
Rhodopsin Protein Mimic. J. Am. Chem. Soc. 2006, 128 (14), 4522–4523.
35. Vasileiou, C.; Vaezeslami, S.; Crist, R. M.; Rabago-Smith, M.; Geiger, J. H.; Borhan, B. Protein 
Design: Reengineering Cellular Retinoic Acid Binding Protein II into a Rhodopsin Protein 
Mimic. J. Am. Chem. Soc. 2007, 129 (19), 6140–6148.
36. Herwig, L.; Rice, A. J.; Bedbrook, C. N.; Zhang, R. K.; Lignell, A.; Cahn, J. K. B.; Renata, H.; 
Dodani, S. C.; Cho, I.; Cai, L.; Gradinaru, V.; Arnold, F. H. Directed Evolution of a Bright 
Near-Infrared Fluorescent Rhodopsin Using a Synthetic Chromophore. Cell Chem. Biol. 
2017, 24 (3).
37. Berbasova, T.; Nosrati, M.; Vasileiou, C.; Wang, W.; Lee, K. S. S.; Yapici, I.; Geiger, J. H.; 
Borhan, B. Rational Design of a Colorimetric PH Sensor from a Soluble Retinoic Acid 
Chaperone. J. Am. Chem. Soc. 2013, 135 (43), 16111–16119.
38. Yapici, I.; Lee, K. S. S.; Berbasova, T.; Nosrati, M.; Jia, X.; Vasileiou, C.; Wang, W.; Santos, E. 
M.; Geiger, J. H.; Borhan, B. “Turn-On” Protein Fluorescence: In Situ Formation of Cyanine 
Dyes. J. Am. Chem. Soc. 2015, 137 (3), 1073–1080.
39. Ferrari, A. R.; Gaber, Y.; Fraaije, M. W. A Fast, Sensitive and Easy Colorimetric Assay for 
Chitinase and Cellulase Activity Detection. Biotechnol. Biofuels 2014, 7 (1), 37.
40. Khersonsky, O.; Tawk, D. S. Chromogenic and Fluorogenic Assays for the Lactonase 
Activity of Serum Paraoxonases. ChemBioChem 2006, 7 (1), 49–53.
41. ai, Y. C.; Szekrenyi, A.; Qi, Y.; Black, G. W.; Charnock, S. J.; Fessner, W. D. Fluorogenic 
Kinetic Assay for High-roughput Discovery of Stereoselective Ketoreductases Relevant 
to Pharmaceutical Synthesis. Bioorg. Med. Chem. 2018, 26 (7), 1320–1326.
BNW_Lieuwe.indd   136 31-08-20   15:18
137
A Colorimetric “Turn-on” Probe for Engineering of Iminium Biocatalysis
42. Baud, D.; Ladkau, N.; Moody, T. S.; Ward, J. M.; Hailes, H. C. A Rapid, Sensitive Colorimetric 
Assay for the High-roughput Screening of Transaminases in Liquid or Solid-Phase. Chem. 
Commun. 2015, 51 (97), 17225–17228.
43. Waddell, W. J. A Simple Ultraviolet Spectrophotometric Method for the Determination of 
Protein. J. Lab. Clin. Med. 1956, 48 (2), 311–314.
44. Zandvoort, E.; Geertsema, E. M.; Baas, B.-J.; Quax, W. J.; Poelarends, G. J. Bridging between 
Organocatalysis and Biocatalysis: Asymmetric Addition of Acetaldehyde to β-Nitrostyrenes 
Catalyzed by a Promiscuous Proline-Based Tautomerase. Angew. Chemie, Int. Ed. 2012, 51 
(5), 1240–1243, S1240/1-S1240/13.
45. Geertsema, E. M.; Miao, Y.; Tepper, P. G.; Dehaan, P.; Zandvoort, E.; Poelarends, G. J. 
Biocatalytic Michael-Type Additions of Acetaldehyde to Nitroolens with the Proline-Based 
Enzyme 4-Oxalocrotonate Tautomerase Yielding Enantioenriched γ-Nitroaldehydes. Chem. 
- Eur. J. 2013, 19 (43), 14407–14410.
4





Synthesis of chiral references
Racemic 3, that served as a reference for analyses by HPLC on a chiral stationary phase, 
was synthesized according to a literature procedure1.
Synthesis of 1b-e
Compounds 1b-e were prepared according to a literature procedure2 and their 1H NMR 
spectra match with earlier reported NMR data3.
R
C HO
( i ) A , T o l u e n e
9 0 o C , 3 h
R
C HO( i i ) B , D C M
r t , 1 2 h
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C O2E t
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8 R = 4 - OH ( 7 3 % )
Figure S1. Synthesis of α,β-unsaturated aldehydes 1b-e via the Wittig reaction.
 (E)-3-(2-hydroxyphenyl)acrylaldehyde (1b). 1H NMR (500 MHz, CDCl3): δ 9.68 (d, 
J = 8.0 Hz, 1H), 7.79 (d, J = 16.0 Hz, 1H), 7.50 (dd, J = 7.8, 1.4 Hz, 1H), 7.31 (td, J = 8.1, 1.6 
Hz, 1H), 7.07 – 6.93 (m, 2H), 6.89 (dd, J = 8.1, 0.8 Hz, 1H), 6.59 (s, 1H).
(E)-3-(4-hydroxyphenyl)acrylaldehyde (1c). 1H NMR (500 MHz, DMSO-d6): δ 10.20 
(s, 1H), 9.58 (d, J = 7.9 Hz, 1H), 7.67 – 7.57 (m, 3H), 6.84 (d, J = 8.6 Hz, 2H), 6.66 (dd, 
J = 15.8, 7.9 Hz, 1H).
(E)-3-(2-methoxyphenyl)acrylaldehyde (1d). 1H NMR (500 MHz, CDCl3): δ 9.67 (d, 
J = 7.9 Hz, 1H), 7.82 (d, J = 16.1 Hz, 1H), 7.52 (dd, J = 7.7, 1.6 Hz, 1H), 7.40 (ddd, J = 8.9, 
7.5, 1.7 Hz, 1H), 6.98 (t, J = 7.5 Hz, 1H), 6.93 (d, J = 8.3 Hz, 1H), 6.77 (dd, J = 16.1, 7.9 
Hz, 1H), 3.89 (s, 3H).
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(E)-3-(3-hydroxyphenyl)acrylaldehyde (1e). 1H NMR (500 MHz, DMSO-d6) δ 9.72 (s, 
1H), 9.65 (d, J = 7.8 Hz, 1H), 7.66 (d, J = 15.9 Hz, 1H), 7.27 (t, J = 7.8 Hz, 1H), 7.18 (d, 
J = 7.7 Hz, 1H), 7.08 (s, 1H), 6.89 (dd, J = 8.0, 2.0 Hz, 1H), 6.74 (dd, J = 15.9, 7.8 Hz, 1H).
Ethyl (E)-3-(4-hydroxyphenyl)acrylate (7). 1H NMR (500 MHz, CDCl3): δ 7.64 (d, 
J = 16.0 Hz, 1H), 7.40 (d, J = 8.6 Hz, 2H), 7.02 (s, 1H), 6.88 (d, J = 8.6 Hz, 2H), 6.29 (d, 
J = 15.9 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H).
(E)-4-(3-hydroxyprop-1-en-1-yl)phenol (8). 1H NMR (500 MHz, DMSO-d6): δ 9.48 (s, 
1H), 7.22 (d, J = 8.5 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 6.41 (d, J = 16.0 Hz, 1H), 6.12 (dt, 
J = 15.9, 5.4 Hz, 1H), 4.79 (t, J = 5.5 Hz, 1H), 4.05 (t, J = 4.8 Hz, 2H).
Supporting gures
Figure S2. Binding curve of 1b to 4-OT M45T/F50A. Following conditions were used: 50 µM 
4-OT M45T/F50A, 1b 4 mM – 0 mM, 2-fold dilution series, 20 mM sodium phosphate pH 7.3, 
5% DMSO, 300 µl reaction volume in 1 mm quartz cuvets.
4
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Figure S3. (a) ESI-MS spectrum of 4-OT M45T/F50A labeled with 1b (expected mass free enzyme 
6706 Da, expected mass labeled enzyme 6838 Da). (b) ESI-MS spectrum of 4-OT M45T/F50A 
no-reduction control (expected mass 6706 Da). (c) ESI-MS spectrum of unmodied 4-OT M45T/
F50A treated with NaCNBH3 (expected mass 6706 Da).
 
Figure S4. (a) ESI-MS spectrum of peptides of 4-OT M45T/F50A labeled with 1b with m/z be-
tween 582 and 584 Da. M/z of 582.83 corresponds to the expected mass of peptide MPIAQIHILE 
(4-OT with an unprocessed N-terminal methionine), m/z of 583.33 corresponds to peptide PIAQ-
IHILE labeled with a molecule of 1b. (b) ESI-MS spectrum of peptides of 4-OT M45T/F50A no-re-
duction control. (c) ESI-MS spectrum of unmodied 4-OT M45T/F50A treated with NaCNBH3.
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Figure S5. (a) e condensation of 1b with DERA was monitored in time by following the increase 
in absorbance at 516 nm directly aer mixing of the enzyme and 1b. As a control, DERA K167L 
was used, an inactive mutant because of substitution of the active-site lysine4. Assay conditions: 
20 mM potassium phosphate (pH 7.0), 5% DMSO, 4 mM 1b, 100 µM DERA, 1 mL in 1 cm quartz 
cuvets. (b) e condensation of 1b with dierent 4-OT mutants was monitored in time by follow-
ing the increase in absorbance at 516 nm directly aer mixing 4-OT with 1b. Assay conditions: 
20 mM HEPES (pH 6.5), 5% ethanol, 0.3 mM 1b, 50 µM 4-OT, 1 mL in 1 cm quartz cuvets.
Figure S6. Whole cell staining of 4-OT single mutants with a mutation at position His-6, Met-45 
or Phe-50. (a) Layout of 4-OT single mutants. EV: empty vector (b) Picture of cell pellets of 4-OT 
single mutants stained with 1b. Indicated with a circle are 4-OT F50A, F50I and F50V.
4
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Figure S7. UV spectra showing the conversion of 1a for the Michael-type addition of 2 to 1a 
catalyzed by 4-OT S37E/M45I/F50A.
Figure S8. UV spectra showing the conversion of 1a for the Michael-type addition of 2 to 1a 
catalyzed by 4-OT A33E/M45I/F50A.
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Figure S9. 1H NMR spectrum of 4-nitro-3-phenylbutanal (3), obtained from the 4-OT S37E/
M45I/F50A catalyzed addition of 2 to 1a (400 MHz, CDCl3).
Figure S10. 1H NMR spectrum of 4-nitro-3-phenylbutanal (3), obtained from the 4-OT A33E/
M45I/F50A catalyzed addition of 2 to 1a (400 MHz, CDCl3).
4
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Figure S11. HPLC chromatogram of racemic and enzymatically prepared derivatized 3.
Supporting tables







1 a 2 3
4 - OT m u t a n t
( R )
Entry Mutant Reaction time (h)b Isolated yield (%) ee (%)c
1 4-OT S37E/M45I/F50A 10.5 95 98 (R)
2 4-OT A33E/M45I/F50A 7.5 55 >99 (R)
 aAssay conditions: 5% ethanol, 20 mg 1a, 25 mM 2, 50 mM sodium formate, 20 mM HEPES (pH 
6.5), 7.5 µM enzyme, 100 mL. bReaction progress was monitored by following the depletion in 
absorbance at 290 nm. cEnzymatic product 3 was rst converted into the corresponding ethylene 
glycol acetal. e ee was determined by HPLC with a chiral stationary phase. e absolute 
conguration was based on literature comparison5.
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e enzyme 4-oxalocrotonate tautomerase (4-OT) can promiscuously catalyze various 
carboligation reactions using acetaldehyde as a nucleophile. However, the highly 
reactive nature of acetaldehyde requires intricate handling, which can impede its usage 
in practical synthesis. erefore, we investigated three enzymatic routes to synthesize 
acetaldehyde in situ in one-pot cascade reactions with 4-OT. Two routes aorded 
practical acetaldehyde concentrations, using an environmental pollutant, trans-3-
chloroacrylic acid, or a biorenewable, ethanol, as starting substrate. ese routes can be 
combined with 4-OT catalyzed Michael-type additions and aldol condensations in one 
pot. is modular systems biocatalysis methodology provides a stepping stone towards 
the development of larger articial metabolic networks for the practical synthesis of 
important chemical synthons.
Keywords
Acetaldehyde, carboligation, biocatalysis, cascade reactions
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Introduction
e enzyme 4-oxalocrotonate tautomerase (4-OT) naturally catalyzes the tautomerization 
of 2-hydroxy-2,4-hexadienedioate to 2-oxo-3-hexenedioate using the N-terminal 
proline as key catalytic base[1]. In addition, 4-OT can promiscuously catalyze several 
carbon-carbon bond-forming reactions, including Michael-type additions and aldol 
condensations, employing Pro-1 as a nucleophile[2–4]. Most notably, 4-OT can catalyze 
Michael-type additions and aldol condensations using the highly reactive acetaldehyde 
(5) as a nucleophile (Scheme 1).
However, the use of 5 in enzymatic reactions causes several practical challenges. 
Compound 5 is toxic, highly volatile and reactive, which requires intricate handling. 
Hence, in situ generation of 5 from less reactive and less toxic compounds is an attractive 
concept to combine with 4-OT in one-pot cascade reactions. Previous studies have 
primarily focused on in situ generation of longer aldehydes, for instance from their 
corresponding carboxylic acids or alcohols using carboxylic acid reductases (CAR) or 
alcohol dehydrogenases respectively[5–8].
Here we investigate three enzymatic routes for the in situ generation of 5 in one-pot 
cascade reactions with 4-OT, using 1, 3 or 4 as starting substrates (Scheme 1). Route 
I involves the dehalogenation of 1 into 2, catalyzed by the enzyme chloroacrylic acid 
dehalogenase (CaaD), followed by the decarboxylation of 2 into 5 by the enzyme 
malonate semialdehyde decarboxylase (MSAD). Route II involves the oxidation of 3 
into 5 catalyzed by the alcohol dehydrogenase from Saccharomyces cerevisiae (ScADH), 
in combination with a commercially available NADH oxidase, PRO-NOX(009), to shi 
the unfavorable reaction equilibrium and to recycle the co-factor. Route III involves 
the decarboxylation of 4 using the pyruvate decarboxylase from Zymomonas mobilis 
(ZmPDC).
Routes I and II proved to be eective routes for in situ generation of 5 and could be 
used in combination with 4-OT to synthesize 7 and 9 in one pot. Interestingly, route II 
aorded a mixture of 9 and 10. e presented work provides a stepping stone towards 
the construction of articial enzymatic metabolic routes for the synthesis of valuable 
chemical commodities.
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Scheme 1. ree envisioned enzymatic routes for in situ generation of acetaldehyde (5). e in situ 
synthesized 5 is used as substrate in a 4-OT L8Y/M45Y/F50A catalyzed Michael-type addition 
and a 4-OT M45T/F50A catalyzed aldol condensation reaction in one pot. Abbreviations: CaaD: 
chloroacrylic acid dehalogenase, MSAD: malonate semialdehyde decarboxylase, ScADH: alcohol 
dehydrogenase, PRO-NOX(009): NADH oxidase, ZmPDC: pyruvate decarboxylase.
Results
ere are several enzymes that naturally produce 5 as their main product, as 5 is at the 
crossway of several metabolic routes. We selected three complementary enzymatic routes 
(route I, II and III, Scheme 1) for in situ generation of 5, using the readily accessible 
starting materials 1, 3 and 4. We initially focused on the enzymatic synthesis of 5 via 
route I. e release of HCl and carbon dioxide in the rst and second step respectively, is 
expected to shi the equilibrium towards the formation of 5. Indeed, initial experiments 
showed that a cascade reaction with CaaD and MSAD resulted in near quantitative 
conversion of 1 into 5 (Figure 1). Notably, no signicant enzyme inhibition occurred 
at this concentration of 5. Optimizing enzyme concentrations aorded 50 mM 5 in 90 
minutes using 5 µM CaaD and 1 µM MSAD (Figure 1).
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Figure 1. Progress curves of enzymatic synthesis of 5 using route I and route II. (a) Formation of 
5 via route I. Assay conditions: 50 mM 1, 100 mM sodium phosphate (pH 7.3). (b) Formation of 
5 via route II. Assay conditions: 100 mM sodium phosphate pH 7.3, 2 mg/mL PRO-NOX(009), 
10 U/mL ScADH, 10% v/v 3, 2 mM NAD+, 5 mL reaction volume, under oxygen atmosphere, 
performed in a 25 mL ask.
We next focused on the enzymatic oxidation of 3 (Scheme 1, route II), which can be 
catalyzed by both alcohol oxidases and alcohol dehydrogenases. Since alcohol oxidases 
are prone to over-oxidation of aldehydes into their corresponding carboxylic acids[9], 
we opted for the use of an alcohol dehydrogenase instead. e commercial available 
Yeast alcohol dehydrogenase, (ScADH, Saccharomyces cerevisiae) was selected as 
biocatalyst because of its high selectivity towards short-chain primary alcohols[10,11]. e 
commercially available NADH oxidase PRO-NOX(009) was selected to recycle NAD+ 
and to overcome the unfavorable reaction equilibrium.
Concentrations of up to 10% v/v 3 were well tolerated by both enzymes, but higher 
concentrations rapidly inactivated at least one of the enzymes. Vigorous stirring of 
the reaction mixture under an oxygen atmosphere signicantly improved the rate of 
5 production compared to an unstirred reaction (Figure 1). Reaction conditions were 
optimized to reach a concentration of approximately 50 mM 5 aer 150 minutes.
Lastly, we focused on the enzymatic decarboxylation of 4 to 5 (Scheme 1, route III). e 
pyruvate decarboxylase from Z. mobilis (ZmPDC) was cloned, expressed and puried to 
homogeneity. However, we were unable to nd conditions that aorded concentrations 
of 5 above 30 mM, due to either inactivation or inhibition of the enzyme by 5. is 
concentration was considered too low for eective catalysis with 4-OT and hence we 
abandoned this route.
5
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Chapter 5
Having established two eective enzymatic routes for the in situ synthesis of 5, we next 
focused our attention on the combination of these routes with 4-OT in one-pot multistep 
cascade reactions. We initially focused on the 4-OT catalyzed Michael-type addition 
of 5 to 6 yielding 7, an important precursor for the γ-aminobutyric acid analogue 
phenibut[4,12]. As a catalyst, the previously engineered 4-OT L8Y/M45Y/F50A variant 
was selected[13]. Combination of 4-OT L8Y/M45Y/F50A and 6 with in situ synthesized 
5 (via both route I and II) aorded R-7 in high enantiopurity (e.r. up to 98:2) and good 
to excellent isolated yields (up to 96% compared to 6) (Table 1).








R o u t e I a
R o u t e I I b







Step I (min)c Step II (min)d e.r.e Isolated yield (%)f
Route I 150 75 98:2 62
Route II 90 85 98:2 96
aDehalogenation of 1 into 2 catalyzed by CaaD, followed by decarboxylation of 2 into 5 catalyzed 
by MSAD, followed by the Michael-type addition of 5 to 6 yielding 7 catalyzed by 4-OT L8Y/
M45Y/F50A. e reaction mixture consisted of 50 mM 1, 4 mM 6, 1 µM MSAD, 5 µM CaaD, 56 
µM 4-OT L8Y/M45Y/F50A, 100 mM sodium phosphate pH 7.3, 10% v/v ethanol. bOxidation of 3 
into 5 catalyzed by ScADH, followed by the Michael-type addition of 5 to 6 yielding 7 catalyzed 
by 4-OT L8Y/M45Y/F50A. PRO-NOX(009) was used for co-factor recycling. e reaction mixture 
consisted of 10% v/v 3, 4 mM 6, 10 U/mL ScADH, 2 mg/mL PRO-NOX(009), 2 mM NAD+, 56 µM 
4-OT L8Y/M45Y/F50A, 100 mM sodium phosphate pH 7.3. cMonitored by HPLC. dMonitored by 
UV spectroscopy. eDetermined by GC with chiral stationary phase or derivatized into a cyclic 
acetal and determined by HPLC with a chiral stationary phase. e absolute conguration was 
determined by comparison to literature[14,15]. fIsolated yield compared to 6.
Next, we focused on combining route I and II with the 4-OT catalyzed aldol condensation 
of 5 with 8, forming 9. e previously engineered 4-OT M45T/F50A was used as a catalyst 
for this reaction[16]. Combination of route I with 8 and 4-OT M45T/F50A aorded 9 in good 
isolated yield (56% compared to 8) (Figure 2 and Table 2). Interestingly, the combination of 
route II with 8 and 4-OT M45T/F50A aorded a mixture of 9 (26% isolated yield compared 
to 8) and cinnamyl alcohol 10 (28% isolated yield compared to 8) (Figure 2 and Table 2). 
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ese results demonstrate some exciting opportunities available for the combination of 
natural metabolic routes with unnatural carboligation reactions in one pot.
Figure 2. Progress curves of the enzymatic cascade synthesis of 9 and 10. (a) Progress curve of the 
4-OT M45T/F50A catalyzed aldol condensation of 5 with 8 using in situ synthesized 5 via route 
I. Assay conditions: 50 mM 1, 4 mM 8, 1 µM MSAD, 10 µM CaaD, 75 µM 4-OT M45T/F50A, 
150 mM sodium phosphate pH 7.3, 5% v/v ethanol, 17.8 mL reaction volume. (b) Progress curve 
of the 4-OT M45T/F50A catalyzed aldol condensation of 5 with 8 using in situ synthesized 5 via 
route II. Assay conditions: 10% v/v 3, 5.7 mM 8, 2 mM NAD+, 133 µM 4-OT M45T/F50A, 10 U/mL 
ScADH, 2 mg/mL PRO-NOX(009), 100 mM sodium phosphate pH 7.3, 30 mL reaction volume.




R o u t e I a











Reaction time (h) Conversion (%)c Isolated yield (%)d
Route I 23.5 71 56
Route II 24 85 26e
aDehalogenation of 1 into 2 catalyzed by CaaD, followed by decarboxylation of 2 into 5 catalyzed 
by MSAD, followed by the aldol condensation of 5 with 8 yielding 9 catalyzed by 4-OT M45T/
F50A. e reaction mixture consisted of 50 mM 1, 4 mM 8, 1 µM MSAD, 10 µM CaaD, 75 µM 
4-OT M45T/F50A, 150 mM sodium phosphate pH 7.3, 5% v/v ethanol. bOxidation of 3 into 5 
catalyzed by ScADH, followed by the aldol condensation of 5 with 8 yielding 9 catalyzed by 4-OT 
M45T/F50A. e reaction mixture consisted of 10% v/v 3, 5.7 mM 8, 2 mM NAD+, 133 µM 4-OT 
M45T/F50A, 10 U/mL ScADH, 2 mg/mL PRO-NOX(009), 100 mM sodium phosphate pH 7.3. 
cDetermined by HPLC. dCompared to 8. ee low yield is caused by partial reduction of 9 into 
10 (Figure 2b). Cinnamyl alcohol 10 could be obtained with 28% isolated yield compared to 8.
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4-OT is unique in that it can use 5 as substrate for C-C bond-forming Michael-type 
additions to nitroolen acceptors and for aldol condensations with benzaldehydes[3,4]. 
Previously, we have demonstrated that 4-OT can be combined with other biocatalysts 
and chemocatalysts to convert 6 and 8 into GABA analogues using two complementary 
one-pot cascade reactions[13,15]. However, both routes rely on 5 as a substrate. e inherent 
high reactivity and toxicity of 5 makes it a less desirable substrate and special care has 
to be taken to prevent polymerization or oxidation. A solution to this problem is the 
enzymatic in situ generation of 5 using less toxic and reactive starting substrates in 
multistep cascade reactions. To this end, we have investigated three enzymatic routes 
for the in situ generation of 5, using dierent starting materials.
e rst route we investigated involves the conversion of soil pollutant 1 into 5. 
Recycling of 1, a degradation product from the xenobiotic soil fumigant trans-1,3-
dichloropropene[17], into GABA precursors provides an interesting example of the rst 
principle of circular chemistry and as such might be desirable for future sustainable 
synthesis[18]. To this end, we selected the enzymes trans-3-chloroacrylic acid dehalogenase 
and malonate semi-aldehyde decarboxylase, which are part of the metabolic pathway 
for the degradation of trans-1,3-dichloropropene in Pseudomonas cichorii 170[19,20]. e 
second route comprises of the oxidation of 3 into 5. As an inexpensive biorenewable, 
3 is an attractive precursor of 5 that can concurrently act as a co-solvent to solubilize 
6 and 8. To catalyze the oxidation of 3, we selected yeast alcohol dehydrogenase, using 
an NADH oxidase for co-factor recycling and as a driving force to overcome the 
unfavorable reaction equilibrium between 3 and 5. irdly, we investigated the readily 
available substrate 4 as precursor for 5, using pyruvate decarboxylase from Z. mobilis 
as biocatalyst.
Gratifyingly, concentrations of 50 mM 5 or higher could be generated in situ using both 
route I and II. Route III only aorded lower concentrations of 5 and unfortunately, we 
were unable to nd conditions to improve this. We speculate that ZmPDC was either 
inactivated or strongly inhibited by 5[21], and the eective use of route III for in situ 
generation of 5 awaits the discovery of 4-OT mutants with a lower KM for 5.
We demonstrated the modularity of our approach by showing that the in situ generated 5 
can be used as a substrate for both 4-OT catalyzed aldol condensations and Michael-type 
additions. e Michael-type addition of 5 to 6 was catalyzed by the previously engineered 
4-OT L8Y/M45Y/F50A and aorded R-7 in good to excellent isolated yield (up to 96% 
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compared to 6) and with an excellent e.r. value of 98:2. e aldol condensation of 5 with 
8 was catalyzed by the previously engineered 4-OT M45T/F50A. Route I aorded 9 in 
55% isolated yield, but route II aorded a mixture of 9 and 10. e reduction of 9 to 10 
is slowly catalyzed by ScADH and by an alcohol dehydrogenase present in the CFE of 
PRO-NOX(009).
In summary, we have investigated three enzymatic synthesis routes, using the 
readily accessible starting materials 1, 3 or 4, for in situ generation of 5 to be used 
as substrate by 4-OT in one-pot cascade syntheses. Route I and route II aorded 5 
in eective concentrations for synthesis with 4-OT, but route III aorded 5 only in 
low concentrations. Route I and route II are fully compatible with 4-OT, which was 
demonstrated by the one-pot cascade synthesis of 7 and 9. ese modular enzymatic 
cascades provide a stepping stone towards the development of larger “articial 
metabolisms” that could facilitate greener and more sustainable synthesis[22].
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Recombinant enzyme expression and purication
4-Oxalocrotonate Tautomerase
4-oxalocrotonate tautomerase (4-OT) variants were expressed in E. coli BL21(DE3) 
harboring a pJExpress414 vector (4-OT L8Y/M45Y/F50A) or pET20b vector (4-OT 
M45T/F50A) with the respective 4-OT gene. Cells were grown overnight at 37 °C in 1 
L LB medium substituted with 0.5% glycerol, 100 µg/ml ampicillin and 100 µM IPTG. 
Aer the expression of 4-OT the cells were collected and the enzymes were puried 
according to previously reported methods1,2. e enzyme concentration was determined 
using the Waddell method, the enzymes were ash frozen in liquid nitrogen and stored at 
– 20 °C until further use3. For each puried 4-OT variant the removal of the N-terminal 
methionine was conrmed by analysis of the correct protein mass using electron spray 
ionization mass spectrometry.
Trans-3-chloroarylic acid dehalogenase
e enzyme trans-3-chlorarylic acid dehalogenase (CaaD) from P. pavonaceae 170 
(previously known as P. cichorii 170) was expressed in E. coli BL21(DE3) harboring 
a pET5a vector with the CaaD gene. A single colony was used to inoculate 50 mL LB 
medium supplemented with 100 µg/ml ampicillin and grown overnight at 37 °C. 10 mL 
of this overnight culture was used to inoculate 1 L LB medium supplemented with 100 
µg/ml ampicillin and incubated at 37 °C. Aer the culture reached an OD of 0.4 – 0.6 the 
expression of CaaD was induced by the addition of 0.5 mM IPTG. e cells were grown 
for 6 h at 37 °C and collected by centrifugation (15 min, 4 °C, 10000 rpm). CaaD was 
puried by a modication of a published procedure4. e cell pellet was resuspended in 
10 mM sodium phosphate buer (pH 8) and the cells were disrupted by ultrasonication. 
Insoluble cell fragments were removed by centrifugation. e supernatant was collected 
and solid (NH4)2SO4 crystals were slowly added to a nal concentration of 1.6 M 
(NH4)2SO4. e solution was kept overnight at 4 °C and then centrifuged for 30 min. e 
supernatant was ltered and loaded onto a 5 ml HiTrap Phenyl HP column equilibrated 
with 10 mM sodium phosphate buer (pH 8) containing 1.6 M (NH4)2SO4. e column 
was washed with 3 column volumes (CV) of 10 mM sodium phosphate buer (pH 8) 
containing 1.6 M (NH4)2SO4, aer which a linear gradient of 10 mM sodium phosphate 
buer (pH 8) 1.6 M to 0 M (NH4)2SO4 over 20 CV was applied. Individual fractions 
were analyzed by SDS-PAGE and the fractions containing high concentrations of CaaD 
were pooled. e buer was exchanged against 20 mM Tris-HCl buer (pH 8.5) on a 
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HiPrep 26/10 Desalting column. e protein solution was loaded on a 5 ml HiTrap Q 
FF column equilibrated with 20 mM Tris-HCl buer (pH 8.5), washed with 3 CV of the 
equilibration buer and eluted with a linear salt gradient (0 – 1 M NaCl) over 20 CV 
with 20 mM Tris-HCl buer (pH 8.5). e fractions with the highest CaaD concentration 
were pooled together, dialyzed in 4 L 10 mM sodium phosphate buer (pH 7.3) and 
concentrated using a vivaspin centrifugal concentrator (Sartorius, 5000 MWCO). e 
enzyme concentration was determined using the Waddell method and the enzyme was 
ash frozen in liquid nitrogen and stored at – 20 °C until further use3. e correct 
molecular mass of CaaD was conrmed by electron spray ionization mass spectrometry.
Malonate semialdehyde decarboxylase
e enzyme malonate semialdehyde decarboxylase (MSAD) was expressed and puried 
by a modication of a published procedure5. A single colony of E. coli BL21(DE3) 
harboring a pET3a vector with the MSAD gene was used to inoculate 50 mL LB medium 
supplemented with 100 µg/ml ampicillin. Aer overnight growth at 37 °C this culture 
was used to inoculate 1 L LB medium supplemented with 100 µg/ml ampicillin. e 
culture was grown at 37 °C until an OD 0.4 -0.6 was reached, aer which protein 
expression was induced by addition of 0.5 mM IPTG. Aer 5 h incubation at 37 °C, the 
cells were collected by centrifugation (10 min, 10000 rpm). e obtained cell pellet was 
resuspended in 10 mM Tris-SO4 buer (pH 8) and disrupted by ultrasonication. Insoluble 
cell fragments were removed by centrifugation and the supernatant was applied to a 5 
ml HiTrap Q FF column equilibrated with 10 mM Tris-SO4 buer (pH 8). e column 
was washed with 5 CV equilibration buer and the proteins were eluted using a linear 
salt gradient of 0-0.5 M Na2SO4 over 20 CV. Individual fractions were analyzed by SDS-
PAGE and the fractions with the highest MSAD concentration were pooled together. 
Solid (NH4)2SO4 crystals were slowly added to this solution until a nal concentration of 
1 M (NH4)2SO4 and the resulting solution was stirred for 1 h at 4 °C. Aer centrifugation 
the supernatant was loaded on a 5 ml HiTrap Phenyl HP column equilibrated with 10 
mM Tris-SO4 buer (pH 8) containing 1 M (NH4)2SO4. e column was washed with 3 
CV of the equilibration buer and retained proteins were eluted with a linear gradient 
(1 – 0 M (NH4)2SO4) over 20 CV. Individual fractions were analyzed by SDS-PAGE and 
the fractions with the highest MSAD concentration were pooled together, 2x dialyzed 
in 4 L 10 mM Na2HPO4 buer (pH 7.3) and concentrated using a vivaspin centrifugal 
concentrator (Sartorius, 5000 MWCO). e enzyme concentration was determined using 
the Waddell method and the enzyme was ash frozen in liquid nitrogen and stored 
at – 20 °C until further use3. e correct molecular mass of MSAD was conrmed by 
electron spray ionization mass spectrometry.
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e enzyme pyruvate decarboxylase from Z. mobilis (ZmPDC) was expressed in E. 
coli BL21(DE3) harboring a pET21a vector containing an E. coli codon-optimized 
ZmPDC gene with a C-terminal His-tag. 1 L LB medium supplemented with 100 µg/ml 
ampicillin was inoculated with cells from an overnight culture. e cells were grown 
at 37 °C until the culture reached an OD 0.4 – 0.6, aer which protein expression was 
induced by the addition of 100 µM IPTG. Aer growth overnight at 20 °C, the cells were 
collected by centrifugation and the cell pellet was resuspended in 50 mM Mes/NaOH, 
0.1 mM DP, 5 mM MgSO4 (pH 6.5). e cells were disrupted by ultrasonication and 
insoluble cell fragments were removed by centrifugation (45 min, 4 °C, 18000 rpm). e 
supernatant was incubated for 1 h at 4 °C with Ni sepharose resin, which had previously 
been equilibrated with lysis buer. e resin loaded with proteins was washed with 6 
mL lysis buer, followed by 6 mL lysis buer (pH 7) containing 20 mM imidazole. e 
retained proteins were eluted with 50 mM Mes/NaOH, 0.1 mM DP, 1 mM MgSO4, 
250 mM imidazole (pH 7.6). e fractions with the highest ZmPDC concentration were 
pooled together and the buer was exchanged to 10 mM Mes/NaOH, 200 mM NaCl, 
5 mM MgSO4, 0.1 mM DP (pH 6.5) using a PD-10 desalting column. e enzyme 
concentration was determined using the Waddell method and the enzyme was ash 
frozen in liquid nitrogen and stored at – 80 °C until further use3.
Alcohol dehydrogenase
ScADH was commercially available from Sigma Aldrich, provided as lyophilized enzyme 
(product number A7011, alcohol dehydrogenase from Saccharomyces cerevisae). Prior to 
each experiment, a sample of the lyophilized enzyme was dissolved in 100 mM Na2HPO4 
buer (pH 7.3) and the unit concentration was determined according to the provided 
protocol. Unit denition: one unit of alcohol dehydrogenase will convert 1.0 µmol of 
ethanol to acetaldehyde per minute in 50 mM sodium phosphate pH 8.8 at 25 °C.
NADH oxidase
PRO-NOX(009) was provided as crude cell-free extract by Prozomix Ltd and used 
without further purication.
In situ synthesis of 5
Route I
Optimization of in situ synthesis of 5 via route I was performed on 1 mL scale. To a 
1.5 mL Eppendorf tube containing 50 mM 1, 10% ethanol, 1 µM MSAD in 100 mM 
Na2HPO4 buer (pH 7.3) was added CaaD (5 µM nal concentration). At timely intervals 
50 µL was collected from the reaction mixture and the aldehyde product was derivatized 
with O-benzylhydroxylamine.
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Route II
Optimization of in situ synthesis of 5 via route II was performed in a 25 mL round-
bottom ask. 3 mL 100 mM Na2HPO4 buer (pH 7.3) was added to the ask. e ask 
was sealed with a rubber stopper and purged with pure oxygen for 30 minutes to saturate 
the buer and airspace. To this was added 0.5 mL 3, PRO-NOX(009) (2 mg/mL nal 
concentration) and ScADH (10 U/mL nal concentration) and 100 mM Na2HPO4 buer 
(pH 7.3) into a nal volume of 5 mL. e reaction was stirred at 250 rpm. At timely 
intervals, 50 µL was collected from the reaction mixture and the aldehyde product was 
derivatized with O-benzylhydroxylamine.
Route III
e activity of ZmPDC was tested based on reported reaction conditions6. In a 1.5 ml 
Eppendorf tube 50 mM sodium pyruvate was added to 50 mM MES/NaOH buer (pH 
6.5) supplemented with 0.1 mM DP, 5 mM MgSO4 and 5% DMSO and the reaction 
was initiated by the addition of 0.1 µM ZmPDC. e nale volume of the reaction was 1 
mL. At timely intervals 50 µL was collected from the reaction mixture and the aldehyde 
product was derivatized with O-benzylhydroxylamine.
Aldehyde derivatization and quantication by HPLC
The aldehyde compounds in collected reaction samples were derivatized with 
O-benzylhydroxylamine and analyzed by reverse-phase HPLC according to a reported 
procedure1. e concentration in the reaction of 5, 8, 9 and 10 (without derivatization) 
was determined by comparing peak areas to known standards of 5, 8, 9 and 10.
Semi-Preparative scale cascade reactions
Synthesis of 7 via route I
To a 25 mL round-bottom ask was added: 90.5 mg 1 (sodium salt), 212 µg MSAD (1 
µM nal concentration) and 1.19 mg CaaD (5 µM nal concentration) in 15 mL 100 mM 
sodium phosphate buer (pH 7.3). At timely intervals, 50 µL of the reaction mixture 
was collected and processed for HPLC analysis to monitor reaction progress. During 
the reaction the pH dropped from pH 7.3 to 6.8. Aer 90 min, 10.14 mg 6 (in 1.7 mL 
ethanol, 4 mM nal concentration) and 6.5 mg 4-OT L8Y/M45Y/F50A (56 µM nal 
concentration) were added (nal volume 17 mL). e reaction progress was monitored 
by UV-spectroscopy following the depletion in absorbance at 320 nm corresponding 
to the concentration of 6. Aer the reaction was nished, the reaction mixture was 
extracted with 3 x 30 mL ethyl acetate. e organic layers were washed with brine, dried 
over anhydrous Na2SO4 and concentrated in vacuo. Silica gel column chromatography 
(petroleum ether/ethyl acetate 9:1) gave the desired product 7 (8.3 mg, 62% yield). e 
5
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1H NMR spectroscopic data were in agreement with previously published data7. e 
aldehyde functionality was derivatized into the corresponding ethylene glycol acetal 
and the enantiomer ratio (e.r.) was determined by reverse phase HPLC (AD-RH column 
150 mm x 4.6 mm, Diacel, 30:70 H2O/ACN, 0.5 mL/min, retention time R-7: 8.1 min, 
S-7: 10.8 min)8.
Synthesis of 9 via route I
To a 25 mL round-bottom ask was added: 50 mM 1 (sodium salt), 1 µM MSAD, 10 
µM CaaD, 4 mM 8 and 75 µM 4-OT M45T/F50A in a nal volume of 17.8 mL 150 mM 
Na2HPO4 buer (pH 7.3), 5% v/v ethanol. At timely intervals, 50 µL of the reaction 
mixture was collected and processed for HPLC analysis to monitor reaction progress. e 
pH of the buer did not signicantly change during the reaction. Aer the reaction was 
nished, the reaction mixture was extracted with 3 x 10 mL ethyl acetate. e organic 
layers were washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. 
Silica gel column chromatography (petroleum ether/ethyl acetate 9:1) gave the desired 
product 9 (6.7 mg, 56% yield). e 1H NMR spectroscopic data were in agreement with 
previously published data9.
Synthesis of 7 via route II
10 mL of 100 mM sodium phosphate pH 7.3 was added to a 100 mL round-bottom ask 
sealed with a rubber stopper. e buer and airspace were saturated with pure oxygen by 
purging oxygen into the solution for 1 h. To this was added: 1.5 mL 3, 0.5 mL of 60 mM 
NAD+, 0.5 mL 15 mg/mL PRO-NOX(009). e reaction was initiated by the addition of 
1 mL 150 U/mL ScADH. e nal conditions were: 10 U/mL ScADH, 2 mg/mL PRO-
NOX(009), 2 mM NAD+, 10% v/v 3 in a nal volume of 15 mL. e reaction was stirred 
and incubated at room temperature. At timely intervals, 50 µL of the reaction mixture 
was collected and processed for HPLC analysis to monitor reaction progress. Aer 150 
min, 10.1 mg of 6 dissolved in 1 mL of 3 (4 mM nal concentration) and 1 mL of 100 
mM sodium phosphate containing 6.5 mg/mL 4-OT L8Y/M45Y/F50A was added to 
the reaction mixture. At timely intervals, 300 µL of the reaction mixture was added to 
a 1 mm quartz cuvette and a UV/VIS spectrum from 200 to 500 nm was recorded. 75 
min aer the addition of 4-OT, the reaction was nished and the reaction mixture was 
extracted 3x with 10 mL ethyl acetate. e organic layers were combined, washed with 
brine and further dried over anhydrous Na2SO4. e organic layer was removed in vacuo 
yielding 7 without any further purication (12.6 mg, 96% isolated yield). e 1H NMR 
spectroscopic data were in agreement with previously published data7. A sample of 7 was 
dissolved in ethyl acetate and injected on a gas chromatograph with a chiral stationary 
phase using a reported method to determine the enantiopurity9.
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Synthesis of 9 via route II
20 mL of 100 mM sodium phosphate pH 7.3 was added to a 100 mL round-bottom ask 
sealed with a rubber stopper. e buer and airspace were saturated with pure oxygen by 
purging oxygen into the solution for 1 h. To this was added: 3 mL of 3 containing 24 mg 
of 8, 1 mL 60 mM NAD+, 3 mL of 100 mM sodium phosphate pH 7.3 containing 20 mg/
mL PRO-NOX(009) and 2 mL 100 mM sodium phosphate pH 7.3 containing 13.5 mg/
mL 4-OT M45T/F50A. e reaction was started by the addition of 1 mL 100 mM Sodium 
phosphate pH 7.3 containing 300 U/mL ScADH. e nal cascade conditions were 10 
U/mL ScADH, 2 mg/mL PRO-NOX(009), 0.89 mg/mL 4-OT M45T/F50A, 2 mM NAD+, 
5.7 mM 8, 10% v/v 3 in a nal volume of 30 mL. e reaction was stirred and incubated 
at room temperature. At timely intervals, 50 µL of the reaction mixture was collected 
and processed for HPLC analysis to monitor reaction progress. Aer 24 h, the reaction 
was extracted 3x with 20 mL of ethyl acetate. e organic layers were combined, washed 
with brine, and dried over anhydrous Na2SO4. e dried organic layer was concentrated 
in vacuo and the residue was puried by silica gel column chromatography (hexane/
ethyl acetate 9:1 for 9 and 4:1 for 10) to obtain 7.5 mg of 9 and 8.0 mg of 10 (26% and 
28% isolated yield respectively). e 1H NMR spectroscopic data were in agreement with 
previously published data9,10.
Synthesis of racemic reference compounds
Racemic 7 was synthesized according to a reported procedure11.
5




Supplementary Figure 1. UV spectra showing the conversion of 6 catalyzed by 4-OT L8Y/M45Y/
F50A using in situ generated 5 via route I.
Supplementary Figure 2. UV spectra showing the conversion of 6 catalyzed by 4-OT L8Y/M45Y/
F50A using in situ generated 5 via route II.
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Supplementary Figure 3. 1H NMR spectrum of enzymatically obtained 4-nitro-3-phenylbutanal 
(7) using in situ generated 5 via route I (400 MHz, CDCl3).
Supplementary Figure 4. 1H NMR spectrum of enzymatically obtained 4-nitro-3-phenylbutanal 
(7) using in situ generated 5 via route II (400 MHz, CDCl3).
Supplementary Figure 5. 1H NMR spectrum of enzymatically obtained (E)-3-(2-chlorophenyl)
acrylaldehyde (9) using in situ generated 5 via route I (400 MHz, CDCl3).
5
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Supplementary Figure 6. 1H NMR spectrum of enzymatically obtained (E)-3-(2-chlorophenyl)
acrylaldehyde (9) using in situ generated 5 via route II (400 MHz, CDCl3).
Supplementary Figure 7. 1H NMR spectrum of enzymatically obtained (E)-3-(2-chlorophenyl)
prop-2-en-1-ol (10) using in situ generated 5 via route II (400 MHz, CDCl3).
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Supplementary Figure 8. HPLC chromatogram of derivatized racemic 4-nitro-3-phenylbutanal 
(top) and derivatized enzymatically obtained 4-nitro-3-phenylbutanal using in situ generated 5 
via route I (bottom).
Supplementary Figure 9. GC chromatogram of racemic 4-nitro-3-phenylbutanal (top) and en-
zymatically obtained 4-nitro-3-phenylbutanal using in situ generated 5 via route II (bottom).
5
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Aromatic β-hydroxyaldehydes, 1,3-diols, and α,β-unsaturated aldehydes are valuable 
precursors to biologically active natural products and drug molecules. Herein we 
report the biocatalytic aldol condensation of acetaldehyde with various aromatic 
aldehydes to give a number of aromatic α,β-unsaturated aldehydes using a previously 
engineered variant of 4-oxalocrotonate tautomerase [4-OT(M45T/F50A)] as carboligase. 
Moreover, an ecient one-pot two-step chemoenzymatic route towards chiral aromatic 
1,3-diols has been developed. is one-pot chemoenzymatic strategy successfully 
combined a highly enantioselective aldol addition step catalyzed by a proline-based 
carboligase [4-OT(M45T/F50A) or TAUT015] with a chemical reduction step to convert 
enzymatically prepared aromatic β-hydroxyaldehydes into the corresponding 1,3-diols 
with high optical purity (e.r. up to >99:1) and in good isolated yield (51-92%). ese 
developed (chemo)enzymatic methodologies oer alternative synthetic choices to prepare 
a variety of important drug precursors.
Keywords
Biocatalysis, aldol reaction, aldolases, β-hydroxyaldehydes, carboligases
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Introduction
e aldol reaction is one of the most important methodologies for the straightforward 
construction of carbon-carbon bonds in synthetic organic chemistry.1 is reaction 
allows complex chiral compounds to be rapidly assembled from simpler building blocks. 
Enzyme catalysis by using native and engineered aldolases oers a powerful strategy 
to perform this transformation.2 With the discovery and engineering of novel aldolase 
activities, an increasing number of applications of aldolases in stereoselective synthesis 
have been reported.2e,2i Despite the rapidly expanding biocatalytic toolbox, aldolases that 
can use various aromatic aldehydes as acceptors for acetaldehyde addition are rare.2f-h 
Such aldolases would provide an attractive synthetic tool for the preparation of chiral 
precursors to various biologically active compounds and drug molecules.
Our group has previously reported that the enzyme 4-oxalocrotonate tautomerase 
(4-OT) from Pseudomonas putida mt-2 promiscuously catalyzes the cross-condensation 
of acetaldehyde (1) with benzaldehyde (2a) to give cinnamaldehyde (4a) (Scheme 1).3 It 
has been shown that 4-OT catalyzes both the initial aldol addition to yield 3-hydroxy-
3-phenylpropanal (3a) as well as the subsequent rapid dehydration of 3a to give 4a, 
preventing the accumulation of chiral aldol adduct 3a in the reaction mixture.3a Rahimi 
and co-workers applied mutability landscape-guided protein engineering to further 
improve this promiscuous aldolase activity of 4-OT. is resulted in the identication 
of a double mutant, 4-OT M45T/F50A, with a remarkable 3300-fold improved catalytic 
eciency (in terms of kcat/Km) over wild-type 4-OT.
3b
4 - OT ( M 4 5 T / F 5 0 A )
C HOC HO
*
OC H3 C HO OH
1
2 a 3 a
4 a
c i n n a m a l d e h y d e
Scheme 1. 4-OT catalyzed aldol condensation of acetaldehyde (1) with benzaldehyde (2a) to yield 
cinnamaldehyde (4a).
Although cinnamaldehydes are valuable synthons in their own right, we were especially 
interested in the enzymatic preparation of chiral aromatic β-hydroxyaldehydes, and the 
corresponding 1,3-diols, which are important precursors to various natural products, 
bioactive compounds and drugs (Figure 1).4,5 We envisioned that these chiral aldol 
adducts could be constructed by the enzymatic addition of acetaldehyde to selected 
aromatic aldehydes, yielding β-hydroxyaldehydes that are not (or slowly) dehydrated, 
6
BNW_Lieuwe.indd   173 31-08-20   15:18
174
Chapter 6
allowing their accumulation in the reaction mixture. Chemical reduction of the 
enzymatically prepared aromatic β-hydroxyaldehydes would provide access to the 
corresponding aromatic 1,3-diols, which are key intermediates in the synthesis of drugs 
such as Fluoxetine (Figure 1).5





































Figure 1. Chiral aromatic β-hydroxyaldehydes and cinnamaldehydes are valuable precursors to 
biologically active compounds and drugs.
Herein we report the 4-OT(M45T/F50A)-catalyzed synthesis of various aromatic 
α,β-unsaturated aldehydes, starting from acetaldehyde and a number of aromatic 
aldehydes, in good isolated yields. We also report the one-pot, two-step chemoenzymatic 
asymmetric synthesis of various aromatic 1,3-diols with high optical purity (e.r. up to 
>99:1) and in good isolated yield (51-92%). is chemoenzymatic strategy highlights 
a highly stereoselective aldol addition of acetaldehyde to diverse aromatic aldehydes, 
catalyzed by either 4-OT(M45T/F50A) or the newly identied carboligase TAUT015, 
yielding various enantioenriched aromatic β-hydroxyaldehydes, which are chemically 
reduced into the corresponding 1,3-diols in the same pot. e applied carboligases accept 
a broad range of aromatic aldehydes for acetaldehyde additions, oering alternative 
synthetic choices to prepare important drug precursors.
We previously reported that an engineered variant of 4-OT (mutant M45T/F50A) 
can eciently catalyze the aldol condensation of acetaldehyde (1) with benzaldehyde 
(2a) to yield cinnamaldehyde (4a).3b is prompted us to start our investigations by 
testing a large set of twenty-ve aromatic aldehydes (2b-y and 2ac) as potential aldol 
acceptor substrates in the 4-OT(M45T/F50A)-catalyzed aldol reaction with donor 
substrate 1 (Scheme 2). e results demonstrate that the 4-OT(M45T/F50A) enzyme 
has a remarkably broad substrate scope, accepting nineteen aromatic aldehydes with 
electron withdrawing substituents (2b-t) as aldol acceptor substrates (Scheme 2, Figures 
S1-S19). On the contrary, aromatic aldehydes with electron-donating substituents (2u-y 
and 2ac) were not, or very poorly, accepted by 4-OT(M45T/F50A) (Scheme 2, Figures 
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S20-S24, S28). While this may be attributed to unfavorable equilibrium constants for 
these aromatic aldehydes in the aldol addition with acetaldehyde, the electron donating 
properties of the substituents on the aromatic ring likely also lead to weak activation of 
the carbonyl carbon for nucleophilic attack.2j,2l
P r o l i n e - b a s e d
t a u t o m e r a s e
4 b - d , 4 f - j , 4 t
R
C HO
5b - d , 5f - g , 5k - n , 5s
R *
OHOH
E l e c t r o n r i c h a c c e p t o r s
R = 4 - OM e - P h ( 2 u ) , 4 - M e - P h ( 2 v ) , 4 - N, N- d i - M e - P h
( 2 w ) 2, 6 - d i - OM e - P h ( 2 x ) , 3 , 4 , 5 - t r i - OM e - P h ( 2 y ) 2- M e -
P h ( 2 z ) , 3 - M e - P h ( 2 a a ) , 2, 4 - d i - OM e - P h ( 2 a b ) 6 - OM e -
Na p t h y l ( 2 a c )
Na B H4
P r o l i n e - b a s e d
t a u t o m e r a s e
E l e c t r o n d e f i c i e n t a c c e p t o r s
R = 2- C l - P h ( 2 b ) , 3 - C l - P h ( 2 c ) , 2, 4 - d i - C l - P h ( 2 d ) , 3 , 4 - d i - C l - P h ( 2 e )
2- NO2- P h ( 2 f ) , 3 - NO2- P h ( 2 g) , 2- F - P h ( 2 h ) , 2- B r - P h ( 2 i )
t e t r a f l u o r o - P h ( 2 j ) , 4 - C N- P h ( 2 k ) , 4 - C F 3 - P h ( 2 l ) p e n t a f l u o r o - P h
( 2 m ) , 3 - C N- 4 - F - P h ( 2 n ) , 4 - B r - P h ( 2 o ) , 4 - C l - P h ( 2 p ) 4 - F - P h





C H3 C HO
OH1
2 3
Scheme 2. Enzymatic aldol reaction of acetaldehyde (1) with various aromatic aldehydes (2) using 
promiscuous proline-based tautomerases as carboligases.
Out of the nineteen well-accepted aromatic aldehydes, fourteen substrates undergo 
an aldol condensation reaction with formation of the corresponding α,β-unsaturated 
aldehydes, whereas ve substrates (2k-n and 2s, see below) undergo conversion without 
signicant formation of the corresponding α,β-unsaturated aldehydes (Figure S1-S19). 
To demonstrate the synthetic usefulness of 4-OT(M45T/F50A) for the preparation of 
α,β-unsaturated aldehydes, nine aromatic aldehydes (2b-d, 2f-j and 2t) that could be 
eciently converted by 4-OT(M45T/F50A) were selected and used in semi-preparative 
scale synthesis (Scheme 3). e corresponding α,β-unsaturated aldehydes (4b-d, 4f-j 
and 4t) could be isolated in moderate to good yields (Scheme 3, Figures S30-S47). 
Notably, ortho-substituted benzaldehydes (e.g. 2b, 2f, 2h and 2i) were better accepted 
by 4-OT(M45T/F50A) than para-substituted benzaldehydes (2p, 2r, 2o and 2q).6 ese 
results underscore the potential of 4-OT(M45T/F50A) for the synthesis of versatile 
aromatic α,β-unsaturated aldehydes, which are important precursors to various 
abundantly prescribed drugs (Figure 1).4f
6
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C HO
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C l 4 f ( 7 3 % ) b , c
C HO
NO2




4 h ( 7 9 % ) b , c
C HO
F






4 j ( 8 5 % ) b , c
F
F 4 t ( 23 % ) b , c
O
C HO







C H3 C HO
OH1
3 b - d , 3 f - j , 3 t
2 b - d , 2 f - j , 2 t
4 - OT ( M 4 5 T / F 5 0 A ) a
Scheme 3. Synthesis of aromatic α,β-unsaturated aldehydes from simpler building blocks using the car-
boligase 4-OT(M45T/F50A). aReaction conditions: reaction mixtures consisted of 100 mM 1, 3 mM 2 and 
0.1 mg/mL 4-OT (M45T/F50A) in 20 mM sodium phosphate buer, 5% DMSO v/v, pH 7.3. e reaction 
volume was 60 mL. bReaction time (48 h, 72 h for 2t). cPuried by silica gel column chromatography.
Interestingly, for the 4-OT(M45T/F50A)-catalyzed aldol addition of 1 to 2k-n and 2s, 
depletion of the starting substrates was observed without signicant accumulation 
of the corresponding α,β-unsaturated aldehydes (Figures S10-S13, S18). ese results 
led us to hypothesize that in these instances the initially formed aldol adducts, 
β-hydroxyaldehydes 3k-n and 3s, were not (or slowly) dehydrated and accumulated 
in the reaction mixture. To conrm this hypothesis, an analytical scale experiment 
was performed using 4-OT(M45T/F50A) in NaPi buer (0.3 mL, pH 7.3, 5% DMSO), 
containing 1 (50 mM) and 2k (2 mM). Reaction progress was monitored by following 
the depletion of 2k by UV-VIS spectrophotometry, and NaBH4 was added to the reaction 
mixture (aer 1 h) to convert the aldol adduct into the more stable 1,3-diol 5k. Analysis 
of chemoenzymatic product 5k by HPLC on a chiral stationary phase, using authentic 
standards with known absolute conguration, revealed high enantiocontrol at the site 
of addition with formation of the R enantiomer (e.r. = 94:6). ese results demonstrate 
that the enzyme 4-OT(M45T/F50A) can indeed catalyze enantioselective aldol additions.
Having established that 4-OT(M45T/F50A) has potential for the asymmetric synthesis 
of enantioenriched aromatic β-hydroxyaldehydes, we rst optimized the reaction 
conditions by varying the pH and the concentration of acetaldehyde, buer and enzyme 
(Figure S88). Using the optimized conditions, the one-pot two-step chemoenzymatic 
cascade synthesis of aromatic 1,3-diols 5k-n and 5s, via enzymatically prepared 
β-hydroxyaldehydes 3k-n and 3s, was achieved with high enantioselectivity (e.r. up to 
99:1) and in good isolated yield (63-92%) (Table 1, Figures S48-S62).
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Table 1. Asymmetric chemoenzymatic synthesis of aromatic 1,3-diols using 4-OT(M45T/F50A) 
as carboligase.a
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1 65 99:1 Rf
aAssay conditions: acetaldehyde (1, 100 mM), aromatic aldehyde (2k-n, 2s, 2 mM) and puried 
4-OT(M45T/F50A) (0.125-0.475 mg/mL) in 20 mM sodium phosphate buer (MOPS for 2k), 
with 5% DMSO (v/v) as cosolvent, at pH 8.0 (pH 7.3 for 2s to increase its electrophilicity) and 
room temperature. e reaction volume was 40 mL. To reduce the aldehyde functionality of the 
enzymatic products 3k-n and 3s, NaBH4 (30 mM) was added to the reaction mixture followed by 
incubation for 3 h at room temperature. bReaction time of the enzymatic step. cIsolated yield of 
the aromatic 1,3-diol product. dDetermined by HPLC analysis on a chiral stationary phase using 
chemically synthesized racemic standards. ee absolute conguration was determined by chiral 
HPLC using chemically prepared authentic standards with known (R) or (S) conguration. fe 
absolute conguration was assigned based on analogy.
6
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To expand the number of enzymatically accessible β-hydroxyaldehyde products (e.g. 
3b-d, 3f and 3g) in principle two dierent approaches can be used: (i) the use of protein 
engineering to create new variants of 4-OT(M45T/F50A) that lack dehydration activity 
and possess unchanged or enhanced aldol addition activity, or (ii) the use of homologous 
enzymes that posses the desired aldol addition activity but lack dehydration activity. To 
selectively eliminate the dehydration activity of 4-OT(M45T/F50A), a structure-based 
approach is favored, which awaits the determination of the enzyme crystal structure 
complexed with one of the β-hydroxyaldehyde products (work in progress). In this 
study, we therefore have chosen to screen a panel of y commercially available 4-OT 
homologues for enzymes with the desired aldol addition activity to yield enantioenriched 
β-hydroxyaldehydes. For initial activity testing, we used donor substrate 1 and aldol 
acceptor substrate 2b. Interestingly, out of the y tested 4-OT homologues, three 
enzymes (TAUT015, TAUT021 and TAUT028) were found to show signicant activity 
towards the aldol addition of 1 to 2b to give the desired product 3b without promoting 
signicant dehydration leading to formation of 4b (Figure S29). Notably, the same 
reaction catalyzed by 4-OT(M45T/F50A) resulted in the formation of α,β-unsaturated 
aldehyde 4b as the sole product, providing additional support that the β-hydroxyaldehyde 
dehydration step is enzyme catalyzed.
We next investigated the substrate scope of the best performing enzyme, TAUT015, 
which shows 28% overall sequence identity to 4-OT (Figure S89), in additions using 1 
as donor substrate and a number of selected benzaldehyde derivatives as potential aldol 
acceptor substrates. e results show that, like 4-OT(M45T/F50A), TAUT015 does not 
accept benzaldehydes with electron donating substituents (2u, 2v, 2z, 2aa and 2ab) 
on the aromatic ring (Figures S25-S27). However, several benzaldehydes with electron 
withdrawing substituents (2b-d, 2f and 2g) were well accepted by TAUT015. Encouraged 
by these ndings, semi-preparative scale reactions were carried out under optimized 
reaction conditions. e reaction progress (1 with 2b-d, 2f and 2g) was monitored by 
UV-VIS spectrophotometry and the enzymatically prepared β-hydroxyaldehydes 3b-d, 
3f and 3g were reduced to the corresponding aromatic 1,3-diols (5b-d, 5f and 5g) using 
NaBH4. ese one-pot, two-step chemoenzymatically prepared compounds 5b-d, 5f 
and 5g were obtained in good isolated yields (up to 72%) and with high e.r. values 
(e.r. up to >99:1) (Table 2, Figures S63-S87). Note that enzymatic access to these useful 
chiral synthons requires the use of TAUT015 as carboligase and is not possible with 
4-OT(M45T/F50A). Hence, the enzyme TAUT015 nicely supplements the toolbox of 
biocatalysts for the production of important chiral aromatic β-hydroxyaldehydes and 
corresponding 1,3-diols.
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Table 2. Asymmetric chemoenzymatic synthesis of aromatic 1,3-diols using TAUT015 as 
carboligase.a






OOH Na B H41
2 b - d , 2 f - g
3 b - d , 3 f - g
C H3 C HO
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O2N 11 56 89:11 R
aAssay conditions: acetaldehyde (1, 100 mM), benzaldehyde derivative (2b-d, 2f-g, 2 mM) and 
enzyme (crude cell extract, 0.33 mg/mL) in 20 mM sodium phosphate buer, containing 5% EtOH 
(v/v) as cosolvent, at pH 6.5 and room temperature. e specic enzyme activity was determined 
to be 0.044 U/mg CFE. Unit denition: 1 U of enzyme converts 1 µmol of 2b in 1 minute; assay 
conditions: 20 mM NaPi pH 6.5, 5% EtOH, 100 mM 1, 2 mM 2b. e reaction volume was 40 mL. 
To reduce the aldehyde functionality of 3b-d and 3f-g, NaBH4 (30 mM) was added to the reaction 
mixture followed by incubation for 3 h at room temperature. bReaction time of the enzymatic 
step. cIsolated yield of the aromatic 1,3-diol product. dDetermined by HPLC analysis on a chiral 
stationary phase using chemically synthesized racemic standards. ee absolute conguration 
was determined by chiral HPLC using chemically prepared authentic standards with known (R) 
or (S) conguration.
In conclusion, our results indicate that members of the 4-OT family of enzymes, 
which possess an uncommon catalytic amino-terminal proline, can function as novel 
carboligases, promoting the cross-aldol reaction of acetaldehyde with diverse aromatic 
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aldehydes to give access to a range of important α,β-unsaturated aldehydes as well as 
enantioenriched β-hydroxyaldehydes. It is feasible that their promiscuous aldol addition 
activities, which are beyond the synthetic scope of currently known aldolases, can be 
further optimized by directed evolution or computational redesign. It is important to 
emphasize that the controlled cross-aldol addition of acetaldehyde is a particularly 
challenging synthetic aim because acetaldehyde is a relatively reactive and dicult to 
tame chemical.5,7 Remarkably, the promiscuous 4-OT enzymes accept acetaldehyde as 
a nucleophile in aldol additions, which is unparalleled among the aldolases, with the 
notable exception of 2‐deoxy‐D‐ribose‐5‐phosphate aldolase (DERA) and d‐fructose‐6‐
phosphate aldolase (FSA), which are also able to use acetaldehyde as a nucleophilic 
substrate.2g,2k,2o As such, these proline-based 4-OT enzymes nicely complement the 
toolbox of biocatalysts for (asymmetric) C-C bond-formation, and open up new 
opportunities to develop practical enzymatic processes for the more sustainable and 
step-economic synthesis of valuable drug precursors starting from simple building 
blocks. Further screening of related proline-based enzymes might prove to be a 
valuable approach to discover new aldolase activities that could be exploited to develop 
synthetically useful biocatalysts for carbon-carbon bond formation.
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Supporting Information
1. Materials and Methods
1.1 Materials
Chemicals were purchased from Sigma Aldrich, Across, Merck or Fluka (unless noted 
otherwise) and were used without further purication. e α,β-unsaturated aldehydes 
2o-r were prepared using a previously reported method.[1a] Synthesis of racemic and 
enantiopure reference compounds, required for chiral analysis of enzymatic products, 
was done according to published protocols.[2]
1.2 General methods
NMR spectra were recorded on a Brucker 500 MHz spectrometer. Enzymatic assays 
were performed on a V-650 or V-660 spectrophotometer from Jasco (IJsselstein, e 
Netherlands). Reverse phase HPLC was carried out using an in-house analytical HPLC 
equipped with a Shimazu LC-10 AT pump and a Shimazu SPD-M10A diode array 
detector.
1.3 Protein expression and purication
e expression and purication of 4-OT(M45T/F50A) mutant was based on a protocol 
described elsewhere.[3] A sample of puried protein was analyzed by ESI-MS to conrm 
that the protein had been processed correctly and the initiating methionine had been 
removed. e puried protein was ash frozen in liquid nitrogen and stored at -80 °C 
until further use.
1.4 Chiral analysis
The enantiomeric ratio and absolute configuration of the chemoenzymatically 
synthesized compounds 5b-d, 5f-g and 5k-m was analyzed by chiral HPLC using 
chemically synthesized racemic 1,3-diols and enantiopure 1,3-diols as reference 
compounds.[2a-b] For compounds 5n and 5s, the enantiomeric ratio was analyzed by chiral 
HPLC using chemically synthesized racemic 1,3-diols[2a] and the absolute conguration 
was based on analogy.
1.5 Analytical scale reactions
Enzymatic and non-enzymatic reactions between substrates 1 and 2 were monitored 
by following the depletion in the absorbance corresponding to the consumption of 2. 
Reaction conditions are given below each gure.
6
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Figure S1. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2b (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S2. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2c (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S3. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2d (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S4. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2e (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S5. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2f (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S6. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2g (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S7. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2h (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S8. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2i (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S9. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2j (2 mM) catalyzed by 
4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S10. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2k (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S11. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2l (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S12. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2m (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S13. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2n (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S14. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2o (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S15. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2p (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S16. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2q (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S17. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2r (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S18. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2s (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S19. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2t (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S20. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2u (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S21. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2v (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S22. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2w (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S23. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2x (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
Figure S24. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2y (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S25. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2z (2 mM) catalyzed 
by TAUT015 (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 6.5. A. Enzymatic 
reaction. B. Non-enzymatic reaction.
Figure S26. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2aa (2 mM) catalyzed 
by TAUT015 (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 6.5. A. Enzymatic 
reaction. B. Non-enzymatic reaction.
Figure S27. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2ab (2 mM) catalyzed 
by TAUT015 (1 mg/mL) in buer [20 mM NaPi/5% (v/v) EtOH, 0.3 mL] at pH 6.5. A. Enzymatic 
reaction. B. Non-enzymatic reaction.
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Figure S28. UV spectra monitoring the aldol reaction of 1 (50 mM) with 2ac (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
2. Screening of 4-OT homologues for aldol addition activity
Fiy 4-OT homologues (selected by Prozomix from in-house metagenomes) were 
provided as crude cell-free extracts (CFEs) by Prozomix Ltd (Station Court, Haltwhistle, 
Northumberland, UK), and used without any further purication. e aldol addition 
activity of the 4-OT homologues was determined using the donor substrate 1 and aldol 
acceptor substrate 2b. Briey, the reaction mixtures (300 µL) consisted of CFE (1 mg/mL), 
1 (50 mM), 2b (2 mM) and ethanol (5% v/v) in 20 mM NaPi buer (pH 6.5). e reaction 
was initiated by the addition of 15 µL from a stock solution of 2b (20 mM in ethanol). 
e progress of the reaction was monitored by following the depletion in absorbance at 
254 nm, which corresponds to the consumption of 2b (Figure S29).
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Figure S29. Screening of 4-OT homologues for the aldol addition of 1 (50 mM) to 2b (2 mM). A. 
General screening results. e conversion (%) was caculated based on the amount of 2b consumed. 
B, C and D. UV spectra monitoring the aldol addition of 1 (50 mM) to 2b (2 mM) catalyzed by 
TAUT015 (B), TAUT021 (C) and TAUT028 (D).
3. Biocatalytic synthesis of α,β-unsaturated aldehydes (4b-d, 4f-j and 
4t) using 4-OT(M45T/F50A)
Reaction mixtures (60 mL) contained acetaldehyde (1, 100 mM), aromatic aldehydes 
(2b-d, 2f-j and 2t, 3 mM) and 4-OT(M45T/F50A) enzyme (0.1 mg/mL) in NaPi buer (20 
mM, pH 7.3). Stock solutions of 2b-d, 2f-j and 2t were prepared in DMSO. e reaction 
mixture was incubated at room temperature and reaction progress was monitored by 
UV-vis spectrophotometry. Aer the completion of the reaction, the reaction mixture 
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was extracted with ethyl acetate (3 × 40 mL). e combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, and concentrated under vacuo. e crude 
products 4b-d, 4f-j and 4t were further puried by silica gel column chromatography 
(petroleum ether/ethyl acetate from 95:5 to 50:50).
(E)-3-(2-chlorophenyl)acrylaldehyde (4b).[1a] White solid; yield = 81% (24 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.76 (d, J = 7.7 Hz, 1H), 7.94 (d, J = 16.0 Hz, 1H), 7.66 (dd, J = 7.7, 
1.7 Hz, 1H), 7.46 (dd, J = 7.9, 1.3 Hz, 1H), 7.39 – 7.29 (m, 2H), 6.70 (dd, J = 16.0, 7.7 Hz, 
1H). e 1H NMR data is in agreement with published data. [1a]
Figure S30. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2b (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
6
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Figure S31. 1H NMR spectrum of enzymatic compound 4b.
(E)-3-(3-chlorophenyl)acrylaldehyde (4c).[1a] White solid; yield = 70% (21 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.72 (d, J = 7.6 Hz, 1H), 7.55 (t, J = 1.7 Hz, 1H), 7.48 – 7.42 (m, 2H), 
7.42 – 7.36 (m, 2H), 6.71 (dd, J = 16.0, 7.6 Hz, 1H). e 1H NMR data is in agreement 
with published data. [1a]
Figure S32. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2c (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
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Figure S33. 1H NMR spectrum of enzymatic compound 4c.
(E)-3-(2,4-dichlorophenyl)acrylaldehyde (4d).[1b] White solid; yield = 71% (25 mg). 
1H NMR (500 MHz, CDCl3) δ 9.76 (d, J = 7.6 Hz, 1H), 7.86 (d, J = 16.0 Hz, 1H), 7.60 (d, 
J = 8.5 Hz, 1H), 7.49 (d, J = 2.1 Hz, 1H), 7.32 (dd, J = 8.5, 1.8 Hz, 1H), 6.69 (dd, J = 16.0, 
7.6 Hz, 1H). e 1H NMR data is in agreement with published data. [1b]
Figure S34. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2d (3 mM) 
catalyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
6
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Figure S35. 1H NMR spectrum of enzymatic compound 4d.
(E)-3-(2-nitrophenyl)acrylaldehyde (4f).[1c] White solid; yield = 73% (23 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.78 (d, J = 7.4 Hz, 1H), 8.42 (t, J = 1.9 Hz, 1H), 8.30 (ddd, J = 8.2, 
2.2, 0.9 Hz, 1H), 7.90 (d, J = 7.7 Hz, 1H), 7.65 (t, J = 8.0 Hz, 1H), 7.54 (d, J = 16.1 Hz, 1H), 
6.82 (dd, J = 16.1, 7.4 Hz, 1H). e 1H NMR data is in agreement with published data. [1c]
Figure S36. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2f (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
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Figure S37. 1H NMR spectrum of enzymatic compound 4f.
(E)-3-(3-nitrophenyl)acrylaldehyde (4g).[1d] White solid; yield = 61% (16 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.79 (d, J = 7.7 Hz, 1H), 8.12 (d, J = 8.2 Hz, 1H), 8.05 (d, J = 15.9 Hz, 
1H), 7.74 – 7.66 (m, 2H), 7.65 – 7.58 (m, 1H), 6.64 (dd, J = 15.8, 7.7 Hz, 1H). e 1H NMR 
data is in agreement with published data. [1d]
Figure S38. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2g (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
6
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Figure S39. 1H NMR spectrum of enzymatic compound 4g.
(E)-3-(2-uorophenyl)acrylaldehyde (4h).[1b] White solid; yield = 79% (21 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.72 (d, J = 7.7 Hz, 1H), 7.66 (d, J = 16.2 Hz, 1H), 7.59 (td, J = 7.6, 1.7 
Hz, 1H), 7.43 (dddd, J = 8.3, 7.2, 5.3, 1.7 Hz, 1H), 7.25 – 7.19 (m, 1H), 7.15 (ddd, J = 10.5, 
8.3, 1.0 Hz, 1H), 6.79 (dd, J = 16.2, 7.7 Hz, 1H). e 1H NMR data is in agreement with 
published data. [1b]
Figure S40. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2h (3 mM) 
catalyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
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Figure S41. 1H NMR spectrum of enzymatic compound 4h.
(E)-3-(2-bromophenyl)acrylaldehyde (4i).[1c] White solid; yield = 85% (32 mg). 1H NMR 
(500 MHz, CDCl3) δ 9.78 (d, J = 7.7 Hz, 1H), 7.91 (d, J = 15.9 Hz, 1H), 7.66 (dt, J = 7.7, 1.2 
Hz, 2H), 7.41 – 7.35 (m, 1H), 7.29 (td, J = 7.8, 1.6 Hz, 1H), 6.68 (dd, J = 15.9, 7.7 Hz, 1H). 
e 1H NMR data is in agreement with published data. [1c]
Figure S42. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2i (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
6
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Figure S43. 1H NMR spectrum of enzymatic compound 4i.
(E)-3-(2,3,5,6-tetrauorophenyl)acrylaldehyde (4j). White solid; yield = 85% (31 mg). 
1H NMR (500 MHz, CDCl3) δ 9.75 (d, J = 7.5 Hz, 1H), 7.52 (d, J = 16.5 Hz, 1H), 7.23 – 
7.11 (m, 1H), 7.02 (dd, J = 16.5, 7.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 193.61, 147.19, 
146.00, 145.21, 143.97, 136.27, 135.72, 135.66, 135.59, 114.86, 108.21, 108.03, 107.85. HRMS 
(ESI+): calcd. for C9H5F4O [M+H]+: 205.0277, found: 205.0268.
Figure S44. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2j (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
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Figure S45. 1H NMR (top) and 13C NMR (bottom) spectra of enzymatic compound 4j.
6
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(E)-3-(furan-2-yl)acrylaldehyde (4t).[1e] White solid; yield = 23% (5 mg). 1H NMR (500 
MHz, CDCl3) δ 9.61 (d, J = 7.9 Hz, 1H), 7.56 (d, J = 1.5 Hz, 1H), 7.22 (d, J = 15.7 Hz, 1H), 
6.77 (d, J = 3.4 Hz, 1H), 6.58 (dd, J = 15.7, 7.9 Hz, 1H), 6.53 (dd, J = 3.4, 1.8 Hz, 1H). e 
1H NMR data is in agreement with published data. [1e]
Figure S46. UV spectra monitoring the aldol condensation of 1 (100 mM) with 2t (3 mM) cat-
alyzed by 4-OT(M45T/F50A) (0.1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3.
Figure S47. 1H NMR spectrum of enzymatic compound 4t.
BNW_Lieuwe.indd   204 31-08-20   15:18
205
Enantioselective Aldol Addition of Acetaldehyde to Aromatic Aldehydes
4. Chemoenzymatic synthesis of 1,3-diols (5k-n and 5s) using 
4-OT(M45T/F50A)
e reaction was performed in NaPi buer (MOPS buer for 2k) [20 mM, pH 8.0 (pH 
7.3 for 2s), 40 mL]. Stock solutions of 2k-n and 2s (40 mM) were prepared in DMSO. 
From the stock solution of aldol acceptor substrate, 2 mL (2 mM nal concentration) 
was added to buer containing acetaldehyde (1, 100 mM) and an appropriate amount 
of puried enzyme 4-OT(M45T/F50A) (0.125-0.475 mg/mL). e reaction mixture 
was incubated at room temperature and the progress of the reaction was monitored by 
UV-vis spectrophotometry, following the consumption of 2k-n and 2s. When there was 
no further depletion of the substrates 2k-n and 2s, NaBH4 was added into the reaction 
mixture (nal concentration 30 mM). Aer 3 h of incubation at rt, the reaction mixture 
was extracted with ethyl acetate (3 × 40 mL). e combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, and concentrated under vacuo. e crude 
products 5k-n and 5s were further puried by silica gel column chromatography (using 
petroleum ether/ethyl acetate from 95:5 to 50:50). e aromatic aldehydes 2k-n and 2s 
were used at a concentration of 2 mM to allow for easy monitoring of their consumption 
by UV-vis spectrophotometry. Notably, slightly higher reaction rates can be achieved 
when using these aldol acceptor substrates at a concentration of 10 mM.
(R)-4-(1,3-dihydroxypropyl)benzonitrile (5k).[4] Clear oil; yield = 92% (13 mg). 1H NMR 
(500 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.1 Hz, 2H), 5.09 – 4.97 (m, 1H), 
3.89 (q, J = 4.7 Hz, 2H), 3.51 (d, J = 3.0 Hz, 1H), 2.31 (s, 1H), 1.94 (q, J = 5.6 Hz, 2H). 13C 
NMR (126 MHz, CDCl3) δ 149.86, 132.45 (2xC), 126.47 (2xC), 118.97, 111.25, 73.67, 61.45, 
40.35. e NMR data are in agreement with published data. [4] e enantiomeric ratio of 
chemoenzymatic product 5k was determined using reverse phase HPLC on a Chiralpak® 
ID column (150 mm × 4.6 mm, Daicel) (MeCN/water = 7:93, 20°C) at a ow rate of 1 mL/
min. UV detection at 210 nm: tR:(major) = 11.6 min, (minor) = 16.8 min. e absolute 
conguration of 5k was assigned by chiral HPLC using chemically prepared authentic 
standards with known conguration.
6
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Figure S48. UV spectra monitoring the aldol addition of 1 (100 mM) to 2k (2 mM) catalyzed 
by 4-OT(M45T/F50A) (0.475 mg/mL) in buer [20 mM MOPS/5% (v/v) DMSO)] at pH 8.0. A. 
Enzymatic reaction. B. Non-enzymatic reaction.
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Figure S49. 1H NMR (top) and 13C NMR (bottom) spectra of chemoenzymatic product 5k.
6

































BNW_Lieuwe.indd   208 31-08-20   15:18
209
Enantioselective Aldol Addition of Acetaldehyde to Aromatic Aldehydes
(R)-1-(4-(triuoromethyl)phenyl)propane-1,3-diol (5l).[2b] White solid; yield = 63% 
(11 mg). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.1 Hz, 
2H), 5.10 – 5.00 (m, 1H), 3.90 (q, J = 4.9 Hz, 2H), 3.22 (d, J = 2.9 Hz, 1H), 2.22 (t, 
J = 4.1 Hz, 1H), 2.06 – 1.90 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 148.39, 129.95, 
129.69, 126.05, 125.61, 125.58, 125.55, 125.52, 73.84, 61.52, 40.47. e NMR data are in 
agreement with published data. [2b] e enantiomeric ratio of chemoenzymatic product 
5l was determined using normal phase HPLC on a Chiralpak® IC column (150 mm × 
4.6 mm, Daicel) (Heptane/IPA = 95:5, 30°C) at a ow rate of 0.5 mL/min. UV detection 
at 210 nm: tR:( minor) = 13.09 min, (major) = 14.73 min. e absolute conguration of 
chemoenzymatically prepared 5l was assigned by chiral HPLC using chemically prepared 
authentic standards with known conguration.
Figure S51. UV spectra monitoring the aldol addition of 1 (100 mM) to 2l (2 mM) catalyzed by 
4-OT(M45T/F50A) (0.125 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 8.0. A. Enzy-
matic reaction. B. Non-enzymatic reaction.
6
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Figure S52. 1H NMR (top) and 13C NMR (bottom) spectra of chemoenzymatic product 5l.
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Figure S53. Chiral HPLC analysis of chemoenzymatic product 5l.
(R)-1-(peruorophenyl)propane-1,3-diol (5m).[2b] White solid; yield = 88% (17 mg). 1H 
NMR (500 MHz, CDCl3) δ 5.33 (d, J = 8.7 Hz, 1H), 3.98 – 3.81 (m, 2H), 3.37 (s, 1H), 2.38 
– 2.30 (m, 1H), 2.27 (s, 1H), 2.01 – 1.89 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 145.93, 
143.97, 141.77, 139.75, 138.72, 136.71, 116.84, 65.43, 61.03, 38.08. e NMR data are in 
agreement with published data. [2b] e enantiomeric ratio of chemoenzymatic product 
5m was determined using reverse phase HPLC on a Chiralpak® ID column (150 mm × 
4.6 mm, Daicel) (MeCN/water = 7:93, 20°C) at a ow rate of 1 mL/min. UV detection 
at 210 nm: tR:(major) = 14.7 min, (minor) = 23.8 min. e absolute conguration of 
chemoenzymatically prepared 5m was assigned by chiral HPLC using chemically 
prepared authentic standards with known conguration.
6
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Figure S54. UV spectra monitoring the aldol addition of 1 (100 mM) to 2m (2 mM) catalyzed by 
4-OT(M45T/F50A) (0.25 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 8.0. A. Enzymatic 
reaction. B. Non-enzymatic reaction.
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Figure S55. 1H NMR (top) and 13C NMR (bottom) spectra of chemoenzymatic product 5m.
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(R)-5-(1,3-dihydroxypropyl)-2-uorobenzonitrile (5n). White solid; yield = 70% (11 
mg). 1H NMR (500 MHz, CDCl3) δ 7.67 (dd, J = 6.0, 2.2 Hz, 1H), 7.62 (ddd, J = 7.5, 5.1, 
2.3 Hz, 1H), 7.20 (t, J = 8.7 Hz, 1H), 5.06 – 4.98 (m, 1H), 3.98 – 3.88 (m, 2H), 3.47 (d, 
J = 2.6 Hz, 1H), 2.04 (s, 1H), 2.02 – 1.88 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 163.47, 
161.41, 141.72, 132.54, 132.47, 130.79, 116.65, 116.49, 114.14, 72.97, 61.55, 40.44. HRMS 
(ESI+): calcd. for C10H11FNO2 [M+H]+: 196.0774, found: 196.0766. e enantiomeric 
ratio of chemoenzymatic product 5n was determined using reverse phase HPLC on a 
Chiralpak® ID column (150 mm × 4.6 mm, Daicel) (MeCN/water = 7:93, 20°C) at a ow 
rate of 1 mL/min. UV detection at 210 nm: tR:(major) = 13.7 min, (minor) = 27.1 min. 
e absolute conguration of chemoenzymatically prepared 5n was tentatively assigned 
based on analogy.
Figure S57. UV spectra monitoring the aldol addition of 1 (100 mM) to 2n (2 mM) catalyzed by 
4-OT(M45T/F50A) (0.25 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 8.0. A. Enzymatic 
reaction. B. Non-enzymatic reaction.
6
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Figure S58. 1H NMR (top) and 13C NMR (bottom) spectra of chemoenzymatic product 5n.
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Figure S59. Chiral HPLC analysis of chemoenzymatic product 5n.
(R)-1-(pyridin-2-yl)propane-1,3-diol (5s).[5] Clear oil; yield = 65% (8 mg). 1H NMR 
(500 MHz, CDCl3) δ 8.55 (d, J = 4.7 Hz, 1H), 7.72 (td, J = 7.6, 1.4 Hz, 1H), 7.32 (d, J = 7.9 
Hz, 1H), 7.23 (dd, J = 7.4, 5.1 Hz, 1H), 5.00 (dd, J = 8.4, 3.2 Hz, 1H), 4.59 (s, 1H), 3.99 
– 3.81 (m, 2H), 2.87 (s, 1H), 2.17 – 2.08 (m, 1H), 1.98 – 1.87 (m, 1H). 13C NMR (126 
MHz, CDCl3) δ 161.52, 148.30, 137.11, 122.60, 120.24, 72.78, 61.26, 39.99. e NMR data 
are in agreement with published data. [5] e enantiomeric ratio of chemoenzymatic 
product 5s was determined using reverse phase HPLC on a Chiralpak® ID column (150 
mm × 4.6 mm, Daicel) (MeCN/water = 7:93, 20°C) at a ow rate of 0.5 mL/min. UV 
detection at 210 nm: tR:(major) = 7.3 min, (minor) = 9.2 min. e absolute conguration 
of chemoenzymatically prepared 5s was tentatively assigned based on analogy.
Figure S60. UV spectra monitoring the aldol addition of 1 (100 mM) to 2s (2 mM) catalyzed by 
4-OT(M45T/F50A) (0.125 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO] at pH 7.3. A. Enzy-
matic reaction. B. Non-enzymatic reaction.
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Figure S61. 1H NMR (top) and 13C NMR (bottom) spectra of chemoenzymatic product 5s.
BNW_Lieuwe.indd   218 31-08-20   15:18
219
Enantioselective Aldol Addition of Acetaldehyde to Aromatic Aldehydes
Figure S62. Chiral HPLC analysis of chemoenzymatic product 5s.
5. Chemoenzymatic synthesis of 1,3-diols (5b-d and 5f-g) using 
TAUT015
e reaction was performed in NaPi buer (20 mM, pH 6.5, 40 mL). Stock solutions of 
2b-d and 2f-g (40 mM) were prepared in absolute ethanol. From the stock solution, 2 
mL (2 mM nal concentration of the aldol acceptor substrate) was added to the NaPi 
buer containing acetaldehyde (100 mM) and an appropriate amount of TAUT015 (crude 
extract, 0.33 mg/mL). e reaction mixture was incubated at room temperature and the 
progress of the reaction was monitored by UV-vis spectrophotometry, following the 
consumption of 2b-d and 2f-g. When there was no further depletion of the substrates 
2b-d and 2f-g, NaBH4 was added into the reaction mixture (nal concentration 30 mM). 
Aer 3 h of incubation at rt, the reaction mixture was extracted with ethyl acetate (3 
× 40 mL). e combined organic layers were washed with brine, dried over anhydrous 
Na2SO4, and concentrated under vacuo. e crude products 5b-d and 5f-g were further 
puried by silica gel column chromatography (using petroleum ether/ethyl acetate from 
95:5 to 50:50).
(R)-1-(2-chlorophenyl)propane-1,3-diol (5b).[2b] yellowish oil; yield = 72% (11 mg). 1H 
NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 7.7, 1.4 Hz, 1H), 7.33 – 7.28 (m, 2H), 7.20 (td, 
J = 7.6, 1.7 Hz, 1H), 5.34 (dd, J = 8.8, 2.6 Hz, 1H), 3.93 – 3.83 (m, 2H), 3.45 (s, 1H), 2.68 
(s, 1H), 2.09 – 1.99 (m, 1H), 1.94 – 1.84 (m, 1H). e 1H NMR data is in agreement 
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with published data. [2b] e enantiomeric ratio (e.r.) of chemoenzymatic product 5b was 
determined by reverse phase HPLC using a Chiralpak® ID column (150 mm × 4.6 mm, 
Daicel) (MeCN/water = 5:95, 25°C) at a ow rate of 1 mL/min. UV detection at 220 nm: 
tR:(major) = 11.1 min, (minor) = 12.5 min.
Figure S63. UV spectra monitoring the aldol addition of 1 (100 mM) to 2b (2 mM) catalyzed by 
TAUT015 (0.33 mg/mL) in NaPi buer [20 mM/5% (v/v) EtOH] at pH 6.5. A. Enzymatic reaction. 
B. Non-enzymatic reaction.
Figure S64. 1H NMR spectrum of chemoenzymatic product 5b.
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Figure S65. HPLC analysis of racemic 5b.
Figure S66. HPLC analysis of authentic standard (R)-5b
Figure S67. HPLC analysis of chemoenzymatic product 5b.
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(R)-1-(3-chlorophenyl)propane-1,3-diol (5c).[6] yellowish oil; yield = 51% (8 mg). 1H 
NMR (500 MHz, CDCl3) δ 7.29 (t, J = 2.1 Hz, 1H), 7.24 – 7.18 (m, 2H), 7.14 – 7.11 (m, 
1H), 4.78 (dd, J = 8.3, 4.4 Hz, 1H), 4.11 (s, 2H), 3.75 – 3.62 (m, 2H), 1.87 – 1.76 (m, 2H). 
e 1H NMR data is in agreement with published data. [6] e enantiomeric ratio of 
chemoenzymatic product 5c was determined by reverse phase HPLC using a Chiralpak® 
ID column (150 mm × 4.6 mm, Daicel) (MeCN/water = 10:90, 25°C) at a ow rate of 1 
mL/min. UV detection at 220 nm: tR:(major) = 9.7 min, (minor) = 14.1 min.
Figure S68. UV spectra monitoring the aldol addition of 1 (100 mM) to 2c (2 mM) catalyzed by 
TAUT015 (0.33 mg/mL) in NaPi buer [20 mM/5% (v/v) EtOH] at pH 6.5. A. Enzymatic reaction. 
B. Non-enzymatic reaction.
Figure S69. 1H NMR spectrum of chemoenzymatic product 5c.
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Figure S70. HPLC analysis of racemic 5c.
Figure S71. HPLC analysis of authentic standard (S)-5c.
 
Figure S72. HPLC analysis of chemoenzymatic product 5c.
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(R)-1-(2,4-dichlorophenyl)propane-1,3-diol (5d).[7] yellowish oil; yield = 62% (11 mg). 
1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 1H), 7.30 (d, J = 2.0 Hz, 1H), 7.24 (dd, 
J = 8.4, 1.8 Hz, 1H), 5.22 (dd, J = 8.7 Hz, 1H), 4.21 (s, 1H), 3.88 – 3.77 (m, 2H), 3.29 
(s, 1H), 2.01 – 1.89 (m, 1H), 1.86 – 1.72 (m, 1H). e 1H NMR data is in agreement 
with published data. [7] e enantiomeric ratio of chemoenzymatic product 5d was 
determined by reverse phase HPLC using a Chiralpak® ID column (150 mm × 4.6 mm, 
Daicel) (MeCN/water = 10:90, 25°C) at a ow rate of 1 mL/min. UV detection at 220 
nm: tR:(major) = 17.9 min, (minor) = 19.1 min.
Figure S73. UV spectra monitoring the aldol addition of 1 (100 mM) to 2d (2 mM) catalyzed by 
TAUT015 (0.33 mg/mL) in NaPi buer [20 mM/5% (v/v) EtOH] at pH 6.5. A. Enzymatic reaction. 
B. Non-enzymatic reaction.
Figure S74. 1H NMR spectrum of chemoenzymatic product 5d.
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Figure S75. HPLC analysis of racemic 5d.
Figure S76. HPLC analysis of authentic standard (S)-5d.
 
Figure S77. HPLC analysis of chemoenzymatic product 5d.
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(R)-1-(2-nitrophenyl)propane-1,3-diol (5f).[2b] yellowish oil; yield = 69% (11 mg). 1H 
NMR (500 MHz, CDCl3) δ 7.92 (ddd, J = 11.9, 8.1, 1.2 Hz, 2H), 7.67 (td, J = 7.6, 1.1 Hz, 
1H), 7.43 (td, J = 8.0, 7.5, 1.4 Hz, 1H), 5.51 (dd, J = 9.0, 2.5 Hz, 1H), 4.04 – 3.92 (m, 2H), 
3.59 (s, 1H), 2.31 (s, 1H), 2.15 – 2.07 (m, 1H), 2.03 – 1.94 (m, 1H). e 1H NMR data is in 
agreement with published data. [2b] e enantiomeric ratio of chemoenzymatic product 
5f was determined by reverse phase HPLC using a Chiralpak® ID column (150 mm × 
4.6 mm, Daicel) (MeCN/water = 10:90, 25°C) at a ow rate of 1 mL/min. UV detection 
at 220 nm: tR:(major) = 5.8 min, (minor) = 6.8 min.
Figure S78. UV spectra monitoring the aldol addition of 1 (100 mM) to 2f (2 mM) catalyzed by 
TAUT015 (0.33 mg/mL) in NaPi buer [20 mM/5% (v/v) EtOH] at pH 6.5. A. Enzymatic reaction. 
B. Non-enzymatic reaction.
Figure S79. 1H NMR spectrum of chemoenzymatic product 5f.
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Figure S80. HPLC analysis of racemic 5f.
Figure S81. HPLC analysis of authentic standard (R)-5f.
 
Figure S82. HPLC analysis of chemoenzymatic product 5f.
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(R)-1-(3-nitrophenyl)propane-1,3-diol (5g).[2b] yellowish oil; yield = 56% (9 mg). 1H 
NMR (500 MHz, CDCl3) δ 8.24 (t, J = 2.0 Hz, 1H), 8.12 (dd, J = 8.3, 2.2 Hz, 1H), 7.72-7.70 
(m, 1H), 7.52 (t, J = 8.0, 1.7 Hz, 1H), 5.16 – 5.02 (m, 1H), 3.98 – 3.85 (m, 2H), 3.71 (s, 1H), 
2.44 (s, 1H), 1.98 (ddd, J = 10.2, 6.2, 4.0 Hz, 2H). e 1H NMR data is in agreement with 
published data. [2b] e enantiomeric ratio of enzymatic product 5g was determined by 
reverse phase HPLC using a Chiralpak® ID column (150 mm × 4.6 mm, Daicel) (MeCN/
water = 10:90, 25°C) at a ow rate of 1 mL/min. UV detection at 220 nm: tR:(major) = 5.8 
min, (minor) = 8.8 min.
Figure S83. UV spectra monitoring the aldol addition of 1 (100 mM) to 2g (2 mM) catalyzed by 
TAUT015 (0.33 mg/mL) in NaPi buer [20 mM/5% (v/v) EtOH] at pH 6.5. A. Enzymatic reaction. 
B. Non-enzymatic reaction.
Figure S84. 1H NMR spectrum of chemoenzymatic product 5g.
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Figure S85. HPLC analysis of racemic 
5g.
Figure S86. HPLC analysis of authentic standard (S)-5g.
Figure S87. HPLC analysis of chemoenzymatic product 5g.
6
BNW_Lieuwe.indd   229 31-08-20   15:18
230
Chapter 6
Figure S88. Eect of pH, acetaldehyde (1) concentration, and buer on the aldol addition of 1 to 
2k. A. Conversion of 2k in the aldol addition of 1 (50 mM or 100 mM) to 2k (2 mM) catalyzed 
by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi/5% (v/v) DMSO, 0.3 mL] at pH 7.3, 7.5 
or 8.0. B. Formation of corresponding cinnamaldehyde in the aldol addition of 1 (100 mM) with 
2k (2 mM) catalyzed by 4-OT(M45T/F50A) (1 mg/mL) in buer [20 mM NaPi or MOPS/5% (v/v) 
DMSO, 0.3 mL] at pH 8.0.
Figure S89. Sequence alignment of 4-OT from P. putida mt-2 and TAUT015. Indicated with a star 
(*) are positions 45 and 50 that were mutated to give 4-OT M45T/F50A. e sequence alignment 
was generated using the online Constraint-based Multiple Alignment Tool (COBALT, NCBI 
https://www.ncbi.nlm.nih.gov/tools/cobalt/) using default parameters.
6. Chemical synthesis of racemic 1,3-diols
6.1. Synthesis of compound 5k
NC d r y T HF , r t , 4 0 h8 1 %














M e OH, r t , 4 h
8 6 %6
7
8 a 8 b 5k
Compound 5k was prepared according to the route shown above, which involves the 
preparation of a mixture of compounds 8a and 8b.
6.1.1. Synthesis of compound 8
Compound 8[8a] was prepared according to a literature procedure and its 1H NMR 
spectrum matches with earlier reported NMR data.[8b]
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6.1.2. Synthesis of compound 5k
e reported literature procedure was slightly modied.[9a] To a stirred solution of a 
mixture of 8a and 8b (1.0 equiv.) in dry MeOH (10 mL) at 0 oC was added NaBH4 
(3.0 equiv.) portion wise, and the reaction was run at room temp for 4 h. Aer 
completion of the reaction, as monitored by TLC (KMnO4 test), the reaction mixture 
was extracted three times with EtOAc. e organic layers were combined, dried over 
Na2SO4 and evaporated under vacuo. e crude product was puried by silica gel column 
chromatography using petroleum ether/ethyl acetate (90:10) as an eluent to give the 
corresponding racemic 1,3-diol 5k. Colorless liquid; yield = 86% (140 mg, starting from 
200 mg of 8). e 1H NMR data of compound 5k[9b] match with earlier reported NMR 
data. 1H NMR (500 MHz, CDCl3) δ 7.66 – 7.63 (m, 2H), 7.50 (d, J = 8.2 Hz, 2H), 5.05 
(t, J = 6.1 Hz, 1H), 3.90 (t, J = 5.5 Hz, 2H), 3.35 (s, 1H), 2.15 – 2.07 (m, 1H), 1.99 – 1.90 
(m, 2H).
6.2. Synthesis of compounds 5m-n and 5s
X
T E A






M e OH, r t , 3 h





R = p e n t a f l u o r o & X = C ( 2 m )
R = 3 - C N, 4 - F & X = C ( 2 n )
R = H & X = N ( 2 s )
7 8 % ( 9 m )
8 6 % ( 9 n )




9 1 % ( 5m )
8 7 % ( 5n )
6 9 % ( 5s )
Compounds 5m-n and 5s were prepared according to the route shown above, which 
involves the preparation of compounds 9m-n and 9s.
6.2.1. Synthesis of compounds 9m-n and 9s
Compounds 9m-n and 9s were prepared according to a literature procedure.[2a]
Ethyl 3-hydroxy-3-(peruorophenyl)propanoate (9m). 1H NMR (500 MHz, CDCl3) δ 
5.59 – 5.46 (m, 1H), 4.26 – 4.17 (m, 2H), 3.27 (d, J = 5.3 Hz, 1H), 3.13 (dd, J = 16.7, 9.4 Hz, 
1H), 2.75 (dd, J = 16.7, 4.1 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 171.37, 146.12, 144.13, 142.08, 140.05, 138.74, 136.72, 115.25, 62.15, 61.42, 40.41, 14.12. 
HRMS (ESI+): calcd. for C11H8F5O2 [MH-H2O]+: 267.0444, found: 267.0436.
Ethyl 3-(3-cyano-4-uorophenyl)-3-hydroxypropanoate (9n). 1H NMR (500 MHz, 
CDCl3) δ 7.67 (dd, J = 6.0, 2.2 Hz, 1H), 7.65 – 7.59 (m, 1H), 7.21 (t, J = 8.6 Hz, 1H), 5.13 
6
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(dt, J = 8.0, 3.9 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.63 (d, J = 3.5 Hz, 1H), 2.75 – 2.59 (m, 
2H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 172.06, 163.62, 161.56, 139.82, 
132.59, 132.52, 130.90, 116.75, 116.60, 113.94, 68.82, 61.40, 43.09, 14.24. HRMS (ESI+): 
calcd. for C12H11FNO2 [MH-H2O]+: 220.0774, found: 220.0765.
Ethyl 3-hydroxy-3-(pyridin-2-yl)propanoate (9s).[10] 1H NMR (500 MHz, CDCl3) δ 8.55 
(d, J = 4.8 Hz, 1H), 7.70 (td, J = 7.7, 1.7 Hz, 1H), 7.42 (d, J = 7.9 Hz, 1H), 7.21 (dd, J = 7.4, 
4.9 Hz, 1H), 5.18 (dt, J = 9.3, 5.0 Hz, 1H), 4.28 (d, J = 5.6 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 
2.90 (dd, J = 16.0, 4.1 Hz, 1H), 2.76 (dd, J = 16.0, 8.4 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H). e 
1H NMR data is in agreement with published data. [10]
6.2.2. Synthesis of compounds 5m-n and 5s
e compounds 5m-n and 5s were obtained by reducing 9m-n and 9s (1.0 equiv.) using 
NaBH4 (3.0 equiv.) following a procedure similar to that used for 5k. e 
1H NMR data 
of compounds 5m [2b] and 5s [5] match with earlier reported NMR data.
1-(peruorophenyl)propane-1,3-diol (5m). 1H NMR (500 MHz, CDCl3) δ 5.53 – 5.24 
(m, 1H), 4.01 – 3.82 (m, 2H), 3.07 (s, 1H), 2.42 – 2.25 (m, 1H), 2.09 – 1.82 (m, 2H). e 
1H NMR data is in agreement with published data. [2b]
5-(1,3-dihydroxypropyl)-2-uorobenzonitrile (5n). 1H NMR (500 MHz, CDCl3) δ 7.61 
(dd, J = 6.0, 2.2 Hz, 1H), 7.57 (ddd, J = 7.5, 5.1, 2.2 Hz, 1H), 7.16 (t, J = 8.7 Hz, 1H), 4.97 
– 4.88 (m, 1H), 3.86 – 3.72 (m, J = 5.7 Hz, 2H), 3.65 (s, 2H), 1.86 (q, J = 5.3 Hz, 2H). 13C 
NMR (126 MHz, CDCl3) δ 163.45, 161.39, 141.77, 141.74, 132.57, 132.50, 130.78, 116.63, 
116.47, 114.15, 72.81, 61.37, 40.43. HRMS (ESI+): calcd. for C10H11FNO2 [M+H]: 196.0729, 
found: 196.0769.
1-(pyridin-2-yl)propane-1,3-diol (5s). 1H NMR (500 MHz, CDCl3) δ 8.43 (d, J = 4.9 Hz, 
1H), 7.67 (td, J = 7.7, 1.6 Hz, 1H), 7.39 (d, J = 7.9 Hz, 1H), 7.16 (dd, J = 7.2, 5.1 Hz, 1H), 
4.98 (dd, J = 8.9, 3.7 Hz, 1H), 3.90 – 3.76 (m, 2H), 2.09 – 1.98 (m, 1H), 1.96 – 1.81 (m, 
1H). e 1H NMR data is in agreement with published data. [5]
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6.3. Synthesis of compounds 5b-d and 5f-g
OH O
O




R = 2- C l ( 9 t )
3 - C l ( 9 u )
2, 4 - d i - C l ( 9 v )
2- NO2 ( 9 w )
3 - NO2 ( 9 x )
9
5
8 1 % ( 5b )
7 5 % ( 5c )
8 6 % ( 5d )
9 0 % ( 5f )
7 9 % ( 5g )
e compounds 5b-d and 5f-g were obtained by reducing 9t-x (1.0 equiv.) using NaBH4 
(3.0 equiv.) following a procedure similar to that used for 5k. e 1H NMR data of 
compounds 5b[2b], 5c[11a], 5d[11b]and 5f-g [2b] match with earlier reported NMR data.
1-(2-chlorophenyl)propane-1,3-diol (5b). 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 7.7, 
1.6 Hz, 1H), 7.27 (qd, J = 7.7, 1.2 Hz, 2H), 7.17 (td, J = 7.6, 1.7 Hz, 1H), 5.29 (dd, J = 8.8, 
2.9 Hz, 1H), 3.86 – 3.77 (m, 2H), 3.63 (s, 2H), 2.04 – 1.94 (m, 1H), 1.88 – 1.77 (m, 1H). 
e 1H NMR data is in agreement with published data. [2b]
1-(3-chlorophenyl)propane-1,3-diol (5c). 1H NMR (500 MHz, CDCl3) δ 7.28 (s, 1H), 
7.25 – 7.16 (m, 2H), 7.13 (dt, J = 6.7, 1.7 Hz, 1H), 4.78 (dd, J = 8.2, 4.4 Hz, 1H), 4.11 (s, 
2H), 3.78 – 3.62 (m, 2H), 1.89 – 1.74 (m, 2H). e 1H NMR data is in agreement with 
published data. [11a]
1-(2,4-dichlorophenyl)propane-1,3-diol (5d). 1H NMR (500 MHz, CDCl3) δ 7.45 (d, 
J = 8.4 Hz, 1H), 7.28 (d, J = 2.1 Hz, 1H), 7.21 (dd, J = 8.4, 2.0 Hz, 1H), 5.18 (dd, J = 8.9, 2.4 
Hz, 1H), 4.55 (s, 1H), 3.80 – 3.76 (m, 3H), 1.96 – 1.88 (m, 1H), 1.79 – 1.68 (m, 1H). e 
1H NMR data is in agreement with published data. [11b]
1-(2-nitrophenyl)propane-1,3-diol (5f). 1H NMR (500 MHz, CDCl3) δ 7.86 – 7.80 (m, 
2H), 7.62 – 7.55 (m, 1H), 7.38 – 7.31 (m, 1H), 5.42 (d, J = 7.7 Hz, 1H), 3.85 (m, 2H), 3.25 
(s, 1H), 2.09 (s, 1H), 2.06 – 1.97 (m, 1H), 1.90 – 1.79 (m, 1H). e 1H NMR data is in 
agreement with published data. [2b]
1-(3-nitrophenyl)propane-1,3-diol (5g). 1H NMR (500 MHz, CDCl3) δ 8.12 (s, 1H), 7.98 
(dd, J = 8.1, 1.8 Hz, 1H), 7.61 (d, J = 7.7 Hz, 1H), 7.42 (t, J = 7.9 Hz, 1H), 4.98 (t, J = 6.1 
6
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Hz, 1H), 4.54 (s, 1H), 3.83 – 3.71 (m, J = 5.3 Hz, 2H), 3.61 (s, 1H), 1.88 – 1.85 (m, 2H). 
e 1H NMR data is in agreement with published data. [2b]
6.4. Synthesis of compound 5l
Compound 5l was prepared according to a literature procedure and its 1H NMR data 
match with earlier reported data.[12]
1-(4-(triuoromethyl)phenyl)but-3-en-1-ol (10). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, 
J = 8.2 Hz, 2H), 7.48 (d, J = 8.1 Hz, 2H), 5.87 – 5.71 (m, 1H), 5.23 – 5.14 (m, 2H), 4.81 (dd, 
J = 8.0, 4.7 Hz, 1H), 2.59 – 2.51 (m, 1H), 2.51 – 2.41 (m, 1H), 2.13 (s, 1H). e 1H NMR 
data is in agreement with published data. [12a]
4-(4-(triuoromethyl)phenyl)butane-1,2,4-triol (11). 1H NMR (500 MHz, CDCl3) δ 
7.58 (d, J = 8.1 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 5.00 (dd, J = 10.0, 2.8 Hz, 1H), 4.01 (ddd, 
J = 9.6, 6.5, 3.2 Hz, 1H), 3.62 (dd, J = 11.2, 3.2 Hz, 1H), 3.47 (dd, J = 11.2, 6.8 Hz, 1H), 1.85 
(dt, J = 14.6, 9.8 Hz, 1H), 1.72 (dt, J = 14.5, 2.8 Hz, 1H). e 1H NMR data is in agreement 
with published data. [12b]
1-(4-(triuoromethyl)phenyl)propane-1,3-diol (5l). 1H NMR (500 MHz, CDCl3) δ 7.61 
(d, J = 8.2 Hz, 2H), 7.50 (d, J = 8.1 Hz, 2H), 5.05 (dd, J = 8.1, 4.1 Hz, 1H), 3.90 (t, J = 5.6 
Hz, 2H), 2.03 – 1.91 (m, 2H). e 1H NMR data is in agreement with published data. [12d]
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7. Chemical synthesis of enantiopure 1,3-diols using Jorgenson and 
Hayashi catalyst
















R = 4 - C N ( 2 k ) , 4 - C F 3 ( 2 l )
p e n t a f l u o r o ( 2 m )
2- C l ( 2 b ) , 2- NO2 ( 2 f )
3 - NO2 ( 2 g)
22 % ( 5k )
20 % ( 5l )
4 0 % ( 5m )
3 1 % ( 5b )
26 % ( 5f )
3 2 % ( 5g)
C a t a l y s t A ( 1 0 m o l % )




Compounds 5k-m[2b], 5b[2b] and 5f-g[2b] were prepared according to literature procedures 
and their 1H NMR spectra match with earlier reported NMR data.[2b]
(R)-4-(1,3-dihydroxypropyl)benzonitrile (5k). 1H NMR (500 MHz, CDCl3) δ 7.65 (d, 
J = 8.2 Hz, 2H), 7.50 (d, J = 8.4 Hz, 2H), 5.11 – 4.99 (m, 1H), 3.93 – 3.90 (m, 2H), 3.64 
(dd, J = 11.0, 3.1 Hz, 1H), 3.40 (dd, J = 11.0, 7.8 Hz, 1H), 1.98 – 1.94 (m, 2H).  e 1H NMR 
data is in agreement with published data. [2b]
(R)-1-(4-(tri uoromethyl)phenyl)propane-1,3-diol (5l). 1H NMR (500 MHz, CDCl3) δ 
7.62 (d, J = 8.1 Hz, 2H), 7.50 (d, J = 8.4 Hz, 2H), 5.06 (dd, J = 8.2, 4.1 Hz, 1H), 3.94 – 3.87 
(m, 2H), 2.00 – 1.96 (m, 2H).  e 1H NMR data is in agreement with published data. [2b]
(R)-1-(per uorophenyl)propane-1,3-diol (5m). 1H NMR (500 MHz, CDCl3) δ 5.40 – 
5.32 (m, 1H), 4.00 – 3.87 (m, 2H), 3.02 (d, J = 4.4 Hz, 1H), 2.35 (ddt, J = 17.4, 9.2, 4.1 Hz, 
1H), 1.97 (ddt, J = 14.4, 6.7, 3.9 Hz, 1H), 1.81 (s, 1H).  e 1H NMR data is in agreement 
with published data. [2b]
(R)-1-(2-chlorophenyl)propane-1,3-diol (5b). 1H NMR (500 MHz, CDCl3) δ 7.62 (dd, 
J = 7.7, 1.4 Hz, 1H), 7.34 – 7.26 (m, 2H), 7.20 (td, J = 7.6, 1.7 Hz, 1H), 5.34 (dd, J = 8.8, 2.7 
Hz, 1H), 3.93 – 3.85 (m, 2H), 3.45 (s, 1H), 2.68 (s, 1H), 2.06 – 2.01 (m, 1H), 1.95 – 1.84 
(m, 1H).  e 1H NMR data is in agreement with published data. [2b]
6
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(R)-1-(2-nitrophenyl)propane-1,3-diol (5f). 1H NMR (500 MHz, CDCl3) δ 7.93 (ddd, 
J = 11.6, 8.0, 1.4 Hz, 2H), 7.67 (td, J = 7.7, 1.4 Hz, 1H), 7.43 (ddd, J = 8.5, 7.4, 1.5 Hz, 1H), 
5.52 (dd, J = 9.0, 2.6 Hz, 1H), 4.09 – 3.91 (m, 2H), 3.54 (s, 1H), 2.23 (s, 1H), 2.17 – 2.08 
(m, 1H), 2.04 – 1.93 (m, 1H).  e 1H NMR data is in agreement with published data. [2b]
(R)-1-(3-nitrophenyl)propane-1,3-diol (5g). 1H NMR (500 MHz, CDCl3) δ 8.13 (s, 1H), 
7.98 (ddd, J = 8.2, 2.3, 1.0 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.41 (t, J = 7.9 Hz, 1H), 4.94 (t, 
J = 15.4, 9.7 Hz, 1H), 4.91 (s, 1H), 4.03 (s, 1H), 3.80 – 3.67 (m, 2H), 1.89 – 1.83 (m, 2H). 
 e 1H NMR data is in agreement with published data. [2b]











R = 3 - C l ( 2 c ) , 2, 4 - d i - C l ( 2 d )
28 % ( 5c )
4 2 % ( 5d )
C a t a l y s t B ( 1 0 m o l % )









 e compounds 5c[2b] and 5d[2b] were obtained by following a procedure similar to that 
used for 5k using enantiocomplementary catalyst B, and their 1H NMR spectra match 
with earlier reported NMR data.[6,13]
(S)-1-(3-chlorophenyl)propane-1,3-diol (5c). 1H NMR (500 MHz, CDCl3) δ 7.35 (s, 1H), 
7.30 – 7.17 (m, 3H), 4.88 (dd, J = 8.2, 4.2 Hz, 1H), 3.80 (m, 3H), 3.41 (s, 1H), 1.98 – 1.84 
(m, 2H).  e 1H NMR data is in agreement with published data. [6,13]
(S)-1-(2,4-dichlorophenyl)propane-1,3-diol (5d). 1H NMR (500 MHz, CDCl3) δ 7.57 
(d, J = 8.4 Hz, 1H), 7.37 – 7.27 (m, 2H), 5.29 (d, J = 8.2 Hz, 1H), 3.96 – 3.85 (m, 2H), 3.78 
(s, 1H), 2.76 (s, 1H), 2.07 – 1.97 (m, 1H), 1.91 – 1.80 (m, 1H).  e 1H NMR data is in 
agreement with published data. [13]
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Summary and Future Perspectives





Enzymes are highly complex molecules, carefully folded to position functional groups 
and form a structure that can accommodate substrate molecules and promote a chemical 
reaction. Despite their high complexity, enzymes can be precisely engineered using 
recombinant DNA technology. By mutating particular base pairs in the gene coding for 
an enzyme, a dierent enzyme variant can be produced with, sometimes, vastly dierent 
properties. However, predicting the eect of a mutation on the properties of an enzyme is 
still highly challenging. As a consequence, a common strategy to engineer enzymes is to 
generate many dierent mutants of an enzyme and test all mutants for a desired property. 
Individual mutants showing the desired property can then be selected and subjected to 
a new round of mutagenesis. is iterative process is referred to as directed evolution 
and has dramatically impacted the biocatalysis community, recently recognized by the 
awarding of one half of the 2018 Nobel Prize in chemistry to Frances H. Arnold for her 
work on the directed evolution of enzymes1.
It is dicult to underestimate the power of directed evolution as scientists have 
demonstrated that computationally designed enzymes, with relative low activity, can 
be engineered to reach activities comparable to natural enzymes, simply by repeating 
the cycle of directed evolution many times2,3. In recent years there are some astounding 
examples of enzymes that were repurposed via directed evolution to catalyze abiological 
reactions4,5. e property of many enzymes to catalyze other reactions than their natural 
ones is also exemplied by the enzyme 4-oxalocrotonate tautomerase (4-OT), which has 
several promiscuous activities, including the ability to catalyze interesting C-C bond-
forming reactions such as the Michael-type addition of aldehydes to nitroalkenes and 
the aldol condensation of acetaldehyde with benzaldehyde6,7.
Engineering 4-OT
Although the activities are still modest, 4-OT might provide a good starting point for 
further engineering towards new C-C bond-forming ‘Michaleases’ or aldolases. e 
small size of 4-OT (only 62 amino acids) provides an excellent scaold for an upcoming 
enzyme engineering strategy termed as mutability-landscape guided enzyme engineering 
(chapter 1). is strategy involves the systematic screening of (nearly) all single mutants 
of an enzyme for a desired property, the results of which can be graphically represented in 
a mutability landscape. Contrary to traditional engineering methodologies, this strategy 
does not only provide information on benecial mutations, but also on neutral and 
detrimental mutations. is provides valuable information on the mutational robustness 
BNW_Lieuwe.indd   242 31-08-20   15:18
243
Summary and Future Perspectives
of an enzyme and on functionally important residue positions. ere are two approaches 
to obtain experimental data for the creation of a protein mutability landscape. e rst 
approach involves the construction and characterization of a dened collection of 
(nearly) all single mutants and the second approach is called deep mutational scanning. 
e latter approach can only be used in combination with high-throughput screening 
assays because oversampling is required, whereas the rst approach can also be used with 
lower throughput screening assays. Mutability-landscape guided enzyme engineering 
has been performed on several dierent enzymes, but the best characterized enzyme is 
4-OT, with reported mutability landscapes on tautomerase activity, ‘Michaelase’ activity, 
enantioselectivity and enzyme expression.
In a thorough study on the enantioselectivity of the 4-OT-catalyzed Michael-
type addition, a double mutant, 4-OT M45Y/F50A was identied with inverted 
enantioselectivity towards the addition of acetaldehyde (1) to nitroalkene acceptors 
(2a-d)8. e resultant products 3a-d are precursors for the pharmaceutically relevant 
enantiomers of a set of γ-aminobutyric acid (GABA) analogues (5a-d, Figure 1). However, 
the enantioselectivity of 4-OT M45Y/F50A is relatively poor, synthesizing 3a-d with an 
enantiomeric ratio (e.r.) between 62:38 and 96:4. erefore, in chapter 2 we aimed to 
improve the enantioselectivity of 4-OT M45Y/F50A for the Michael-type addition of 
1 to 2a-d. We initially studied the eect of cosolvents on the enantioselectivity for the 
addition of 1 to 2b, catalyzed by 4-OT M45Y/F50A. We found that DMSO and ethanol 
negatively aected the enantioselectivity of the enzyme, whereas small diols, such as 
1,3-propanediol and ethylene glycol, positively aected the enantioselectivity improving 
the e.r. of 3b from 90:10 to 95:5. However, enzyme engineering was necessary to further 
enhance the enantioselectivity. Guided by a reported crystal structure of 4-OT M45Y/
F50A in complex with 2a8, we randomized Ile-2 and Leu-8 and screened for mutants 
with improved enantioselectivity for the addition of 1 to 2b. We found that substitution 
of Leu-8 to phenylalanine or tyrosine signicantly improved the enantioselectivity, 
allowing the synthesis of 3b with an e.r. of 99:1. 4-OT L8Y/M45Y/F50A proved to be more 
active and more stable in the presence of the cosolvent ethanol compared to 4-OT L8F/
M45Y/F50A, and hence we continued with this mutant. Crystallization of 4-OT L8Y/
M45Y/F50A revealed that the volume of the enzyme active site was reduced compared 
to 4-OT M45Y/F50A. We hypothesized that this reduces the rotational freedom of the 
nitroalkene substrate and hence promotes the enantioselective synthesis of products 
3a-d.
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Figure 1. Synthesis route for GABA analogues. e asymmetric Michael-type addition of acet-
aldehyde (1) to nitroalkenes 2a-d catalyzed by 4-OT yields γ-nitroaldehydes 3a-d, which can be 
converted into γ-nitrocarboxylic acids 4a-d and nally into GABA analogues 5a-d.
Solubilization of nitroalkene substrates requires the use of cosolvents. High 
concentrations of cosolvents can signicantly destabilize enzymes, as enzymes have 
evolved for catalysis in the aqueous environment of the cell. In chapter 3 we employed 
mutability-landscape guided engineering to identify “hot-spot” positions that promote 
catalysis in the presence of high concentrations of ethanol. Two “hot-spot” positions were 
identied, Ser-30 and Ala-33. Targeting “hot-spot” position Ala-33 in the context of the 
highly enantioselective, but ethanol-sensitive, mutant 4-OT L8F/M45Y/F50A (chapter 
2), resulted in a set of quadrupole mutants with signicantly improved performance in 
high concentrations of ethanol. e best mutant, 4-OT L8F/A33I/M45Y/F50A, could 
be used to catalyze the Michael-type addition of 1 to 2a in the presence of up to 40% 
v/v ethanol, whereas 4-OT L8F/M45Y/F50A lost all activity already in 10% v/v ethanol. 
is is an interesting showcase of the power of mutability-landscape guided enzyme 
engineering, where targeting of a single “hot-spot” position results in a dramatic increase 
in ethanol resistance of an enzyme.
We have shown that mutability-landscape guided enzyme engineering aords valuable 
information on positions in the enzyme that aect a desired characteristic. However, 
follow-up engineering can still be cumbersome, as even a library specically targeting 
“hot-spot” positions oen consists of a large fraction of inactive mutants. As a result, 
the screening of a library of mutants is typically the bottleneck in enzyme engineering9. 
erefore, in chapter 4, we developed a novel pre-screening assay to exclude inactive 
mutants from the subsequent screening. We focused on the 4-OT-catalyzed Michael-
type addition of nitromethane (6) to cinnamaldehyde (7a) forming 3a (Figure 2). e 
mechanism of this reaction involves the formation of a covalent iminium species between 
7a and Pro-1 of 4-OT, which subsequently undergoes nucleophilic attack by 6.
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Figure 2. 4-OT catalyzed Michael-type addition of 6 to 7a and iminium activation of 7b by 
4-OT. A) Enantioselective iminium-mediated Michael-type addition of 6 to 7a catalyzed by 4-OT 
mutants. B) Iminium activation of 7b by 4-OT forming a zwitterionic merocyanine-dye complex.
We showed that the reaction of Pro-1 with 2-hydroxycinnamaldehyde (7b) results in the 
formation of a zwitterionic, merocyanine-dye complex, with notable absorption at 516 
nm that can clearly be observed by the naked eye. 4-OT mutants that did not form this 
brightly colored species proved to be poor catalysts for the Michael-type addition of 6 
to 7a. We exploited this in a facile solid-phase pre-screening assay, which reduced the 
screening burden up to 20-fold. Aer two rounds of directed evolution, two mutants 
were identied, 4-OT S37E/M45I/F50A and 4-OT A33E/M45I/F50A, which showed up 
to 39-fold improvement in activity.
Applying 4-OT in multistep cascade reactions
e enzyme 4-OT provides an interesting platform to explore new (promiscuous) 
catalytic activities which could be applied for the synthesis of various pharmaceuticals. 
e successful engineering of 4-OT described above highlights the potential of 4-OT 
as an ecient biocatalyst. However, the synthesis of pharmaceuticals typically consists 
of many consecutive reactions, and product loss during intermediate workup can 
signicantly reduce the overall yield of the process. e combination of (bio)catalysts 
in one-pot reaction cascades is an emerging concept in biocatalysis which prevents 
the necessity of intermediate purication. In chapter 2 we use the newly engineered 
articial ‘Michaelase’ 4-OT L8Y/M45Y/F50A in combination with a natural aldehyde 
dehydrogenase, PRO-ALDH(003), and a natural NADH oxidase, PRO-NOX(009) in 
a 2-step reaction cascade aording nitrocarboxylic acids 4a-d in good isolated yield 
(up to 70%) and excellent enantiopurity (e.r. up to 99:1). Finally, using nickel boride as 
chemocatalyst, we also developed a three-step one-pot chemoenzymatic reaction cascade 
synthesizing the nal GABA-analogues 5a-d in good isolated yield (up to 70%) and with 
excellent e.r. values of up to 99:1.
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4-OT is unique in that it can use acetaldehyde (1) as a nucleophile in Michael-type 
additions to nitroalkenes or the aldol condensation with benzaldehyde (12a). However, 
1 is highly toxic and reactive and as a consequence requires intricate handling, which 
can impede its usage in practical synthesis. erefore, in chapter 5, we report a study 
on three complementary routes for the in situ synthesis of 1 (Figure 3).
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Figure 3. Enzymatic complementary routes for in situ generation of acetaldehyde (1). e in situ 
synthesized 1 is used as a substrate in a 4-OT L8Y/M45Y/F50A catalyzed Michael-type addition 
or a 4-OT M45T/F50A catalyzed aldol condensation reaction in one pot. Abbreviations: CaaD: 
chloroacrylic acid dehalogenase, MSAD: malonate semialdehyde decarboxylase, ScADH: alcohol 
dehydrogenase, PRO-NOX(009): NADH oxidase, ZmPDC: pyruvate decarboxylase.
Route I involves the dehalogenation of 8 into 9, catalyzed by the enzyme chloroacrylic 
acid dehalogenase (CaaD), followed by the decarboxylation of 9 into 1 by the enzyme 
malonate semialdehyde decarboxylase (MSAD). Route II involves the oxidation of 
ethanol (10) into 1 catalyzed by the alcohol dehydrogenase from Saccharomyces 
cerevisiae (ScADH), in combination with the NADH oxidase, PRO-NOX(009). Route 
III involves the decarboxylation of pyruvate (4) into 1 using pyruvate decarboxylase 
from Zymomonas mobilis (ZmPDC). Route I and II proved to be eective routes for the 
in situ generation of 1 and could be used in combination with the 4-OT L8Y/M45Y/F50A 
catalyzed Michael-type addition of 1 to 2a and the 4-OT M45T/F50A catalyzed aldol 
condensation of 1 with 12c. ese results demonstrate how modular reaction cascades 
can provide interesting articial metabolic networks for the synthesis of important 
pharmaceuticals.
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Reaction engineering
Previously, the enzyme 4-OT M45T/F50A was identied as a promising catalyst for 
the aldol condensation of 1 and 12a10. e aldol-condensation reaction comprises of 
two steps: the initial aldol coupling and the subsequent dehydration, which are both 
catalyzed by 4-OT11. Since, the aldol-coupling product contains an asymmetric C-atom, 
which is lost upon dehydration, in chapter 6 we aimed to prevent dehydration and use 
4-OT to synthesize chiral β-hydroxyaldehydes. We tested a range of aldol acceptors and 
found that primarily acceptors with electron withdrawing substituents were accepted 
as substrates by 4-OT M45T/F50A. Out of these acceptors, ve yielded aldol products 
that did not undergo dehydration, and in situ reduction by NaBH4 aorded 1,3-diols 
13l-p in good to excellent isolated yield (up to 92%) and in high enantiopurity (e.r. 
up to 99:1). To expand the scope of accessible chiral 1,3-diols, we screened through 
a panel of 4-OT homologues to nd new promiscuous aldolase activities. e 4-OT 
homologue TAUT015 was identied as a promising biocatalyst and could be used for 
the enantioselective synthesis of 1,3-diols 13c-e and 13g-h (e.r. up to >99:1). As the aldol 
acceptors that were tested are not known to be accepted by natural aldolases, this study 
illustrates that members of the 4-OT superfamily, exemplied by 4-OT M45T/F50A and 
TAUT015, nicely complement the toolbox of biocatalysts available for asymmetric C-C 
bond-forming reactions.
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Figure 4. Aldol condensations and coupling reactions catalyzed by 4-OT or TAUT015. A) 
Aldol condensation and coupling reactions catalyzed by 4-OT M45T/F50A. B) Aldol coupling 
reactions catalyzed by 4-OT homologue TAUT015.
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In summary, we showcase the potential of 4-OT as a biocatalyst in new synthetic 
pathways towards various pharmaceuticals. Enzyme engineering aorded several 
mutants with improved ethanol resistance, improved enantioselectivity and improved 
‘Michaelase’ activity. e engineered 4-OT mutants could be combined with other (bio)
catalysts in one-pot cascade reactions providing articial metabolic networks that can 
be used for the total synthesis of GABA analogues. Finally, via ‘substrate engineering’ 
and homologue screening, we obtained access to a range of chiral 1,3-diols via a new 
chemoenzymatic synthesis route.
Future perspectives
e presented work in this thesis provides a stepping stone towards the development 
of novel 4-OT-based synthetic routes that could, for example, be applied for the 
synthesis of various GABA analogues. Signicant progress has been made in terms of 
enantioselectivity, activity and solvent stability of 4-OT. However, industrial application 
of 4-OT still requires extensive engineering and reaction optimization. e activities of 
the engineered 4-OT variants (chapter 2 and chapter 4) are still modest with a kobs in the 
range of 0.1 s-1 for both the Michael-type addition of 1 to 2a-d catalyzed by 4-OT L8Y/
M45Y/F50A and the Michael-type addition of 6 to 7a catalyzed by 4-OT S37E/M45I/
F50A and 4-OT A33E/M45I/F50A. An increase in activity of at least 10-fold is desirable. 
e developed AICS pre-screening assay developed in chapter 4 might be a helpful tool 
to achieve this. Furthermore, machine-learning algorithms are becoming a powerful tool 
to predict beneciary mutations. e mutational data that has been obtained for 4-OT 
from mutability-landscape studies presented in this thesis, as well as in previous studies, 
are excellent training data for these algorithms. Several successful engineering studies 
have been reported using the ASRA and Innov’SAR algorithms12-14 and, in collaboration 
with others, further engineering of 4-OT via machine-learning is ongoing.
e reaction cascades described in chapter 2 and chapter 5 nicely demonstrate the 
opportunities available for combining dierent catalysts in one pot, but further 
optimization is required. Ideally, these reaction cascades are not performed stepwise, 
but in continuous mode. A continuous system would allow for higher substrate loadings 
as the nal GABA analogues are highly soluble under aqueous conditions. In addition, 
a continuous reaction cascade would overcome unfavorable reaction equilibria which 
would prevent the need of using one substrate in large excess compared to the other. 
However, the aldehyde dehydrogenase used in chapter 2, PRO-ALDH(003), could also 
oxidize 1 which prohibited an ecient continuous reaction cascade. Utilization of an 
aldehyde dehydrogenase that is selective towards γ-nitroaldehydes would solve this issue, 
but identication of an aldehyde dehydrogenase that is selective towards γ-nitroaldehydes 
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and can withstand high concentrations of 1 might be dicult. Alternatively, an aldehyde 
dehydrogenase could be used in combination with the 4-OT catalyzed Michael-type 
addition of 6 to 7a (chapter 4). A stepwise reaction cascade using PRO-ALDH(003) has 
already been reported for this reaction15. A continuous system requires an aldehyde 
dehydrogenase that is selective towards 3a, but does not oxidize 7a. e identication of 
such an aldehyde dehydrogenase might be easier due to the marked electronic dierences 
between the aldehyde functionality of 7a compared to 3a.
A fully continuous reaction cascade requires an alternative strategy for the reduction 
of the nitro group of 4a-d, as the conditions use for chemical reduction (chapter 2) are 
not compatible with the previous enzymatic steps. Ideally, NiCl2 would be replaced by 
a nitroreductase. However, no nitroreductases have been reported that can fully reduce 
nitro functionalities that are not in direct conjugation with an aromatic ring. Reported 
nitroreductases do not accept aliphatic nitro groups and oen catalyze only partial 
reduction to reactive nitroso or hydroxylamine species, which results in the formation 
of unwanted side products16. Currently, work is ongoing in our lab to identify novel 
nitroreductases and explore reaction conditions that allow for the full reduction of the 
nitro functionalities present in 4a-d. Our ultimate goal is to obtain a fully enzymatic 
system, either as whole cells or puried enzymes, which can be used to eciently 
synthesize GABA analogues under environmentally friendly conditions. 7
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Enzym modicatie
Enzymen zijn zeer complexe moleculen die bestaan uit lange ketens van aminozuren. 
Er zijn 20 verschillende aminozuren met allemaal een verschillend karakter. Er zijn 
bijvoorbeeld hydrofobe aminozuren (aminozuren die niet met water in contact willen 
komen) en hydroele aminozuren (aminozuren die juist graag met water in contact 
willen komen) en er zijn aminozuren met een positieve lading en aminozuren met een 
negatieve lading. Door deze verschillende eigenschappen is een enzym niet slechts een 
chaotische sliert van aminozuren, maar vouwt de sliert van aminozuren zich tot een 
complex driedimensionaal molecuul (Figuur 1A).
Alle levende organismen gebruiken enzymen als katalysator om chemische reacties mee 
te katalyseren. Een katalysator is een stof (bijvoorbeeld een enzym) die ervoor zorgt 
dat een chemische reactie sneller verloopt. In auto’s zit bijvoorbeeld een katalysator 
die ervoor zorgt dat allerlei giige gassen die uit de motor komen snel reageren tot 
koolstofdioxide, stikstof en water. Cellen van organismen hebben de beschikking over 
allerlei soorten enzymen die allemaal gespecialiseerd zijn in verschillende reacties. 
Hierdoor kunnen heel veel verschillende reacties plaatsvinden in een cel, die bijvoorbeeld 
nodig zijn voor het verteren van voedsel.
Veel wetenschappers zijn erin geïnteresseerd om enzymen te gebruiken als katalysator 
voor het maken van allerlei nuttige stoen zoals medicijnen. Enzymen hebben namelijk 
een aantal grote voordelen ten opzichte van andere katalysatoren. Enzymen zijn 
bijvoorbeeld volledig hernieuwbaar en biologisch areekbaar (dit in tegenstelling tot 
de driewegkatalysator in auto’s die bestaat uit zware metalen zoals platina, rodium of 
palladium).
Om enzymen te kunnen gebruiken in industriële processen, zoals de synthese van 
medicijnen, is het nodig om op grote schaal enzymen te produceren. Chemisch 
synthetiseren van enzymen is echter nagenoeg onmogelijk (en bovendien extreem duur) 
omdat enzymen zulke complexe moleculen zijn. Daarom wordt er gebruikt gemaakt 
van bacteriën om enzymen te produceren. Om ervoor te zorgen dat bacteriën het juiste 
enzym maken wordt aan het bacteriële DNA een klein stukje extra DNA toegevoegd. 
Dit stukje extra DNA, dat ook wel plasmide wordt genoemd, bevat het bouwplan voor 
het betreende enzym, zodat de bacterie weet in welke volgorde de aminozuren aan 
elkaar moeten worden gekoppeld om het enzym te maken (Figuur 1B). De bacteriën 
kunnen eenvoudig op grote schaal worden gegroeid en geoogst waarna het enzym uit 
de bacteriën kan worden gezuiverd.
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Figuur 1. A) Schematische weergave van een enzym. Een enzym is een keten van aminozuren. 
De verschillende eigenschappen van de aminozuren zorgen ervoor dat het enzym zich vouwt tot 
een complexe structuur. B) Plasmide DNA bevat het bouwplan voor het enzym. Een mutatie in 
het DNA resulteert in een enzym met een kleine gewijzigde aminozuurvolgorde.
Enzymen hebben echter ook een aantal nadelen waarvoor oplossingen moeten worden 
gevonden voordat ze gebruikt kunnen worden als katalysator in een industrieel proces. 
Omdat enzymen vaak zeer gespecialiseerd zijn in het katalyseren van één specieke 
reactie, is het niet altijd eenvoudig om een enzym te vinden dat geschikt is voor de 
reactie waarin bijvoorbeeld een medicijnfabrikant geïnteresseerd is. Het is daarom vaak 
nodig om natuurlijke enzymen te modiceren zodat ze geschikt zijn om te gebruiken 
in een industriële setting. Om enzymen te modiceren wordt het plasmide DNA een 
klein beetje gewijzigd (gemuteerd), zodat de bacterie vervolgens een enzym maakt met 
een klein beetje gewijzigde aminozuurvolgorde. Het is precies bekend hoe een bepaalde 
wijziging van het DNA zich vertaalt naar de aminozuurvolgorde van het enzym. Echter, 
het is veel moeilijker om te voorspellen hoe een gewijzigd enzym zich zal gedragen 
ten opzichte van het oorspronkelijke enzym. Daarom worden er meestal heel veel 
verschillende plasmiden gemaakt met allemaal een heel kleine wijziging in het DNA. 
Deze verschillende plasmiden worden allemaal aan aparte bacterieculturen toegevoegd 
waardoor er allemaal verschillende enzym varianten worden geproduceerd. Vervolgens 
wordt getest welke enzym variant het beste als katalysator werkt voor de reactie waarin 
men is geïnteresseerd. Het plasmide DNA van de beste enzym variant(en) wordt 
vervolgens uit de bacterie geïsoleerd en kan vervolgens opnieuw worden gemuteerd, 
waardoor de cyclus weer opnieuw kan beginnen. Dit proces van muteren van DNA en 
&
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selecteren van enzym varianten wordt vaak een aantal keren herhaald en kan resulteren 
in enzymen met zeer sterk verbeterde eigenschappen. Omdat dit proces veel lijkt op hoe 
in de natuur enzymen evolueren wordt dit proces vaak aangeduid als directed evolution.
Directed evolution kan ook worden toegepast op enzymen die in de natuur totaal 
andere reacties katalyseren. Een goed voorbeeld hiervan is het enzym 4-oxalocrotonate 
tautomerase (4-OT) dat gevonden wordt in de bacterie Pseudomonas putida. 
De natuurlijke reactie die dit enzym katalyseert is de reactie van 2-hydroxy-2,4-
hexadienedioate (1) naar 2-oxo-3-hexenedioate (2) (Figuur 2A). Wetenschappers 
hebben echter ontdekt dat dit enzym ook de reactie van acetaldehyde (3) met diverse 
nitroalkenen (4a-d) kan katalyseren. De producten van deze reactie (5a-d) kunnen via 
twee relatief eenvoudige reacties worden omgezet in een aantal belangrijke medicijnen 
zoals pregabalin (lyrica), phenibut en baclofen. Daarom is in deze thesis gekeken of, met 
behulp van directed evolution, 4-OT varianten konden worden gevonden die zeer goed 
waren in het katalyseren van de reactie van 3 met 4a-d.
4-OT modicatie
Om effectief enzym varianten te vinden met verbeterde eigenschappen is het 
belangrijk om via een slimme strategie het DNA te muteren. Omdat 4-OT een zeer 
klein enzym is van slechts 62 aminozuren, is het zeer geschikt om gebruik te maken 
van mutability landscape enzym modicatie. Hoofdstuk 1 beschrij een overzicht 
van studies die gebruik hebben gemaakt van deze techniek. Bij deze techniek wordt 
voor elke aminozuurpositie het oorspronkelijke aminozuur gemuteerd tot elk van de 
19 andere aminozuren. In het geval van 4-OT komt dit theoretisch dus neer op 1178 
(19*62) verschillende varianten. Het voordeel van deze techniek is dat het veel informatie 
oplevert over aminozuurposities waar mutaties een eect hebben op de eigenschappen 
van het enzym. Hierdoor wordt het eenvoudiger om in een volgende ronde van directed 
evolution eectief posities te kiezen om te muteren.
De stoen 5a-d hebben allen een asymmetrisch koolstofatoom, oewel een koolstofatoom 
dat verbonden is met vier verschillende groepen (Aangeduid met [*] in Figuur 2B). 
Daardoor bestaan er twee verschillende varianten van die stof die precies elkaars 
spiegelbeeld zijn. Deze varianten worden ook wel enantiomeren genoemd. Hoewel de beide 
enantiomeren van een stof dus zeer veel op elkaar lijken, kunnen ze een zeer verschillend 
eect hebben als medicijn. Een dramatisch voorbeeld hiervan is soenon, dat in de jaren 
vijig werd voorgeschreven aan zwangere vrouwen tegen ochtendmisselijkheid. Ook 
de werkzame stof in soenon bevat een asymmetrisch koolstofatoom en later bleek dat 
het ene enantiomeer hielp tegen ochtendmisselijkheid, terwijl het andere enantiomeer 
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ernstige schade veroorzaakte bij het ongeboren kind. Daarom is het belangrijk om bij de 
synthese van stoen met een asymmetrisch koolstofatoom ervoor te zorgen dat alleen het 
juiste enantiomeer wordt gemaakt. 4-OT bleek echter vrijwel uitsluitend het ‘verkeerde’ 
enantiomeer te maken, dat wil zeggen het enantiomeer dat uiteindelijk niet geschikt is 
als medicijn. In het verleden is met behulp van mutability landscape enzym modicatie 
een 4-OT variant gevonden die hoofdzakelijk het juiste enantiomeer maakt. Deze variant 
had een mutatie op positie 45 en positie 50 (4-OT M45Y/F50A) en kon de stoen 5a-d 
maken met een enantiomeer ratio variërend tussen de 62:38 en 96:4. Hoewel dit een grote 
verbetering is ten opzichte van 4-OT, is dit nog niet goed genoeg om te worden toegepast 
in de industrie. Daarom wordt in hoofdstuk 2 een nieuwe ronde van directed evolution 
beschreven gericht op het verbeteren van de enantioselectiviteit. 4-OT M45Y/F50A wordt 
als start-variant gebruikt. Op grond van een kristalstructuur van 4-OT M45Y/F50A, 
waarin je in 3D kunt zien hoe het enzym eruitziet, worden twee posities uitgekozen 
(positie 2 en positie 8) om tegelijk gemuteerd te worden binnen 4-OT M45Y/F50A. 
Na het screenen van een serie van mutanten werden twee 4-OT varianten gevonden 
met sterk verbeterde enantioselectiviteit. Beide varianten hadden een extra mutatie op 
positie 8, waarbij het relatief kleine aminozuur leucine werd vervangen door het grotere 
aminozuur phenylalanine of tyrosine (4-OT L8F/M45Y/F50A en 4-OT L8Y/M45Y/
F50A respectievelijk). 4-OT L8Y/M45Y/F50A bleek ook nog een signicant snellere 
katalysator te zijn en bovendien stabieler in de aanwezigheid van ethanol vergeleken met 
start-variant 4-OT M45Y/F50A. De kristalstructuur van 4-OT L8Y/M45Y/F50A werd 
vervolgens opgehelderd en vergeleken met de kristalstructuur van start-variant 4-OT 
M45Y/F50A. Daaruit bleek dat de verbetering in enantioselectiviteit waarschijnlijk wordt 
veroorzaakt doordat het grote aminozuur tyrosine ervoor zorgt dat startmaterialen 4a-d 
dieper in het enzym worden geduwd. Acetaldehyde (3) kan hierdoor slechts vanaf één 
kant reageren met 4a-d, waardoor er slechts één enantiomeer wordt gemaakt.
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Figuur 2. A) Natuurlijke reactie van 4-OT. B) Onnatuurlijke reacties van 3 met stoen 4a-d. 4-OT 
maakt het ‘verkeerde’ enantiomeer, maar twee 4-OT mutanten maken het andere enantiomeer dat 
in 2 stappen kan worden omgezet in de stoen 7a-d hetgeen de werkzame stoen in een aantal 
belangrijke medicijnen zijn.
De stoen 4a-d zijn slecht oplosbaar in water. Om toch voldoende op te kunnen lossen in 
water moeten er co-solvents aan worden toegevoegd. Dit zijn stoen die goed oplossen in 
water en ervoor zorgen dat slecht oplosbare stoen toch opgelost kunnen worden. Omdat 
enzymen gebouwd zijn om in water reacties te katalyseren, kan de aanwezigheid van 
hoge concentraties co-solvents enzymen sterk destabiliseren. Daarom is er in hoofdstuk 
3 gekeken naar mutaties die de stabiliteit van 4-OT in de aanwezigheid van co-solvents 
verbeteren. Er is speciek gekeken naar de co-solvent ethanol, omdat ethanol een 
goedkope hernieuwbare co-solvent is en daarom erg aantrekkelijk om te gebruiken in de 
industrie. De katalytische activiteit van 4-OT voor de reactie van 3 met 4a werd gemeten 
in de aanwezigheid van 5% en 25% ethanol. Het bleek dat 4-OT ongeveer 50% activiteit 
verloor bij 25% ethanol in vergelijking met 5%. Hetzelfde werd getest voor een collectie 
van 1040 4-OT varianten met elk één mutatie. De resultaten hiervan werden in een 
solvent-stabiliteit mutability landscape gezet. Dit is een soort kaart waaruit gemakkelijk 
kan worden afgelezen welke mutaties voordelig zijn en welke juist nadelig zijn. Het bleek 
dat mutaties op positie 30 en positie 33 veelal een positief eect hadden op de solvent 
stabiliteit van 4-OT. Echter, hoewel deze enkelmutanten van 4-OT stabieler waren in 
de aanwezigheid van ethanol, maken ze hoofdzakelijk het ‘verkeerde’ enantiomeer van 
5a. Daarom werd besloten om positie 33 te muteren in start-variant 4-OT L8F/M45Y/
F50A (zie hoofdstuk 2). Deze mutant maakt hoofdzakelijk het juiste enantiomeer van 
5a, maar hee een zeer lage stabiliteit in de aanwezigheid van ethanol. Het alanine-
aminozuur op positie 33 werd gemuteerd tot alle 19 mogelijke andere aminozuren en 
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elke variant werd getest voor stabiliteit in de aanwezigheid van ethanol. De variant 
met een isoleucine-aminozuur op positie 33 (4-OT L8F/A33I/M45Y/F50A) bleek het 
meest stabiel in de aanwezigheid van ethanol. Deze variant kon gebruikt worden in de 
aanwezigheid van 40% ethanol, terwijl start-variant 4-OT L8F/M45Y/F50A al bij 10% 
ethanol geen enkele activiteit meer had.
Zoals aan het begin al werd gezegd is het heel moeilijk om vooraf te voorspellen of een 
bepaalde enzym-variant betere of juist minder goede eigenschappen hee. Het is daarom 
vaak nodig om heel veel enzym-varianten te testen voordat er een variant wordt gevonden 
met de gewenste eigenschappen. Het is zelfs niet ongebruikelijk dat meer dan de hel van 
de geteste varianten geen enkele activiteit hee omdat die specieke mutatie het enzym 
kapot maakt. Om toch eciënt enzymen te modiceren is het daarom noodzakelijk om 
technieken te ontwikkelen waarmee het mogelijk is om heel veel verschillende varianten 
snel te testen. In hoofdstuk 4 wordt een nieuwe methode beschreven om op een eenvoudige 
wijze actieve varianten te scheiden van inactieve varianten. Het doel was om verbeterde 
4-OT varianten te vinden voor de reactie van 8 met 9a tot 5a (Figuur 3A). Het product van 
deze reactie is dus hetzelfde als bij de reactie beschreven in hoofdstuk 2 en hoofdstuk 3, 
maar er wordt gebruik gemaakt van verschillende startmaterialen. Om te begrijpen hoe 
de nieuwe methode werkt die in dit hoofdstuk wordt beschreven is het noodzakelijk om 
iets preciezer naar het reactiemechanisme van 4-OT te kijken. Het reactiemechanisme 
wil zeggen welke chemische stappen de startmaterialen ondergaan voordat ze reageren 
tot het uiteindelijke product. 4-OT hee als eerste aminozuur een proline, die een heel 
belangrijke rol speelt in het reactiemechanisme. Deze proline kan namelijk reageren met 
9a om een enzym-substraat complex te vormen, een complex van het enzym met een van 
de startmaterialen. Dit is de eerste stap in het reactiemechanisme van 4-OT. Daarom geldt 
in principe dat als een 4-OT variant niet het enzym-substraat complex kan vormen, het 
geen goede katalysator kan zijn voor de reactie. In hoofdstuk 4 wordt een assay beschreven 
die gebruik maakt van stof 9b, een variant van de stof 9a. Deze stof kan ook met 4-OT 
reageren tot een enzym-substraat complex en vormt dan een chemische structuur die veel 
lijkt op de structuur van bepaalde kleurstoen en krijgt daarom een rode kleur (Figuur 
3B). Wanneer een 4-OT variant dus geen rode kleur krijgt in de aanwezigheid van 9b, 
dan betekent dit dat deze variant geen enzym-substraat complex kan vormen en daarom 
ook geen goede katalysator is. Met deze eenvoudige kleurreactie kan een collectie van 
4-OT varianten eenvoudig worden voorgesorteerd en kunnen de inactieve varianten uit 
de collectie worden gelterd. Met deze techniek, die Activated Imminium Colony Staining 
(AICS) wordt genoemd, kon tot wel 95% aan inactieve varianten uit een 4-OT mutanten 
collectie worden gelterd. Na twee ronden van directed evolution, werden twee 4-OT 
varianten gevonden met een tot wel 39 keer hogere activiteit.
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Figuur 3. A) Onnatuurlijke reactie van 4-OT waarbij 8 en 9a reageren tot 5a. De eerste stap in het 
reactiemechanisme is de reactie van de proline-1 van 4-OT met 9a. Dit enzym-substraat complex 
reageert vervolgens met stof 8 tot stof 5a en het vrije enzym. B) Reactie van proline-1 van 4-OT 
met 9b. Het gevormde enzym-substraat complex lijkt op de structuur van bepaalde kleurstoen en 
hee daarom een rode kleur. C) De chemische structuur van de kleurstof Brookers‘ merocyanine.
4-OT in cascadereacties
We hebben hiervoor gezien dat 4-OT gebruikt kan worden als katalysator voor de 
synthese van 5a-d via twee verschillende chemische routes. Echter, om de stoen 5a-d 
om te zetten in medicijnen zijn nog twee chemische stappen nodig: de reactie van 5a-d 
tot 6a-d gevolgd door de reactie tot 7a-d, waar weer andere katalysatoren voor nodig 
zijn. Bij chemische syntheses wordt vaak na iedere reactiestap het product gezuiverd 
omdat de volgende reactiestap onder andere condities moet worden uitgevoerd. Een 
groot voordeel van enzymen is dat ze, hoewel ze heel verschillende reacties kunnen 
katalyseren, redelijk vergelijkbare reactiecondities nodig hebben. In cellen moeten alle 
enzymen immers ook samenwerken onder de reactiecondities van de cel. Hierdoor is het 
soms mogelijk om meerdere reacties achter elkaar uit te voeren zonder dat tussentijds 
producten moeten worden gezuiverd. Dit worden cascadereacties genoemd. In hoofdstuk 
2 wordt een 3-staps cascadereactie beschreven: de reactie van 3 met 4a-d gekatalyseerd 
door 4-OT, gevolgd door de reactie van 5a-d tot 6a-d gekatalyseerd door een aldehyde 
dehydrogenase enzym en uiteindelijk de reactie van 6a-d tot 7a-d gekatalyseerd door 
het metaal nickel chloride. De uiteindelijke medicijnen (stoen 7a-d) kunnen via deze 
3-staps cascadereactie worden verkregen in hoge opbrengst (tot wel 70%) en met zeer 
hoge enantio-zuiverheid (met een enantiomeer ratio van 99:1).
Stof 3 is een belangrijke bouwsteen die gebruikt kan worden door 4-OT in verschillende 
reacties. Deze stof is echter ook toxisch en vrij reactief, waardoor het lastig is om reacties 
met deze stof op te schalen. In hoofdstuk 5 worden drie enzymatische routes onderzocht 
om 3 te produceren (Figuur 4). Twee van deze routes werkten zeer goed en konden 
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worden gebruikt in cascadereacties met 4-OT. Hierdoor is het niet meer nodig om 3 
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Figuur 4. Drie enzymatische routes om acetaldehyde (3) te synthetiseren. Het gesynthetiseerde 3 
kan vervolgens door 4-OT worden gekoppeld aan 4a of 14c. Aortingen: CaaD: chloroacrylic acid 
dehalogenase, MSAD: malonate semialdehyde decarboxylase, ScADH: alcohol dehydrogenase, 
ZmPDC: pyruvate decarboxylase.
Reactiemodicatie
Een andere reactie die door 4-OT kan worden gekatalyseerd is de reactie van 3 met 14a 
tot 9a (Figuur 5). Deze reactie bestaat uit twee stappen. De eerste stap is de koppeling van 
stof 3 met stof 14a. Daarna volgt een dehydratie stap, waarbij water wordt geëlimineerd. 
Beide stappen worden door 4-OT gekatalyseerd. Hoewel stof 9a, en derivaten daarvan, 
van zichzelf ook interessant zijn om te maken, waren we geïnteresseerd om alleen de 
eerste koppelingsreactie te laten plaatsvinden en te voorkomen dat water geëlimineerd 
zou worden. In plaats van enzymmodicatie, zoals in hoofdstuk 2, 3 en 4, gebruikten 
we in hoofdstuk 6 een andere strategie: reactiemodicatie. Bij reactiemodicatie is het 
doel om door kleine aanpassingen te maken aan één van de startmaterialen, de uitkomst 
van de reactie te veranderen. In dit geval werd de door 4-OT gekatalyseerde reactie van 
3 met de stoen 14c tot 14u getest om te zien of er reacties konden worden gevonden 
waarbij 3 wel gekoppeld zou worden, maar waarbij water niet geëlimineerd zou worden. 
&
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Bij een deel van deze derivaten vond zowel koppeling als dehydratie plaats (de derivaten 
14c-k en 14q-u) maar de derivaten 14l-p koppelden wel aan 3, maar de resulterende 
producten werden niet gedehydrateerd (Figuur 5). Omdat deze ‘koppelingsproducten’ 
niet erg stabiel zijn, werd de stof NaBH4 aan de reactie toegevoegd die ervoor zorgt dat 
de koppelingsproducten reageren tot de stoen 15l-p. De stoen 15l-p (zogenaamde 1,3-
diolen) hebben een asymmetrisch koolstofatoom. De stoen 15l-p die op deze manier 
gemaakt waren, hadden een zeer goede enantiomere verrijking (met enantiomeer ratio’s 
tot wel 99:1). Vervolgens hebben we gekeken of we nog meer 1,3-diolen konden maken, 
door een panel van 4-OT homologen te testen als katalysator. Een 4-OT homoloog is een 
variant van 4-OT die in andere organismen wordt gevonden. Naast Pseudomonas putida 
zijn er namelijk veel meer organismen die een 4-OT enzym hebben, maar meestal met 
een enigszins gewijzigde aminozuurvolgorde. Uit een panel van vijig 4-OT homologen 
vonden we dat de 4-OT homoloog TAUT015 goed gebruikt kon worden als katalysator 
voor de synthese van de stoen 15c-e en 15g-h. Ook in dit geval konden de stoen 15c-e 
en 15g-h met een zeer goede enantiomere verrijking worden verkregen (met enantiomeer 
ratio’s tot wel meer dan 99:1).






R = P h ( 1 4 a ) , 2- C l - P h ( 1 4 c ) , 3 - C l - P h ( 1 4 d ) , 2, 4 - d i - C l - P h ( 1 4 e ) , 3 , 4 - d i - C l - P h
( 1 4 f ) , 2- NO2- P h ( 1 4 g ) , 3 - NO2- P h ( 1 4 h ) , 2- F - P h ( 1 4 i ) , 2- B r - P h ( 1 4 j ) ,
t e t r a f l u o r o - P h ( 1 4 k ) , 4 - C N- P h ( 1 4 l ) , 4 - C F 3 - P h ( 1 4 m ) , p e n t a f l u o r o - P h
( 1 4 n ) , 3 - C N- 4 - F - P h ( 1 4 o ) , f u r a n y l ( 1 4 p ) , 4 - C l - P h ( 1 4 q ) , 4 - F - P h ( 1 4 r ) ,
4 - NO2- P h ( 1 4 s ) , P y r i d y l ( 1 4 t ) , 4 - B r - P h ( 1 4 u )
R R *
OOHO O
31 4 a , 1 4 c - u
4 - OT M 4 5 T / F 5 0 A
4 - OT M 4 5 T / F 5 0 A
R R *
OOHO O
31 4 c - e , 1 4 g- h
T A U T 0 1 5 Na B H4
R *
OHOH
1 5l - p





Figuur 5. A) 4-OT gekatalyseerde reactie van 3 met 14a, 14c-u. Een deel reageert tot het gedehy-
drateerde product (9a, 9c-k, 9q-u) en een deel reageert tot 1,3-diolen na toevoeging van NaBH4 
(15l-p). B) De reactie van 3 met 14c-e, 14g-h gekatalyseerd door de 4-OT homoloog TAUT015. 
In dit geval reageert alles tot 1,3-diolen na toevoeging van NaBH4.
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Samengevat laat deze thesis het potentieel van 4-OT zien als katalysator voor 
verschillende koolstof-koolstoindingvormende reacties. Nieuwe 4-OT varianten zijn 
ontdekt met een zeer goede enantioselectiviteit en solvent-stabiliteit. Gecombineerd met 
andere (bio)katalysatoren konden deze varianten worden toegepast in cascadereacties 
waardoor een serie van farmaceutisch relevante GABA-derivaten zonder tussentijdse 
zuivering konden worden gesynthetiseerd vanuit zeer simpele bouwstoen. Verder laten 
we zien dat 4-OT kan worden toegepast in een nieuwe syntheseroute voor 1,3-diolen, 
belangrijke bouwstenen voor de productie van medicijnen.
&
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